2019 Annual Meeting | P4 - Poster Session 4

Date Wednesday 05/08/19

Time 11:30 AM - 06:30 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Practice, Policy, and Ethics, Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuroepidemiology, Neuromuscular and Clinical Neurophysiology (EMG), Research Methodology, ��ɫ��, and History

CME Available No CME available

Program Materials Program Evaluations

Event Timeline
05:30 PM - 06:30 PM EDT	Abstract	9-002 - Baseline Characteristics from a Phase III Trial of Crenezumab in Early (Prodromal-to-Mild) Alzheimer’s Disease (CREAD) Kaycee Sink, MD
05:30 PM - 06:30 PM EDT	Abstract	9-004 - GeneMatch: A Novel Recruitment Registry using APOE Genotyping to Accelerate Referrals to Alzheimer’s Prevention Studies Jessica Langbaum, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-005 - The Alzheimer Prevention Initiative Generation Program: Evaluation of CNP520 in Preclinical Alzheimer's Disease
05:30 PM - 06:30 PM EDT	Abstract	9-006 - A Multidomain Precision Medicine Intervention in Patients at Risk for Dementia due to Alzheimer’s disease Richard S. Isaacson, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	9-007 - Efficacy of Memantine Added to Cholinesterase Inhibitors on SIB Higher-Order Cognitive Domains: Pooled Post Hoc Analysis of 2 Randomized Controlled Trials in Patients With Moderate to Severe AD Frederick A. Schmitt, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-008 - SIB Maintenance of Response With Memantine Added to Cholinesterase Inhibitors: Pooled Post Hoc Analysis of 2 Randomized Controlled Trials in Patients With Moderate to Severe AD Frederick A. Schmitt, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-009 - Sildenafil Alters Hippocampal Fractional Amplitude of Low Frequency Fluctuations (fALFF) in Patients with Alzheimer’s Disease Niyatee Samudra, MD
05:30 PM - 06:30 PM EDT	Abstract	9-010 - Metformin and Newer Oral Hypoglycemic Agents are Associated with Better Cognitive Test Performance Over Ten Years in Older Diabetic Men Siena Duarte, MD, MAS
05:30 PM - 06:30 PM EDT	Abstract	9-011 - Long-Term Efficacy for Parkinsonism and Safety of Zonisamide in Patients with Dementia with Lewy Bodies: A Phase III Trial Shunji Toya
05:30 PM - 06:30 PM EDT	Abstract	9-012 - Long-term Efficacy of Zonisamide on Parkinsonism in Dementia with Lewy Bodies: A Post-hoc Analysis of Phase 3 Trial
05:30 PM - 06:30 PM EDT	Abstract	9-013 - Transcranial Direct Current Stimulation Improves Verbal Fluency in Patients with Primary Progressive Aphasia Mahdieh Hosseini, MD
05:30 PM - 06:30 PM EDT	Abstract	9-014 - Safety and Efficacy of Medical Cannabis in Elderly Patients: A Retrospective Review in a Neurological Outpatient Setting. Vincent H. Bargnes III
05:30 PM - 06:30 PM EDT	Abstract	9-015 - Intranasal Glulisine in Down Syndrome: A Pilot Safety and Tolerability Trial Michael H. Rosenbloom, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	9-016 - Structured delirium care pathway is associated with reductions in length of stay, cost and readmissions in hospitalized adults Sara LaHue, MD
05:30 PM - 06:30 PM EDT	Abstract	9-017 - Snow laughing matter: Delirium severity increases in winter months compared with summer months Vanja C. Douglas, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	9-018 - Identifying Common Themes in ICU Deaths of Patients with a Diagnosis of Alzheimer Disease Ian M. Grant, MD
05:30 PM - 06:30 PM EDT	Abstract	9-019 - Caregiver Depression and Emergency Department Utilization in Dementia Elan Guterman, MD
05:30 PM - 06:30 PM EDT	Abstract	9-020 - The Lived Experience of Lay Caregivers Caring for Persons with Dementia Ann M. Mayo, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-021 - Real World Treatment of Parkinson’s Disease Dementia (PDD) in the United States (U.S.) Krista Schroeder
05:30 PM - 06:30 PM EDT	Abstract	9-022 - MCI and OSA Sanskruti Patel, MD
05:30 PM - 06:30 PM EDT	Abstract	9-023 - Vascular dementia in elderly .Population-based study in Matanzas. Rodny Munoz-Perez II, MD
05:30 PM - 06:30 PM EDT	Abstract	9-024 - Characteristics of Young-onset and Late-onset Dementia Patients at a Rural and Remote Memory Clinic Jennifer Wong
05:30 PM - 06:30 PM EDT	Abstract	9-025 - Subjective Cognitive Impairment: A Clinical and neuropsychological Entity, sustained by a specific Topography of Lesions. The Cingulum Cohort of Marseille, France. Nathalie Sambuchi
05:30 PM - 06:30 PM EDT	Abstract	9-026 - The Free and Cued Selective Reminding Test Predicts Alzheimer’s Disease Neuropathology Ellen H. Grober, PhD
05:30 PM - 06:30 PM EDT	Abstract	9-027 - Color Vision Impairment in Prodromal and Dementia Stages of Lewy Body Disease versus Alzheimer’s Disease Robert Unger
05:30 PM - 06:30 PM EDT	Abstract	9-028 - The Role of Population Receptive Fields' Size in Understanding Complex Visual Dysfunctions: Posterior Cortical Atrophy Model Pieter B. De Best
05:30 PM - 06:30 PM EDT	Abstract	9-029 - Quantification of Real-World Life Space from Instrumented Vehicles in Drivers with Cognitive Aging Jennifer Merickel
05:30 PM - 06:30 PM EDT	Abstract	15-001 - Neurologic Adverse Events associated with Immune Checkpoint Inhibitor Therapy Sophie Lan-Linh Duong, MD
05:30 PM - 06:30 PM EDT	Abstract	15-002 - Pembrolizumab-Associated Paraneoplastic Disorders: A Case Series Alexander J. Gill, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-003 - Immune checkpoint inhibitor induced anti-GAD limbic encephalitis Matthew Chung, MD
05:30 PM - 06:30 PM EDT	Abstract	15-004 - Characterization of Encephalopathy Associated with Immune Checkpoint Inhibitor Therapy Danmeng Wei, MBBS
05:30 PM - 06:30 PM EDT	Abstract	15-005 - Nivolumab-induced myasthenia gravis with myositis in patients with genitourinary cancer Ruiqing Sun, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-006 - Hunting the real culprit: a complex case of nivolumab-related myelitis. Valentina Poretto, MD
05:30 PM - 06:30 PM EDT	Abstract	15-007 - Pembrolizumab-Induced Myasthenia Gravis Mohanad A. AlGaeed, MD
05:30 PM - 06:30 PM EDT	Abstract	15-008 - NFL pattern in progressive Multiple Sclerosis cohort under MD1003 treatment Beatrice Pignolet
05:30 PM - 06:30 PM EDT	Abstract	15-009 - Longitudinal stability of anti–JC virus (JCV) antibody index over 2 years in multiple sclerosis (MS) patients treated with natalizumab in the ASCEND study Louise Mason
05:30 PM - 06:30 PM EDT	Abstract	15-010 - Two Cases of Meningitis Associated with Ocrelizumab Therapy Michael E. Theriault, MD
05:30 PM - 06:30 PM EDT	Abstract	15-011 - Fingolimod related cryptococcal meningitis and immune reconstitution inflammatory syndrome in two patients with multiple sclerosis Fernando X. Cuascut Lassus, MD
05:30 PM - 06:30 PM EDT	Abstract	15-012 - Leprosy in two patients with Relapsing Remitting Multiple Sclerosis (RRMS) treated with Fingolimod Alfred Balasa, MD
05:30 PM - 06:30 PM EDT	Abstract	15-013 - Dimethyl Fumarate Dose Reduction in Lymphopenic Relapsing Remitting Multiple Sclerosis Patients: Clinical and MRI Outcomes Ka-Ho Wong
05:30 PM - 06:30 PM EDT	Abstract	15-014 - Infectious Risk Stratification in Multiple Sclerosis Patients Receiving Immunotherapy – An Update Jonas Graf
05:30 PM - 06:30 PM EDT	Abstract	15-015 - Evaluating the Tolerability and Safety of Switching from Rituximab to Ocrelizumab: Infusion Related Reactions in Relapsing Forms of Multiple Sclerosis Enrique Alvarez, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-016 - A Rare Complication of Fingolimod: Case Report of Posterior Reversible Encephalopathy Syndrome Carrie Downey, DO
05:30 PM - 06:30 PM EDT	Abstract	15-017 - Among Real-world Multiple Sclerosis Patients That Experience Delayed-release Dimethyl Fumarate-associated Lymphopenia, Meaningful Lymphocyte Reconstitution Occurs Approximately 3 Months After Discontinuation of Delayed-release Dimethyl Fumarate John W. Rose, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	15-018 - No significant risk of malignant melanoma growth under cladribine treatment: in vitro studies
05:30 PM - 06:30 PM EDT	Abstract	15-019 - Serious Adverse Events in Rituximab-Treated Patients with Multiple Sclerosis and Related Disorders Asya I. Wallach, MD
05:30 PM - 06:30 PM EDT	Abstract	15-020 - Central Nervous System T Cell Lymphoproliferative Disease Following Treatment with Alemtuzumab Lindsay A. Horton, MD
05:30 PM - 06:30 PM EDT	Abstract	15-021 - Risk factors for Development of Lymphopenia in Dimethyl Fumarate-treated Patients with Multiple Sclerosis
05:30 PM - 06:30 PM EDT	Abstract	15-022 - Severe skin reactions associated with Cladribine treatment in patients with multiple sclerosis Maria Mateo-Casas
05:30 PM - 06:30 PM EDT	Abstract	15-023 - Delayed-release Dimethyl Fumarate-associated Lymphopenia: On-treatment and Post-treatment Implications Andrew Chan
05:30 PM - 06:30 PM EDT	Abstract	15-024 - Immunization and Multiple Sclerosis: Recommendations from the French Multiple Sclerosis Society Christine Lebrun Frenay, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	15-025 - Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis Stephen L. Hauser, MD
05:30 PM - 06:30 PM EDT	Abstract	15-026 - Influence of Clinical and Cerebrospinal Fluid Parameters on the Effect of Therapeutic Plasma Exchange in Patients with Multiple Sclerosis
05:30 PM - 06:30 PM EDT	Abstract	15-027 - Cytomegalovirus (CMV) Primoinfection in a patient with Multiple Sclerosis treated with Alemtuzumab Clara Aguirre Hernandez
05:30 PM - 06:30 PM EDT	Abstract	15-028 - Changes in the immune cell profile in fingolimod-treated patients with relapsing multiple sclerosis: primary analysis of the FLUENT study Yang Mao-Draayer, MD
05:30 PM - 06:30 PM EDT	Abstract	15-029 - Multiple sclerosis treatment strategy after natalizumab-associated progressive multifocal leukoencephalopathy
05:30 PM - 06:30 PM EDT	Abstract	15-030 - Increased Multiple Sclerosis disease activity in patients transitioned from fingolimod to dimethyl fumarate Sylvia R. Delgado, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	15-031 - The Marburg Multiple Sclerosis - Cohort — Loss of MEDA under two standard treatment sequences Jan P. Jurs
05:30 PM - 06:30 PM EDT	Abstract	15-032 - Immunosuppresion following alemtuzumab in relapsing-remitting multiple sclerosis patients previously treated with fingolimod Jose Maria Cabrera Maqueda
05:30 PM - 06:30 PM EDT	Abstract	15-033 - PML Risk Perception in Patients Initiating Natalizumab for Multiple Sclerosis Regina Berkovich, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-034 - Temporal profile of lymphocytes following treatment with cladribine tablets in patients switching from lymphocyte depleting or sequestering disease modifying drugs (DMDs) Suzanne J. Hodgkinson, MD, MBBS, PhD, FRACP
05:30 PM - 06:30 PM EDT	Abstract	15-035 - Predicting Natalizumab Discontinuation due to Breakthrough Disease in Multiple Sclerosis Patients Devon Conway, MD
05:30 PM - 06:30 PM EDT	Abstract	15-036 - Skin Warts during Fingolimod Treatment in Patients with Multiple Sclerosis Bassem I. Yamout, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	15-037 - Limited Effects of Interferon ß-1a in an IgG-driven Model of Multiple Sclerosis Pathology Jeffrey L. Bennett, MD, PhD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	15-038 - Autoimmune Hemolytic Anemia after Treatment with Fingolimod: A Case Report Arif Husain, DO
05:30 PM - 06:30 PM EDT	Abstract	15-039 - Longitudinal analysis of Peripheral Blood Mononuclear Cells in Lymphopenic and Non-lymphopenic Relapsing-Remitting Multiple Sclerosis (RRMS) patients treated with Dimethyl Fumarate
05:30 PM - 06:30 PM EDT	Abstract	15-040 - Stability of JC Virus Index over Time – a Five Year Retrospective Study. Maria Gaughan, MBBS
05:30 PM - 06:30 PM EDT	Abstract	15-041 - Characterization of the Peripheral Blood Transcriptome in Alemtuzumab-Treated Relapsing-Remitting Multiple Sclerosis Patients From the CARE-MS I and II Studies
05:30 PM - 06:30 PM EDT	Abstract	15-042 - The Effect of Ocrelizumab Therapy on Immunoglobulin Levels in Patients with Multiple Sclerosis
05:30 PM - 06:30 PM EDT	Abstract	15-043 - VERISMO: A Post-Marketing Safety Study to Determine the Incidence of All Malignancies and Breast Cancer in Patients With Multiple Sclerosis Treated With Ocrelizumab David Wormser
05:30 PM - 06:30 PM EDT	Abstract	15-044 - ADA Genetic Variants Influence Central Inflammation and Clinical Characteristics in MS: Implications for Cladribine Treatment
05:30 PM - 06:30 PM EDT	Abstract	15-045 - Dissection of the Distinct Susceptibility of Hematopoietic Precursors and Immune Cells to Cladribine
05:30 PM - 06:30 PM EDT	Abstract	15-046 - Updated safety analysis of cladribine tablets in the treatment of patients with multiple sclerosis Stuart D. Cook, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	15-047 - Efficacy and Safety of Teriflunomide in Patients of Differing Ages: Analysis of Pooled Clinical Trials Mariana Espinosa-Polanco
05:30 PM - 06:30 PM EDT	Abstract	15-048 - Effects of Fingolimod on Cytokine and Chemokine Levels in Patients with Multiple Sclerosis Murat Kurtuncu, MD
05:30 PM - 06:30 PM EDT	Abstract	15-049 - Effects of Ocrelizumab on Immune Parameters in a Cohort of MS Patients Ye Hu, MD
05:30 PM - 06:30 PM EDT	Abstract	15-050 - Intrathecal MSC-NP Treatment in Patients with Progressive Multiple Sclerosis is Associated with Modulation of Cerebrospinal Fluid Biomarkers Shayna Zanker
05:30 PM - 06:30 PM EDT	Abstract	15-051 - Immunological phenotyping identifies a subgroup of MS patients experiencing a pro-inflammatory immune cell activation upon therapeutic B cell removal
05:30 PM - 06:30 PM EDT	Abstract	15-052 - Turning mechanistic immunomodulatory insights into personalized treatment strategies for multiple sclerosis
05:30 PM - 06:30 PM EDT	Abstract	15-053 - Delayed-release Dimethyl Fumarate Treatment Shifts the Immune Repertoire in Patients With Relapsing-Remitting Multiple Sclerosis: Results of PROCLAIM, an Open-label Phase 3 Study Derrick Robertson, MD
05:30 PM - 06:30 PM EDT	Abstract	15-054 - Clinical and Radiological Correlates of Multiple Sclerosis in patients of Middle Eastern and North African ancestry residing in Ontario, Canada. Isobel A. Hawes
05:30 PM - 06:30 PM EDT	Abstract	15-055 - The Frequency of Longitudinally Extensive Transverse Myelitis in Multiple Sclerosis in the Era of Glial Biomarkers; A Population-Based Study Solmaz Asnafi, MD
05:30 PM - 06:30 PM EDT	Abstract	15-056 - Integrative analysis of risk burden, microbiome and metabolome in people at risk for multiple sclerosis Zongqi Xia, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-057 - Variation in Employment Status among People with MS in the United States, United Kingdom and Germany
05:30 PM - 06:30 PM EDT	Abstract	15-058 - Increased Risk of Comorbidities in Patients Before and After Multiple Sclerosis Diagnosis and Initiation of Treatment: A Study Using the US Department of Defense Database
05:30 PM - 06:30 PM EDT	Abstract	15-059 - Prevalence of Vascular Co-morbidities in patients with Multiple Sclerosis in a Racially Diverse and Low Socioeconomic Status Population Van Hellerslia, PharmD
05:30 PM - 06:30 PM EDT	Abstract	15-060 - Untreated Patients with Multiple Sclerosis: Prevalence and Characteristics in Denmark and in the United States
05:30 PM - 06:30 PM EDT	Abstract	15-061 - Diet during adolescence and association with Multiple Sclerosis in Colombian patients Jaime Toro, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	15-062 - Multiple Sclerosis Prevalence Rates Within a Healthcare Delivery System in Northern California: A Retrospective, Electronic Health Records-Based Study From 2010 to 2016 Robert Romanelli
05:30 PM - 06:30 PM EDT	Abstract	15-063 - Dietary Intake and the Effect on Disease Progression in People with Multiple Sclerosis Elisa Meier-Gerdingh, MD
05:30 PM - 06:30 PM EDT	Abstract	15-064 - Multiple Sclerosis (MS) and Neuromyelitis optica (NMO): Admission trends, In-hospital Events, Outcomes, Treatment and Regional Differences In Distribution: A study of the National Inpatient Sample 2006-2014 Mohammad Rauf A. Chaudhry, MD
05:30 PM - 06:30 PM EDT	Abstract	15-065 - The Economic Impact of Multiple Sclerosis: A Preliminary Look at the North American Registry for Care and Research in Multiple Sclerosis (NARCRMS) (On behalf of the NARCRMS Health Economics Outcomes Research [HEOR] Advisory Group) Terrie Livingston, PharmD
05:30 PM - 06:30 PM EDT	Abstract	15-066 - A Modified Mediterranean Dietary Intervention for Multiple Sclerosis: Results of a Pilot Study Ilana B. Katz Sand, MD
05:30 PM - 06:30 PM EDT	Abstract	15-067 - The North American Registry for Care and Research in Multiple Sclerosis (NARCRMS) (On behalf of the NARCRMS Site PIs) Kottil W. Rammohan, MD
05:30 PM - 06:30 PM EDT	Abstract	15-068 - Food Allergies Are Associated With Increased Disease Activity In Multiple Sclerosis Rami Fakih, MD
05:30 PM - 06:30 PM EDT	Abstract	15-069 - The Impact of Social Capital on Patients with Multiple Sclerosis Saul Reyes, MD
05:30 PM - 06:30 PM EDT	Abstract	15-070 - The Natural History of Primary Progressive Multiple Sclerosis in Buenos Aires, Argentina Catalina Bensi
05:30 PM - 06:30 PM EDT	Abstract	15-071 - National estimate of incidence and predictors of 30-day readmission associated with multiple sclerosis using nationwide readmission database
05:30 PM - 06:30 PM EDT	Abstract	15-072 - Lack of Low-Frequency Complete-Penetrance Coding Variants Responsible from Familial Multiple Sclerosis Aksel Siva, MD
05:30 PM - 06:30 PM EDT	Abstract	15-073 - Oxysterols and Apolipoproteins in Multiple Sclerosis: A 5-year Follow-up Study Murali Ramanathan, PhD
05:30 PM - 06:30 PM EDT	Abstract	15-074 - Generalizability of the Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS-PATHS) Data: Experience from a Single Site Gabrielle Macaron, MD
05:30 PM - 06:30 PM EDT	Abstract	15-075 - Late Onset Multiple Sclerosis: Clinical and Radiographic Characteristics Smathorn Thakolwiboon, MD
05:30 PM - 06:30 PM EDT	Abstract	15-076 - Sociodemographic Factors Associated with Clinical Outcomes in CNS Inflammatory and Infectious Diseases: A Retrospective Cohort Study Dan Tong Jia, MD
05:30 PM - 06:30 PM EDT	Abstract	15-077 - Driving Continuous Improvement of MS Care Quality –Year One Experience and Findings from the Multiple Sclerosis Continuous Quality Improvement (MS-CQI) Research Collaborative Brant Oliver
05:30 PM - 06:30 PM EDT	Abstract	15-078 - Cognitive and clinical predictors of employment status among patients with Multiple Sclerosis in Argentina Sandra Vanotti, MD
05:30 PM - 06:30 PM EDT	Abstract	15-079 - Worsening of MS Associated With Relapse Contributes to Disability Over the First 15 years Daniel Diehl, MD
05:30 PM - 06:30 PM EDT	Abstract	15-080 - Personality traits and perception of health-related quality of life in people with multiple sclerosis: An analysis of the NEO-FFI-3 and MSIS-29 questionnaires Virginia Meca Lallana
05:30 PM - 06:30 PM EDT	Abstract	15-081 - Characteristics of Multiple Sclerosis Patients Treated With Disease-Modifying Therapies in Puerto Rico
05:30 PM - 06:30 PM EDT	Abstract	15-082 - Disability Level and Comorbidity Burden among Multiple Sclerosis (MS) Patients in the US
05:30 PM - 06:30 PM EDT	Abstract	15-083 - MS race: How does speed affect our patients Ricardo Alonso
05:30 PM - 06:30 PM EDT	Abstract	15-084 - Modifiable Risk Factors and Risk of Disability Progression after a First Demyelinating Event: a Long Term Follow-Up Study Gloria Dalla Costa
05:30 PM - 06:30 PM EDT	Abstract	15-085 - Benign Multiple Sclerosis - Recognition as a Defined Clinical Subtype Sophia Yang, MD
05:30 PM - 06:30 PM EDT	Abstract	15-086 - Multiple sclerosis mortality in patients from an Argentine cohort Franco E. Appiani, MD
05:30 PM - 06:30 PM EDT	Abstract	15-087 - Updates to the National Institute of Neurological Disorders and Stroke (NINDS) Multiple Sclerosis (MS) Common Data Element (CDE) Recommendations: 2018 MS Oversight Committee (OC) Review Katelyn E. Gay
05:30 PM - 06:30 PM EDT	Abstract	15-088 - Multiple Sclerosis and Headache: A Further Examination of these Comorbid Conditions in Patients Receiving Care in a Multiple Sclerosis Center: A Cross-Sectional Study Kathryn B. Schaubhut
05:30 PM - 06:30 PM EDT	Abstract	15-089 - Economic Burden of Multiple Sclerosis in Egypt – A Societal Perspective Magd F. Zakaria, MD
05:30 PM - 06:30 PM EDT	Abstract	15-090 - No Evidence of Disease Activity in Pediatric-onset Multiple Sclerosis Patients Receiving Rituximab Nikita Shukla, MD
05:30 PM - 06:30 PM EDT	Abstract	15-091 - A Survey Study of Pregnancy-Related Issues in Multiple Sclerosis Patients: the Patient’s Voice. Casey Engel
05:30 PM - 06:30 PM EDT	Abstract	15-092 - Neurofilament Light Chain Levels In Pregnant Multiple Sclerosis Patients Juan Pablo Cuello
05:30 PM - 06:30 PM EDT	Abstract	15-093 - The use natalizumab in multiple sclerosis patients during pregnancy is safe and prevents disease reactivation Raed Alroughani, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	15-094 - Anti CD20 Therapies and Pregnancy in Neuroimmunological Disorders – A Case Series from Germany Tania Kuempfel, MD
05:30 PM - 06:30 PM EDT	Abstract	15-095 - Pregnancy Outcomes From an International Registry of Patients Treated With Delayed-release Dimethyl Fumarate Nicholas J. Everage
05:30 PM - 06:30 PM EDT	Abstract	15-096 - Pregnancy outcomes in patients with multiple sclerosis and exposure to branded glatiramer acetate
05:30 PM - 06:30 PM EDT	Abstract	15-097 - Minimal concentrations of rituximab in the breastmilk of women treated for multiple sclerosis Sara LaHue, MD
05:30 PM - 06:30 PM EDT	Abstract	15-098 - Obstructive Sleep Apnea in Pediatric Neuroinflammatory Conditions Michelle J. Jaeggi, MD
05:30 PM - 06:30 PM EDT	Abstract	15-099 - Comparison Of Continuous vs. Cyclic Oral Contraceptives in Women with Multiple Sclerosis Chelsea S. Chen
05:30 PM - 06:30 PM EDT	Abstract	15-100 - Pregnancy Outcome in Multiple SclerosisPatients Exposed to Disease ModifyingTherapies. Samar F. Ahmed, MD
05:30 PM - 06:30 PM EDT	Abstract	15-101 - Pregnancy Outcomes from the Global Pharmacovigilance Database on Interferon Beta-1b Exposure Kerstin Hellwig
05:30 PM - 06:30 PM EDT	Abstract	15-102 - Effects of Pregnancy on Specific Domains of Multiple Sclerosis Symptoms: A Quality Improvement Project at UPMC Shreya Nayak, MD
05:30 PM - 06:30 PM EDT	Abstract	15-103 - Rituximab for Treatment of Aggressive Multiple Sclerosis During Pregnancy: A Case Series Jessica Rice, MD
05:30 PM - 06:30 PM EDT	Abstract	15-104 - Diagnostic value of oligoclonal bands in children: A nationwide population-based cohort study Magnus Spangsberg Boesen, MD
05:30 PM - 06:30 PM EDT	Abstract	15-105 - Plasma Exchange and Natalizumab Rescue Therapy for Severe Intrapartum Multiple Sclerosis Relapses Eoghan P. Deasy, MBBS
05:30 PM - 06:30 PM EDT	Abstract	15-106 - Grip Fatigability but not Strength Discriminates those with Pediatric Onset Multiple Sclerosis from Controls Giuseppina Pilloni, PhD
05:30 PM - 06:30 PM EDT	Abstract	3-001 - Mid-Atlantic Region State Ratios of Emergency Hyperbaric Chambers (EHC) to Comprehensive Stroke Centers (CSC) for Symptomatic Cerebral Air Embolus (SCAE) Reid D. Taylor, MD
05:30 PM - 06:30 PM EDT	Abstract	3-002 - Unusual Cause of Acute Ischemic Stroke: A Case of Cerebral Air Embolism Post Transthoracic Lung Biopsy Golshan Fahimi, MD
05:30 PM - 06:30 PM EDT	Abstract	3-003 - A Rare Case of Air Embolus During Administration of tPA for Acute Ischemic Stroke Kristopher Southard, MD
05:30 PM - 06:30 PM EDT	Abstract	3-004 - A case of accidental ingestion of Hydrogen Peroxide causing massive cerebral gas embolic strokes Panna L. Bhattacharyya, MD, MBBS
05:30 PM - 06:30 PM EDT	Abstract	3-005 - Cerebral Fat Embolus (CFE): A Rare Cause of Multifocal Infarctions with Potential for Full Recovery Reid D. Taylor, MD
05:30 PM - 06:30 PM EDT	Abstract	3-006 - Tip-of-the-Basilar Stroke secondary to Fat Embolization after Hip Arthroplasty Mangala Gopal, MD
05:30 PM - 06:30 PM EDT	Abstract	3-007 - Erythrocytapheresis: An emerging treatment option for cerebral fat embolism from hemoglobinopathy related bone marrow necrosis. Areeba Siddiqui, MD
05:30 PM - 06:30 PM EDT	Abstract	3-008 - Delayed Diagnosis of Fibrocartilaginous Embolism: Assessing the Vertebral Body on MRI Estevana Isaac, MD
05:30 PM - 06:30 PM EDT	Abstract	3-009 - CNS Manifestations of Hemophagocytic Lymphohistiocytosis (HLH) Hunter Edwards, DO
05:30 PM - 06:30 PM EDT	Abstract	3-010 - Secondary Polycythemia as an Uncommon Cause of Large Vessel Occlusion Resulting in Acute Ischemic Stroke Bhageeradh Mulpur, MD
05:30 PM - 06:30 PM EDT	Abstract	3-011 - Multiterritorial ischemic strokes in idiopathic hypereosinophilic syndrome Paula K. Lee, MD
05:30 PM - 06:30 PM EDT	Abstract	3-012 - Acute Ischemic Stroke in Cancer Patients. A Case-Control Study Agustin Pappolla, MD
05:30 PM - 06:30 PM EDT	Abstract	3-013 - Prudent testing of factor V Leiden in Ischemic stroke Shivakrishna Kovi, MD, MBBS
05:30 PM - 06:30 PM EDT	Abstract	3-014 - An Uncommon Cause of Multifocal Intracerebral Hemorrhages: Adult-Onset Leukoencephalopathy with Calcifications and Cysts Nataliya Pyatka, MD
05:30 PM - 06:30 PM EDT	Abstract	3-015 - Lacunar Strokes in Cryptococcal Meningitis: Clinical and Radiographic Features in a U.S. Cohort Daniel Vela-Duarte, MD
05:30 PM - 06:30 PM EDT	Abstract	3-016 - Hypertension Increases Risk of Ischemic Stroke in Multiple Sclerosis: Retrospective Analysis of a National Database Asad Ikram, MD, MBBS
05:30 PM - 06:30 PM EDT	Abstract	3-017 - Fabry disease and Stroke: Effectiveness of Enzyme Replacement Therapy (ERT) in Stroke Prevention, a Review with Meta-Analysis Sen Sheng, MD
05:30 PM - 06:30 PM EDT	Abstract	3-018 - Sickle Cell Trait and Risk for Early-Onset Ischemic Stroke Rebecca V. Zhang
05:30 PM - 06:30 PM EDT	Abstract	3-019 - Degos' disease: the hint is in the skin Daniel Calame, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	3-020 - Diagnostic Challenges in Vascular Myelopathies Michlene Passeri, MD
05:30 PM - 06:30 PM EDT	Abstract	3-021 - Isolated Cervical Anterior Spinal Artery Aneurysms (CASAAs): A Case Series and The Comprehensive Outcome Analysis of surgical vs non-surgical interventions Pooja SirDeshpande, MBBS
05:30 PM - 06:30 PM EDT	Abstract	3-022 - Intravascular Lymphoma Presenting with Spinal Cord Infarct and Recurrent Ischemic Strokes Stephanie Lyden, MD
05:30 PM - 06:30 PM EDT	Abstract	3-023 - Simultaneous Epidural and Intramedullary Hemorrhage: A Case Report. Shailee S. Shah, MD
05:30 PM - 06:30 PM EDT	Abstract	3-024 - Spinal Claudication Due to Anterior Disco-osteo-arterial Conflict Mimicking Stiff Person Syndrome Olwen Murphy, MD
05:30 PM - 06:30 PM EDT	Abstract	3-025 - Spinal Cord Infarction: A Diagnostic Challenge Michlene Passeri, MD
05:30 PM - 06:30 PM EDT	Abstract	3-026 - CADASIL in a Patient with Bilateral Internal Carotid Artery Agenesis Allycia MacDonald, MBBS
05:30 PM - 06:30 PM EDT	Abstract	3-027 - Rapidly progressive dementia with seizures due to venous hypertension from arteriovenous hemodialysis graft Maria Antonietta Mazzola, MD
05:30 PM - 06:30 PM EDT	Abstract	3-028 - Recurrent Stroke in Giant Cell Arteritis Despite Immunotherapy Benjamin C. Cox, MD
05:30 PM - 06:30 PM EDT	Abstract	3-029 - Outcomes of Mechanical Retrieval Therapy in Basilar Artery Occlusions: A Single Center Study Angela M. Hawkins, RN
05:30 PM - 06:30 PM EDT	Abstract	3-030 - Outcomes of Acute Basilar Occlusion Ischemic Strokes with Advent of Modern Thrombectomy Devices, a New York State Experience Husitha Reddy Vanguru, MBBS
05:30 PM - 06:30 PM EDT	Abstract	3-031 - Thermoregulatory Dysfunction in a Patient with Locked-in Syndrome Due to Bilateral Ventral Pontine Infarction Morgan Jordan, DO
05:30 PM - 06:30 PM EDT	Abstract	3-032 - Outcome in Acute Basilar Artery Occlusion Based on Time and Severity at Presentation: A Retrospective Review Sajid Suriya, MD
05:30 PM - 06:30 PM EDT	Abstract	3-033 - Association of Functional Outcome in Basilar Artery Occlusion in Relation to Baseline Comorbidities: A Retrospective Review Piotr Bzdyra, MD
05:30 PM - 06:30 PM EDT	Abstract	3-034 - Interrater Agreement for Measurements of Vertebral Artery Origin Stenosis Caitlin Bell
05:30 PM - 06:30 PM EDT	Abstract	3-035 - Comparison Between Medical Therapy And Endovascular Treatment Of Extracranial Atherosclerotic Vertebral Artery Disease: A Systematic Review David Daniel, MD
05:30 PM - 06:30 PM EDT	Abstract	3-036 - Prevalence of Atherosclerotic Vertebrobasilar Disease in patients with Ischemic Stroke in an Argentinian cohort of patients
05:30 PM - 06:30 PM EDT	Abstract	3-037 - Second Generation Drug-Eluting Stents for Endovascular Treatment of Ostial Vertebral Artery Stenosis: A Single-Center Experience Aldo Mendez Ruiz, MD
05:30 PM - 06:30 PM EDT	Abstract	3-038 - : Vertebral artery origin stenosis: systematic review of randomized clinical trials Chizoba Ezepue, MD
05:30 PM - 06:30 PM EDT	Abstract	3-039 - Concerning Temporal Trends in Transient Ischemic Attack Hospitalization Jonathan W. Sahawneh
05:30 PM - 06:30 PM EDT	Abstract	3-040 - Healthcare Utilization Prior to Fatal Stroke Admission: Nationally Representative Data Sarah A. Levy, MD
05:30 PM - 06:30 PM EDT	Abstract	3-041 - A Comparative Case Series of Haitian and non-Haitian Acute Stroke Patients at a Single Center in Miami, Florida Kristen T. Ashourian
05:30 PM - 06:30 PM EDT	Abstract	3-042 - Stroke in Himalayan Region of Nepal: Knowledge and Awareness of Early Management Rajeev Ojha, MD
05:30 PM - 06:30 PM EDT	Abstract	3-043 - Acute Stroke Management: A Plight of Nepal
05:30 PM - 06:30 PM EDT	Abstract	3-044 - Hospital-based Stroke Register Studies and Clinical Features and Outcomes of Stroke Patients in China and other Asian Countries: A Systematic Review Chen Ye
05:30 PM - 06:30 PM EDT	Abstract	3-045 - Effect of Documentation Patterns on Prevalence of Comorbid Conditions in Ischemic Stroke Dinesh V. Jillella, MD
05:30 PM - 06:30 PM EDT	Abstract	3-046 - Genome-wide DNA methylation profiling in peripheral blood from different TOAST-subtypes stroke patients. Juan Marta-Enguita, MD
05:30 PM - 06:30 PM EDT	Abstract	3-047 - Serious Misdiagnosis-Related Harms Due to Missed Vascular Events in the United States—Incidence, Settings, and Causes Ali Saber Tehrani, MD
05:30 PM - 06:30 PM EDT	Abstract	3-048 - Prevalence and Prognosis of Atrial Fibrillation Among Hospitalized Ischemic Stroke Patients with Comobid Seizures in the United States Alain Z. Lekoubou Looti, MD
05:30 PM - 06:30 PM EDT	Abstract	3-049 - Factors associated with atrial fibrillation detection on longterm cardiac monitoring in Stroke Jane Khalife, MD
05:30 PM - 06:30 PM EDT	Abstract	3-050 - N-Terminal Probrain Natriuretic Peptide as a marker for diagnosis of Cardioembolic Stroke Virti D. Shah, Sr., MD, MBBS
05:30 PM - 06:30 PM EDT	Abstract	3-051 - Recurrent Ischemic Stroke secondary to Left Ventricular Non-compaction Keithan Sivakumar, MD
05:30 PM - 06:30 PM EDT	Abstract	3-052 - Advanced Cardiac Imaging In Patients With Ischemic Stroke. When To Scan? Mohamad Orabi, MD
05:30 PM - 06:30 PM EDT	Abstract	3-053 - Neurologic Complications during Short-term Cardiac Support with Impella Devices Catherine Hassett, MD
05:30 PM - 06:30 PM EDT	Abstract	3-054 - Rate of ischemic stroke and intracranial hemorrhage following left ventricular assist device placement: a systematic review Mohammed Alhaidar, MD
05:30 PM - 06:30 PM EDT	Abstract	3-055 - Therapeutic Anticoagulation after Ischemic Stroke in Patients with LVADs does not cause Hemorrhagic Conversion: A Single Center Retrospective Study Jeffrey Ruta, MD
05:30 PM - 06:30 PM EDT	Abstract	3-056 - Simultaneous cardio-cerebral infarction: A rare phenomenon Parul Goyal, MBBS
05:30 PM - 06:30 PM EDT	Abstract	3-057 - A Retrospective Analysis of Anticoagulation Reinstitution in Patients with Left Ventricular Assist Device who Developed Intracerebral Hemorrhage at Mayo Clinic Arizona Sara Dawit, MD
05:30 PM - 06:30 PM EDT	Abstract	3-058 - Comparison of Point of Care Ultrasound to Standard Transthoracic Echocardiography for Acute Stroke and TIA
05:30 PM - 06:30 PM EDT	Abstract	3-059 - Neurological outcomes of patients with mycotic aneurysms in infective endocarditis Hang Shi, MD
05:30 PM - 06:30 PM EDT	Abstract	3-060 - Outcome of Thrombectomy in Stroke Due to Infective Endocarditis: A Case Series Elie Sader, MD
05:30 PM - 06:30 PM EDT	Abstract	3-061 - Utility Of Retrieved Thromboembolism Tissue Culture In A Patient With Suspected Infective Endocarditis Anand V. Patel, MD
05:30 PM - 06:30 PM EDT	Abstract	3-062 - Prior Antithrombotic Therapy is Associated with Cerebral Microbleeds in Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease Yajun Cheng
05:30 PM - 06:30 PM EDT	Abstract	3-063 - Trends of patent foramen ovale (PFO) closure from 2008 to 2014 at National level: US experience Rakesh Khatri, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	3-064 - Identifying Patients with Cryptogenic Stroke Eligible for PFO Closure Mona Al Banna, MB BCh BAO
05:30 PM - 06:30 PM EDT	Abstract	3-065 - Does Risk of Paradoxical Embolism (ROPE) score correlate with PFO closure criteria? Apameh Salari, MD
05:30 PM - 06:30 PM EDT	Abstract	3-066 - The Impact of Chronic Kidney Disease Stage on Intracranial Vascular Resistance Shivani Ghoshal, MD
05:30 PM - 06:30 PM EDT	Abstract	3-067 - Impact of renal failure on acute stroke Franco E. Appiani, MD
05:30 PM - 06:30 PM EDT	Abstract	3-068 - Stroke and Retinal Microvascular Abnormalities
05:30 PM - 06:30 PM EDT	Abstract	3-069 - The Black Sheep of Stroke Etiologies: Visual Abnormalities and Cerebral Infarction in Association with Lambl’s Excrescences Micah Etter, MD
05:30 PM - 06:30 PM EDT	Abstract	3-070 - Exploring the Relationship Between Chronic Obstructive Pulmonary Disease and Posterior Reversible Encephalopathy Syndrome—a possibly under-recognized cause of an uncommon syndrome Nneka S. Amadife, MD
05:30 PM - 06:30 PM EDT	Abstract	3-071 - Predictors of favorable response to the placement of the ventriculoperitoneal shunt in patients with idiopathic normal pressure hydrocephalus Mario E. Ricciardi, Sr., MD
05:30 PM - 06:30 PM EDT	Abstract	12-001 - A case of aggressive motor neuron disease without profound loss of motor neuron cells Yin A. Liu, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	12-002 - Correlation between Slow Vital Capacity Measured in the Home and in the Clinic for Patients with Amyotrophic Lateral Sclerosis Lisa Meng
05:30 PM - 06:30 PM EDT	Abstract	12-003 - Survival prediction models in motor neuron disease Edoardo G. Spinelli, MD
05:30 PM - 06:30 PM EDT	Abstract	12-004 - Meta-analysis of Genetic Expression Profiles in Amyotrophic Lateral Sclerosis Samuel A. Frank, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	12-005 - Two Cases of Spinal Muscular Atrophy due to Mutations in the VRK1 Gene Angela R. Sung, MD
05:30 PM - 06:30 PM EDT	Abstract	12-006 - Oculomotor Dysfunction in Motor Neuron Disease Christine Lu, MD
05:30 PM - 06:30 PM EDT	Abstract	12-007 - Observational Quantitative Data in Adult Patients with SMA Dosed with Nusinersen Cosette M. Burian, PA
05:30 PM - 06:30 PM EDT	Abstract	12-008 - Feasibility and Validation of Modified Oculobulbar Facial Respiratory Score (mOBFRS) in Amyotrophic Lateral Sclerosis Namita Goyal, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	12-009 - Monitoring and promoting effectiveness and adherence to non-invasive ventilation in motor neurone disease using EncoreAnywhere telemonitoring: a pilot and feasibility, randomised controlled trial.
05:30 PM - 06:30 PM EDT	Abstract	12-010 - Accelerated Pathology in Chlorovirus (ATCV-1) Infected SOD1G93A Transgenic ALS Mice and Association of Increased Serum Anti-ATCV-1 IgG1 Subclass with ALS Gary L. Pattee, MD
05:30 PM - 06:30 PM EDT	Abstract	12-011 - Brain White Matter MRI Differentiates Kennedy’s Disease from Other Motor Neuron Disease Clinical Phenotypes Edoardo G. Spinelli, MD
05:30 PM - 06:30 PM EDT	Abstract	12-012 - Nusinersen for spinal muscular atrophy - results of an expanded access programme Maria Mazurkiewicz-Beldzin
05:30 PM - 06:30 PM EDT	Abstract	12-013 - Fat mass loss correlates with survival in amyotrophic lateral sclerosis patients: prospective cohort study Ikjae Lee, MD
05:30 PM - 06:30 PM EDT	Abstract	12-014 - Validation of a staging system in ALS: Comparison of the US and European Populations Justin Y. Kwan, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	12-015 - Nusinersen in Adults with Spinal Muscular Atrophy, A Single Center Experience Orly Moshe-Lilie, MD
05:30 PM - 06:30 PM EDT	Abstract	12-016 - Spinal Muscular Atrophy: A Review of Epidemiology, Burden and Unmet Needs
05:30 PM - 06:30 PM EDT	Abstract	12-017 - Determinants of Mortality Among Hospitalized Patients with Amyotrophic Lateral Sclerosis – Results from the 2016 National Inpatient Sample Gilbert J. L'Italien
05:30 PM - 06:30 PM EDT	Abstract	12-018 - Analysis of nutritional status as a predictor of survival in patients with bulbar amyotrophic lateral sclerosis (ALS) Mariela Bettini, MD
05:30 PM - 06:30 PM EDT	Abstract	12-019 - Dextromethorphan-Quinidine (Nuedexta) Improves Swallowing in Bulbar Onset ALS Patients with Pseudobulbar Affect - Pre-Post Observational Study in 86 ALS Patients
05:30 PM - 06:30 PM EDT	Abstract	12-020 - Structural and Functional Organization of the Brain Connectome in Patients with Different Motor Neuron Diseases: A Multicenter Study Federica Agosta
05:30 PM - 06:30 PM EDT	Abstract	12-021 - CX3CL1 Disruption Differentially Influences the Neuroprotective Effects of Mesenchymal Stromal Cells on ALS Dongya Huang, MD
05:30 PM - 06:30 PM EDT	Abstract	12-022 - Adherence to Riluzole Therapy Improves Time to and Frequency of All Cause Hospitalization in ALS Patients: A Claims-Based Longitudinal Comparative Effectiveness Analysis. Gilbert J. L'Italien
05:30 PM - 06:30 PM EDT	Abstract	12-023 - Diffusion Tension Imaging as the Biomarker for Amyotrophic Lateral Sclerosis Seol-Hee Baek, MD
05:30 PM - 06:30 PM EDT	Abstract	12-024 - Diminshed Muscle Oxygenation During Exercise in Ambulatory Spinal Muscular Atrophy Patients Jacqueline Montes, PT, EdD, NCS
05:30 PM - 06:30 PM EDT	Abstract	12-025 - Population Based Surveillance and Survival Characteristics of Amyotrophic Lateral Sclerosis (ALS) Cases in the Atlanta Metropolitan Area, 2009 – 2011 Alex Exuzides
05:30 PM - 06:30 PM EDT	Abstract	12-026 - Factors Associated with Poor Compliance of Non-invasive Ventilator Support in Patients with ALS Anem Kohli, MBBS
05:30 PM - 06:30 PM EDT	Abstract	12-027 - Clinical Factors Predicting Cognitive Errors in The Misdiagnosis of Amyotrophic Lateral Sclerosis (ALS) Rohit Gummi, MD
05:30 PM - 06:30 PM EDT	Abstract	12-028 - Facial Onset Sensory-Motor Neuronopathy: A Series of Two Cases Illustrating a Disease Spectrum Rabia Yasin, MD
05:30 PM - 06:30 PM EDT	Abstract	12-029 - Frequency, Symptomology, and Course of HIV-Associated ALS: Case Series and Review Zachary Satin
05:30 PM - 06:30 PM EDT	Abstract	12-030 - Primary Lateral Sclerosis (PLS) vs. Hereditary Spastic Paraperesis (HSP) in Presenilin-1 (PSEN1) related Dominant Dementia Ghazaleh Ahmadi Jazi, MD
05:30 PM - 06:30 PM EDT	Abstract	12-031 - Multielectrode array analysis of human iPSC-motor neuron maturation following co-culture with iPSC- spinal cord astrocytes Arens Taga, MD
05:30 PM - 06:30 PM EDT	Abstract	12-032 - Patient-Reported Outcomes Measures in Children with Spinal Muscular Atrophy
05:30 PM - 06:30 PM EDT	Abstract	12-033 - Co-existing riboflavin transporter deficiency (RTD) type 2 and muscle AMP deaminase deficiency in two long-term RTD survivors: report of a family Lin Zhang, FRACP
05:30 PM - 06:30 PM EDT	Abstract	12-034 - Effect of Radicava on Uric Acid Levels: Preliminary Results Terry D. Heiman-Patterson, MD
05:30 PM - 06:30 PM EDT	Abstract	12-035 - Hybrid Recording System of Electromyography and Ultrasound in Neuromuscular Disorder Kenji Sekiguchi, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	12-036 - Safety of Needle Electromyography in Critically Ill Intensive Care Unit (ICU) Patients Elanagan Nagarajan, MD
05:30 PM - 06:30 PM EDT	Abstract	12-038 - The Neurophysiology of Oxaliplatin Effects on Peripheral Nerve Mark M. Stecker, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	12-039 - Increased Incidence of Martin Gruber Anastomosis in Individuals with Ulnar Neuropathy Shreya Gandhy, DO
05:30 PM - 06:30 PM EDT	Abstract	12-040 - The Sensitivites of Median Mixed Palmar Distal Latencies in the Diagnosis of Carpal Tunnel Syndrome (Onset, Peak, Either Onset or Peak, or Onset and Peak) Elie Sader, MD
05:30 PM - 06:30 PM EDT	Abstract	12-041 - The effect of botulinum toxin injections on EMG Robin Warner, DO
05:30 PM - 06:30 PM EDT	Abstract	6-001 - Lack of Standardization of the Level of Encephalopathy on EEG: a Barrier to the Widespread Use of EEG for Brain Monitoring Carolina B. Maciel, MD, MSCR, FAAN
05:30 PM - 06:30 PM EDT	Abstract	6-002 - The Sounds of Seizures: Audio-Triggered Detection by Convolutional Neural Network (CNN) Maysaa M. Basha, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	6-003 - Long-term Stability of Interictal Spike Trajectories in Pediatric Invasive EEG Recordings Samuel Tomlinson
05:30 PM - 06:30 PM EDT	Abstract	6-004 - EEG source localization comparing low-density EEG including subtemporal coverage with high density EEG Omar A. Danoun, MD
05:30 PM - 06:30 PM EDT	Abstract	6-005 - Age Norms of EEG during Sleep from 0 to 100 years old Luis Paixao, BMBCh, MSc
05:30 PM - 06:30 PM EDT	Abstract	6-006 - EEG Source Imaging from Standard Long-term Video EEG Recording in Patients with Medically-refractory Focal Epilepsy Benjamin C. Cox, MD
05:30 PM - 06:30 PM EDT	Abstract	6-007 - Longitudinal Analysis of Interictal EEGs in Patients with TLE and Hippocampal Sclerosis Mariana R. Brito, MD
05:30 PM - 06:30 PM EDT	Abstract	6-008 - Quantitative EEG of Intracranial Recordings for Detection of Seizure Onset and Localization Compared to Standard Intracranial Tracing Steven Gangloff, MD
05:30 PM - 06:30 PM EDT	Abstract	6-009 - Validation of a dry-electrode EEG recording system: Results of a multi-reader blinded comparison to standard EEG Katherine A. Zarroli, MD
05:30 PM - 06:30 PM EDT	Abstract	6-010 - Surface-Electromyography (sEMG) Patterns of Clonic Bursts during Generalized Tonic-Clonic (GTC) Seizures Damon P. Cardenas, PhD
05:30 PM - 06:30 PM EDT	Abstract	6-011 - In the kingdom of triphasic waves, white matter is the eminence grise Ivan Kotchetkov, MD
05:30 PM - 06:30 PM EDT	Abstract	6-012 - Diagnostic Utility of Continuous sEMG Monitoring in a Home Setting - Real-world use of the SPEAC® System Luke Whitmire, PhD
05:30 PM - 06:30 PM EDT	Abstract	6-013 - Is There a Role for Magnetoencephalography in Pre-surgical RNS Implantation in Drug-Resistant Temporal Lobe Epilepsy? Abdullah Alshammaa, MD
05:30 PM - 06:30 PM EDT	Abstract	6-014 - Glossokinetic Potentials: Insights from intracranial EEG
05:30 PM - 06:30 PM EDT	Abstract	6-015 - Ictal urinary urgency localized by Stereo-electroencephalogram. Dhara Murray-Frank, MD
05:30 PM - 06:30 PM EDT	Abstract	6-016 - The Prognostic Value of Quantitative EEG in Patients Undergoing Mechanical Thrombectomy for Acute Ischemic Stroke Adam Dickey, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	6-017 - Wearable Sensors for the Detection of Convulsive Seizures Ryan J. McGinn, MD
05:30 PM - 06:30 PM EDT	Abstract	6-018 - The Use of Collodion versus Traditional Paste for Reducing Artifact in Ambulatory Electroencephalography Studies in the Pediatric Population Danielle R. Brigham, MD
05:30 PM - 06:30 PM EDT	Abstract	6-019 - An Effective Tool for Teaching EEG Interpretation to Residents and Medical Students Meghan Hubert, MD
05:30 PM - 06:30 PM EDT	Abstract	6-020 - Case Report: Change in Electrocorticogram Detection of RNS with Initiation of Ketogenic Diet Janet Greenwood
05:30 PM - 06:30 PM EDT	Abstract	6-021 - Correlation of Indicators of P300 Cognitive Potentials with Epilepsy Forms Marufjon Salokhiddinov, MD
05:30 PM - 06:30 PM EDT	Abstract	6-022 - Assessing Retinal Cytoarchitecture between Temporal Onset Focal and Primary Generalized Seizure Types Utilizing Optical Coherence Tomography Samuel Lichtman-Mikol, BA
05:30 PM - 06:30 PM EDT	Abstract	6-023 - Normalized transfer entropy used as an informational transfer measure of ictal pathophysiology in patients undergoing stereo-EEG for epilepsy surgery Angelica M. Lee, DO
05:30 PM - 06:30 PM EDT	Abstract	6-024 - The Relationship between Seizures, Ictal-Interictal EEG Activity, Clinical Outcome, and Dynamic Neurologic Changes following Traumatic Brain Injury Muhammad Muzzammil Edhi, MBBS
05:30 PM - 06:30 PM EDT	Abstract	6-025 - Seizures after Cardiovascular Surgery: An unexpected complication Carla F. Bolano Diaz, MD
05:30 PM - 06:30 PM EDT	Abstract	6-026 - Prognosis and Clinical Factors to Predict Seizure Recurrence in Patients with Alcohol-Related Seizures Min Young Chun, MD
05:30 PM - 06:30 PM EDT	Abstract	6-027 - Acute Seizure Incidence in Ischemic Stroke Patients Treated with Mechanical retrieval therapy: A Single Center Study Harold H. Morris III, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	6-028 - Postencephalitic Epilepsy and Acute Symptomatic Seizures, in Infectious, Undetermined Etiology and Autoimmune Encephalitis Abril Marone, MD
05:30 PM - 06:30 PM EDT	Abstract	6-029 - Epilepsia Partialis Continua Secondary to Diabetic Ketoacidosis Jacob L. Van Orman, MD
05:30 PM - 06:30 PM EDT	Abstract	6-030 - Two Cases of Provoked Seizure Associated With Kratom Ingestion Devin J. Burke, MD
05:30 PM - 06:30 PM EDT	Abstract	6-031 - Medically Refractory Epilepsy Associated with Celiac Disease Amy Postelnik, MD
05:30 PM - 06:30 PM EDT	Abstract	6-032 - Profile and Outcome of Psychogenic Nonepileptic Seizures Patients undergoing Video-EEG Monitoring Madison L. Wolfe
05:30 PM - 06:30 PM EDT	Abstract	6-033 - An Institutional Experience on Semiology of Psychogenic Nonepileptic Seizures Golshan Fahimi, MD
05:30 PM - 06:30 PM EDT	Abstract	6-034 - Serum Levels of Inflammasome Complex Factors are Suppressed in Focal Epilepsy Patients Ebru Nur Yavuz, MD
05:30 PM - 06:30 PM EDT	Abstract	6-036 - Spanish Epilepsy ��ɫ�� Available on the Web Reyna M. Duron, MD
05:30 PM - 06:30 PM EDT	Abstract	7-001 - Clinical Characteristics of a Large Cohort of US Patients Enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010–2015 Jaime Raymond
05:30 PM - 06:30 PM EDT	Abstract	7-002 - A comparison of the clinical and genetic features of Amyotrophic Lateral Sclerosis across Latin American and European populations Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-003 - Incidence of Venous Thromboembolic Events Among Amyotrophic Lateral Sclerosis Patients in a US Health Insurance Claims Database
05:30 PM - 06:30 PM EDT	Abstract	7-004 - Progression of Symptoms in relation to the Site of Onset in Amyotrophic Lateral Sclerosis: new Evidence supporting the Prion-like Hypothesis Adriano Chio, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-005 - An Analysis of Free-text Responses by Individuals Enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry Heather Jordan, MPH, CPH, MCHES
05:30 PM - 06:30 PM EDT	Abstract	7-006 - PRO-ACE: Global Collaborative Ecosystem in a Post-PRO-ACT Era Alexander Sherman
05:30 PM - 06:30 PM EDT	Abstract	7-007 - Forecasting Multiple Sclerosis Hospitalization and Healthcare Burden in the United States from 2017 to 2040 Kanika Sharma, MD
05:30 PM - 06:30 PM EDT	Abstract	7-008 - Effects of cigarette smoking and smoking cessation on Multiple Sclerosis severity: a cross-sectional study Andrei Ivashynka, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	7-009 - An increase in the prevalence of Multiple Sclerosis has moved Kuwait to a high-risk zone Raed Alroughani, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-011 - Lewy body dementia (LBD) prevalence and cholinesterase inhibitor use in Florida Bhavana U. Patel, DO
05:30 PM - 06:30 PM EDT	Abstract	7-012 - Vision loss in Parkinson’s disease: prevalence and association with outcomes among Medicare beneficiaries Ali G. Hamedani, MD, MHS
05:30 PM - 06:30 PM EDT	Abstract	7-013 - Risk of readmission for injury in patients with epilepsy in the US Yoni Goldstein
05:30 PM - 06:30 PM EDT	Abstract	7-014 - Characteristics of periventricular nodules in patients with 22q11. 2 deletion syndrome
05:30 PM - 06:30 PM EDT	Abstract	7-015 - Cognitive decline after a mild or moderate stroke and TIA: evidence from the SWIFT Trial Bernadette Boden-Albala, DrPH
05:30 PM - 06:30 PM EDT	Abstract	7-016 - Seasonal Variation in Stroke Incidence in Black versus White Medicare Beneficiaries Tehniyat Baig, MD
05:30 PM - 06:30 PM EDT	Abstract	7-017 - Disparities, Predictors and Trends of Left Atrial Appendage Closure Among Hospitalized Patients with Atrial Fibrillation in the United States
05:30 PM - 06:30 PM EDT	Abstract	7-018 - Comparing the Outcomes of Patients with Idiopathic Subarachnoid Hemorrhage by Three Distinct Perimesencephalic Bleed Patterns Jeffrey C. Wagner, MD
05:30 PM - 06:30 PM EDT	Abstract	7-019 - Time Trends, Race Disparities, and Administration of Intravenous Thrombolysis for Acute Ischemic Stroke: A Statewide Study Jolanta Marszalek, MD
05:30 PM - 06:30 PM EDT	Abstract	7-020 - For Men Only, High Hematocrit Values Are Associated With Stroke In The Young Russell E. Bartt, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-021 - Systematic Characterization of Large Vessel Occlusion Strokes at a CSC Shashvat Desai, MD
05:30 PM - 06:30 PM EDT	Abstract	7-022 - Is Altitude Associated With Ischemic Stroke In The Young? Kristin Salottolo, MPH
05:30 PM - 06:30 PM EDT	Abstract	7-023 - Acute neurological complications after adult single and double lung transplant Yasmeen Rauf, MBBS
05:30 PM - 06:30 PM EDT	Abstract	7-024 - Association between neurological syndromes and Arbovirus in Buenos Aires - Relationship between Guillain Barre Syndrome, Encephalitis and Myelitis with Zika, Dengue and Chikungunya Alejandro Kohler
05:30 PM - 06:30 PM EDT	Abstract	7-025 - Long-Term Outcomes of Guillain-Barre Syndrome Associated with Zika Virus Infection
05:30 PM - 06:30 PM EDT	Abstract	7-026 - The Pattern of Neurologic Disease in Tanzanian Tribal Populations Whitley W. Aamodt, MD
05:30 PM - 06:30 PM EDT	Abstract	7-027 - Migraine and the Prevalence of Metabolic Syndrome among Women Pamela Rist, PhD
05:30 PM - 06:30 PM EDT	Abstract	7-028 - Genetic testing of >1300 patients with cerebral palsy reveals an etiology in one-third of cases, underscoring the need for broad genetic testing and a significant recurrence risk for families. Francisca Millan Zamora, MD
05:30 PM - 06:30 PM EDT	Abstract	7-029 - Evalualuation of Tremor in Childhood Electrophysiologically Influences Prognosis and Outcome Bennett L. Lavenstein, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-030 - Alice in Wonderland Syndrome: Case Series and Analysis Edward J. Fine, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-031 - Neuropsychological Assessment In Patients With Alternating Hemiplegia Of Childhood (AHC) Cecilia Fernandes, MD
05:30 PM - 06:30 PM EDT	Abstract	7-032 - Insights into Alternating Hemiplegia of Childhood from EEG Monitoring during an Episode, and Successful Prophylaxis with Levetiracetam Alex Mirzoev, MD
05:30 PM - 06:30 PM EDT	Abstract	7-033 - A Very Rare Cause of a Common Tremor Yasser Kabbani, MD
05:30 PM - 06:30 PM EDT	Abstract	7-034 - KMT2B early childhood onset dystonia presenting as failure to thrive Andrew Ng, MD
05:30 PM - 06:30 PM EDT	Abstract	7-035 - Cortical Abnormalities and Cognitive Impairment in Pediatric MS Patients Ermelinda De Meo
05:30 PM - 06:30 PM EDT	Abstract	7-036 - Imaging analysis differentiates vascular versus inflammatory myelopathies in children Maria A. Garcia-Dominguez, MD
05:30 PM - 06:30 PM EDT	Abstract	7-037 - Autoimmune encephalitis associated with N-type voltage-gated calcium channels in children: a case series Jeffrey M. Kornitzer, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-038 - Autoimmune Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Following Herpes Simplex Encephalitis (HSE) in a pediatric patient Maureen Handoko-Yang, MD
05:30 PM - 06:30 PM EDT	Abstract	7-039 - Unilateral Primary CNS Vasculitis in a Child Associated with Increased ICP and Treated with Maximal Medical Therapy and Decompressive Hemicraniectomy Cynthia X. Wang, MD
05:30 PM - 06:30 PM EDT	Abstract	7-040 - Disability Scores After Idiopathic Pediatric Transverse Myelitis are Associated with Clinical Features at Onset of Illness Jordan J. Cole, MD
05:30 PM - 06:30 PM EDT	Abstract	7-041 - Limbic Encephalitis as Presentation of Hodgkin Lymphoma in a Pediatric Patient: The Ophelia Syndrome Gabriela Tuttrup, MD
05:30 PM - 06:30 PM EDT	Abstract	7-042 - Prospective characterization of children positive for anti-MOG antibodies meeting Multiple Sclerosis diagnostic criteria Giulia Fadda, MD
05:30 PM - 06:30 PM EDT	Abstract	7-043 - Natural History of Neurological and Neuroimaging Progression in Childhood Cerebral X-Linked Adrenoleukodystrophy (CCALD). Mohammed A. Almuqbil, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-044 - Developmental outcomes of Aicardi Goutières Syndrome Laura A. Adang, MD
05:30 PM - 06:30 PM EDT	Abstract	7-045 - Autoimmune hepatitis in Aicardi-Goutières Syndrome Zachary Cross
05:30 PM - 06:30 PM EDT	Abstract	7-046 - Cross-analysis of Interferon Signature in a cohort of Aicardi-Goutières Syndrome subjects Francesco Gavazzi, MD, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	7-047 - Consensus Guidelines: MRI Surveillance of Children with Presymptomatic Adrenoleukodystrophy Bela Turk, MD
05:30 PM - 06:30 PM EDT	Abstract	7-048 - Metachromatic Leukodystrophy: An Approach to Treatment Christian Krarup, MD, DMSc, FRcP, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-049 - Expanded Phenotype of GFPT1-related Disorder is a Mimicker of Mitochondrial Leukoencephalopathy Guy T. Helman
05:30 PM - 06:30 PM EDT	Abstract	7-050 - Language Skills in Children with Alexander Disease Debra Levin, MA, CCC-SLP
05:30 PM - 06:30 PM EDT	Abstract	7-051 - The Pediatric Evaluation of Disability Inventory Computer Adaptive Test Captures Impairments in Alexander Disease Hannah R. Cooper
05:30 PM - 06:30 PM EDT	Abstract	7-052 - Utilization of Wearable Technology to Characterize the Natural History of Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation Amena Smith, MD
05:30 PM - 06:30 PM EDT	Abstract	7-053 - The Children’s Hospital of Philadelphia Pediatric Dysphagia Instrument (CHOP PDI): a Novel Tool for Swallow Dysfunction Christina Minkoff, CCC/SLP
05:30 PM - 06:30 PM EDT	Abstract	7-054 - A Comprehensive and Dynamic Approach for Genetic Testing for Patient with Leukodystrophy Demonstrates a Genetic Etiology in 33% of Cases
05:30 PM - 06:30 PM EDT	Abstract	7-055 - Novel Classifications of Alexander Disease Based on MRI Phenotypes Amy T. Waldman, MD
05:30 PM - 06:30 PM EDT	Abstract	7-056 - Clinical Outcome Assessments in TUBB4A-associated Leukoencephalopathies Adeline Vanderver, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	7-057 - Diagnostic tips from a case series of patients with Late Onset Tay Sachs disease Giulietta Riboldi, MD
05:30 PM - 06:30 PM EDT	Abstract	7-058 - AGIL-AADC Gene Therapy Results in Sustained Improvements in Motor and Developmental Milestones Over 5 Years in Children With AADC Deficiency Yin-Hsiu Chien
05:30 PM - 06:30 PM EDT	Abstract	7-059 - Patients with Inherited Metabolic Disorders (IMD) transplanted with MGTA-456, a CD34+ Expanded Cell Therapy Product, Show Rapid Engraftment in Preliminary Phase 2 Trial Results Paul Orchard
05:30 PM - 06:30 PM EDT	Abstract	7-060 - Exploring mTOR Inhibition as Treatment for Mitochondrial Disease Abigail N. Schwaede, MD
05:30 PM - 06:30 PM EDT	Abstract	7-061 - Exploring Triheptanoin as Treatment for Short Chain Enoyl CoA Hydratase Deficiency Kristin Engelstad
05:30 PM - 06:30 PM EDT	Abstract	7-062 - Mitochondrial Dysfunction: Consider SPATA5 mutations Saranya Khurana
05:30 PM - 06:30 PM EDT	Abstract	7-063 - Can pathology help in functional interpretation of genetic variants – A case report of Novel variants in NARS2 gene with mitochondrial dysfunction presenting as early infantile epileptic encephalopathy with cardiac and skeletal muscle involvement Wilson D. Heredia, MD
05:30 PM - 06:30 PM EDT	Abstract	7-064 - Aberrant Mitophagy In The Pediatric Neurodegenerative Syndrome TBCKE
05:30 PM - 06:30 PM EDT	Abstract	7-065 - Mitochondrial Encephalomyopathy, Lactic acidosis, And Stroke-like episodes(MELAS) manifesting with Intermittent Cortical Blindness secondary to Occipital Lobe Seizures Rashid A. Ahmed, MD
05:30 PM - 06:30 PM EDT	Abstract	7-066 - Late-onset multiple acyl-CoA dehydrogenase deficiency with a complex genetic finding Joao L. Durães, MD
05:30 PM - 06:30 PM EDT	Abstract	7-067 - Undiagnosed Late-onset Ornithine transcarbamylase (OTC) Deficiency Presenting With Psychiatric Symptoms Syeda Maria Muzammil, MD
05:30 PM - 06:30 PM EDT	Abstract	7-068 - Expanded newborn screening (NBS) leads to early diagnosis and treatment in children with Cobalamin C disease (CblC) and aids in identifying and treating presymptomatic affected family members Isabella Herman, MD
05:30 PM - 06:30 PM EDT	Abstract	7-069 - Epilepsy in Alternating Hemiplegia of Childhood: Characteristics, Neuroimaging, and Response to Therapy Julie C. Uchitel
05:30 PM - 06:30 PM EDT	Abstract	7-070 - Loss of Function Variants in the CSTB Gene Cause Microcephaly, Developmental Delay, Hyperkinetic Movements, and Early Onset Epilepsy Amanda Rogers, MD
05:30 PM - 06:30 PM EDT	Abstract	7-071 - Episodic status epilepticus with hemiplegia and involuntary movements associated with novel ATP1A2 mutation Daniel Calame, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	7-072 - Behavioral alterations associated with the use of levetiracetam in pediatric patients with epilepsy Carla Manterola
05:30 PM - 06:30 PM EDT	Abstract	1-001 - Substantia Nigra (SN) Hyperechogenicity is a Reliable Biomarker for Disease Progression From Stage I to Stage II in Early Onset Parkinson’s Disease (EOPD) Samyuktha Ravi
05:30 PM - 06:30 PM EDT	Abstract	1-002 - The Pseudodystonia: Important Pitfalls in the Diagnosis of Dystonia Ling Pan, MD
05:30 PM - 06:30 PM EDT	Abstract	1-003 - Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2) Brent L. Fogel, MD, PhD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	1-004 - A single ascending dose (SAD) study of a D1 receptor positive allosteric modulator (LY3154207) in healthy volunteers Kjell Svensson
05:30 PM - 06:30 PM EDT	Abstract	1-005 - Preliminary validation of a novel, comprehensive digital biomarker smartphone application to assess motor symptoms in recently diagnosed Parkinson patients Florian Lipsmeier
05:30 PM - 06:30 PM EDT	Abstract	1-006 - STN LFP and SUA characterization of dyskinesia in PD using microelectrode recordings Joohi Jimenez Shahed, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	1-007 - Gender disparities in deep brain stimulation surgery for Parkinson’s disease Daniel Garbin Di Luca, MD
05:30 PM - 06:30 PM EDT	Abstract	1-008 - Hyperglycemic Induced Chorea-Ballismus Responsive to Valbenazine: a Video Case Report and Review of the Literature. Victor Saunders, MD
05:30 PM - 06:30 PM EDT	Abstract	1-009 - Gait Analysis of GBA Mutation Carriers with Parkinson’s Disease Anjali Gera, MD
05:30 PM - 06:30 PM EDT	Abstract	1-010 - Changes to Levodopa Daily Dose in Parkinson’s Disease (PD) Patients with Dyskinesia While on GocovriTM (Amantadine) Extended Release Capsules: a Two-Year Phase 3 Open Label Study Analysis Stuart H. Isaacson, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-001 - Muscle pattern changes in patients with cervical dystonia (CD) receiving botulinum toxin (BTX) Eric Gutflais, MD
05:30 PM - 06:30 PM EDT	Abstract	10-002 - Long-term outcomes of late deep brain stimulation in DYT1 dystonia Hwai Y. Ooi, MD
05:30 PM - 06:30 PM EDT	Abstract	10-003 - Pilot feasibility study of a semi-automated three-dimensional scoring system for cervical dystonia Genko Oyama, MD, PhD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-004 - The Dystonia Coalition Natural History Project: Nine Years of Progress Scott Norris, MD
05:30 PM - 06:30 PM EDT	Abstract	10-005 - Neural Responses Are Abnormal During Reflexive Blinking in Blepharospasm: An Event-Related fMRI Study Phuong Nguyen
05:30 PM - 06:30 PM EDT	Abstract	10-006 - Wireless, Wearable, Soft Electronics for Blepharospasm Assessment Laura M. Scorr, MD
05:30 PM - 06:30 PM EDT	Abstract	10-007 - Golfer’s Cramp: Effect of Propranolol and Looking at the Hole Charles H. Adler, MD, PhD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-008 - Hand Motor Control in Patients with Cervical Dystonia: an fMRI Study Pavel Hok, MD
05:30 PM - 06:30 PM EDT	Abstract	10-009 - Cervical dystonia patient’s satisfaction level after 3 years of botulinum toxin treatment Vivay Peter Misra, MD
05:30 PM - 06:30 PM EDT	Abstract	10-010 - Basal Ganglia and Cerebellar Circuits Have Distinct Roles in Blepharospasm Amanda Glickman
05:30 PM - 06:30 PM EDT	Abstract	10-012 - Immunogenicity of DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia from a Phase 2 Dose-Escalation Multicenter Study Allison Brashear, MD, MBA, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-013 - Implementation of the current dystonia classification from 2013 to 2017 Alberto Albanese, MD
05:30 PM - 06:30 PM EDT	Abstract	10-014 - A dopa-responsive dystonia-Parkinsonism-cerebellar syndrome associated with GCH1 gene mutation. Andrew Garrett, DO
05:30 PM - 06:30 PM EDT	Abstract	10-015 - Assessment of standing balance by force plate posturography in X-linked Dystonia Parkinsonism (XDP) Christopher D. Stephen, MB ChB, FRCP, MSc, SM
05:30 PM - 06:30 PM EDT	Abstract	10-016 - Botulinum toxin injection changes resting state cerebellar connectivity in cervical dystonia. Martin Nevrly, MD
05:30 PM - 06:30 PM EDT	Abstract	10-017 - Jaw Opening Oromandibular Dystonia following Acute Stroke: Analysis and Review Jeenendra P. Singhvi, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-018 - ATP1A3 Gene Mutations Associated with Rapid-Onset Dystonia-Parkinsonism (RDP) Presenting with Functional Neurologic Disorder: A Report of Two Cases Tara M. Biller, NP
05:30 PM - 06:30 PM EDT	Abstract	10-019 - Pilot trial of botulinum toxin and occupational therapy for Writer’s Cramp Jung E Park, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	10-020 - Identifying Reliable Measures of Impairment in Focal Hand Dystonia Patients Noreen Bukhari-Parlakturk, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	10-021 - Indications, Outcomes and Cost of pediatric Deep Brain Stimulation Surgeries in the United States: An Analysis of the Kids’ Inpatient Sample Emmanuel O. Akano, MD
05:30 PM - 06:30 PM EDT	Abstract	10-022 - Kufor-Rakeb Syndrome with Prominent Dystonia and New Mutations in ATP13A2 Gene in Two Siblings Tritia R. Yamasaki, MD, PhD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-023 - The Trend in Botulinum Toxin Injection among Medicare Neurology Providers in the United States from 2012 to 2016 Shahnaz Miri, MD
05:30 PM - 06:30 PM EDT	Abstract	10-024 - RimabotulinumtoxinB (MYOBLOC) in the treatment of adult sialorrhea William Ondo, MD
05:30 PM - 06:30 PM EDT	Abstract	10-025 - Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Patient and Clinician Satisfaction in the ASPIRE Study
05:30 PM - 06:30 PM EDT	Abstract	10-026 - Individualized OnabotulinumtoxinA Treatment for Lower Limb Spasticity Resulted in High Patient and Clinician Satisfaction in the ASPIRE Study Alberto Esquenazi, MD
05:30 PM - 06:30 PM EDT	Abstract	10-027 - Botulinum Toxin for the treatment of muscle spasms associated with Stiff Person Syndrome Emile S. Moukheiber, MD
05:30 PM - 06:30 PM EDT	Abstract	10-028 - Tremor in the Degenerative Cerebellum: Towards the Understanding of Brain Circuitry for Tremor Sheng-Han Kuo, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-029 - Cerebellar Structure in Patients with Parkinson’s Disease and Essential Tremor Alexander M. Lopez
05:30 PM - 06:30 PM EDT	Abstract	10-030 - The importance of intra-operative assessment in VIM DBS for Tremor: Insights from 145 procedures Abhimanyu Mahajan, MD, MHS, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-031 - Risk Factors Causing Extended Hospitalizations due to Altered Arousal and Speech Dysfunction Following Deep Brain Stimulation for Essential Tremor Shannon Anderson, PA, DAAN
05:30 PM - 06:30 PM EDT	Abstract	10-032 - Distinguishing tremor components in Essential Tremor: a digital spirography study Thomas Osterholt
05:30 PM - 06:30 PM EDT	Abstract	10-033 - Cortical hyperexcitability in sialidosis type 1 Felipe Vial, MD
05:30 PM - 06:30 PM EDT	Abstract	10-034 - Hyperkinetic Movement Disorders Associated With Immunosuppressant And Cefepime Use In Inpatients
05:30 PM - 06:30 PM EDT	Abstract	10-035 - Effects of Concomitant Medication Use on Tardive Dyskinesia Outcomes in Long-Term Valbenazine Trials Cynthia L. Comella, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-036 - RECLAIM-DCP: A Randomized, Double-Blind, Placebo-Controlled Study of Deutetrabenazine for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents Daniel O. Claassen, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-037 - Diagnosis and Treatment Experiences in a Real-World Sample of Tourette Syndrome and Tic Disorder Sufferers Irene Malaty, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-038 - Self-Reported Substance Use in a Real-World Sample of Subjects with Tourette Syndrome and Other Tic Disorder. Wissam G. Deeb, MD
05:30 PM - 06:30 PM EDT	Abstract	10-039 - Physical activity, sleep and tic severity in children Tamara M. Pringsheim, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-040 - The Impact of Tourette Syndrome and Tic Disorders on ��ɫ��, Occupational, and Personal Life Irene Malaty, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-041 - Assessing the social determinants of health in Tourette Syndrome Marisela E. Dy-Hollins, MD, MSCR, FAAN
05:30 PM - 06:30 PM EDT	Abstract	10-042 - Development of an EMG Based Tic Detector Wissam G. Deeb, MD
05:30 PM - 06:30 PM EDT	Abstract	10-043 - Prescriptions for Alpha Agonists and Antipsychotics in Children and Youth with Tic Disorders: A National Pharmacoepidemiologic Study Nicholas Cothros, MD
05:30 PM - 06:30 PM EDT	Abstract	10-044 - Longitudinal follow-up of dual-lead thalamic deep brain stimulation for patients with treatment refractory multiple sclerosis tremor Bhavana U. Patel, DO
05:30 PM - 06:30 PM EDT	Abstract	10-045 - Outcomes with VIM deep brain stimulation in dystonic tremor versus essential tremor Takashi Tsuboi, PhD
05:30 PM - 06:30 PM EDT	Abstract	10-046 - Smartphone Accelometry in Diagnosing Orthostatic Tremor Nicholas Calvo, MD
05:30 PM - 06:30 PM EDT	Abstract	10-047 - Psychiatric Comorbidities in United States Military Veterans with Movement Disorders in Tampa, Florida Chetan P. Gandhy, MD
05:30 PM - 06:30 PM EDT	Abstract	10-048 - TANGO2 Mutation: A Novel Cause of Movement Disorders Matthew R. Burns, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	10-049 - Hereditary Spastic Paraplegia: The Relationships of Patient Perceived Functional Impact and Objective Quantified Multi-Dimensional Gait Analysis Jared Srinivasan
05:30 PM - 06:30 PM EDT	Abstract	10-050 - Autonomic Testing Profiles in Scans Without Evidence of Dopaminergic Deficit (SWEDD) Lauren Jackson, MD
05:30 PM - 06:30 PM EDT	Abstract	10-051 - Novel Mutation of NUS1 Gene Presenting With Developmental and Epileptic Encephalopathy and Movement Disorders Neha Prakash, MD
05:30 PM - 06:30 PM EDT	Abstract	10-052 - Hemi Masticatory Spasm: Series of 8 Cases Divya Madathiparambil
05:30 PM - 06:30 PM EDT	Abstract	4-001 - Cognitive Performance and Total and Regional Brain Volumes in Zambian Youth with HIV Owen Dean
05:30 PM - 06:30 PM EDT	Abstract	4-002 - Increased Caloric Intake is Associated with Lower Cognitive Scores in HIV-Positive Women Lakshmi Warrior, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-003 - Rare Case of Human T-lymphotropic Virus-1 (HTLV-1) with Amyotrophic lateral sclerosis Shaweta Khosa
05:30 PM - 06:30 PM EDT	Abstract	4-004 - Teriflunomide Reduces Spontaneous Lymphoproliferation of Peripheral Blood Mononuclear Cells From Patients With Human T-Lymphotropic Virus (HTLV)-1–Associated Myelopathy/Tropical Spastic Paraparesis Steven Jacobson
05:30 PM - 06:30 PM EDT	Abstract	4-005 - Neurofilament Light Chain Protein Levels in HIV Positive Subjects with Neuropathy Anne D. Yacoub, MD
05:30 PM - 06:30 PM EDT	Abstract	4-006 - Inhibiting Mononuclear Phagocyte Functions in a HIV Associated Neurocognitive Disorders Mouse Model William R. Tyor, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-007 - Occurrence of pneumocystis pneumonia in patients with neurological disease on immunosuppression: a single-center investigation
05:30 PM - 06:30 PM EDT	Abstract	4-008 - Minimal Effect on Cognitive Function Despite High Prevalence of Mental Health Disorders in Treated HIV Elizabeth Horne
05:30 PM - 06:30 PM EDT	Abstract	4-009 - Inflammatory HIV-associated progressive multifocal leukoencephalopathy associated with high CD4 count Joy Z. Ding, MD
05:30 PM - 06:30 PM EDT	Abstract	4-010 - Thrombotic thrombocytopenic purpura (TTP) presenting with severe neurological manifestations in a patient with well-controlled HIV-1 Tara A. Kimbrough, MD
05:30 PM - 06:30 PM EDT	Abstract	4-011 - Immune Reconstitution Inflammatory Syndrome in a newly diagnosed patient with HIV and Central Nervous System Tuberculosis (TB) Osama M. Abu-hadid, MD
05:30 PM - 06:30 PM EDT	Abstract	4-012 - PML presenting as an isolated vertigo: a diagnositic challange Bayan Moustafa, DO
05:30 PM - 06:30 PM EDT	Abstract	4-013 - An Unusual Case of Multiple-Ring-Enhancing Lesions on Brain MRI in Varicella Zoster Virus Encephalitis Tasneem F. Hasan, MD
05:30 PM - 06:30 PM EDT	Abstract	4-014 - Hepatitis E virus infection and posterior reversible encephalopathy syndrome: a case report and review of the literature. Andrea Loggini, MD, MPH MBA
05:30 PM - 06:30 PM EDT	Abstract	4-015 - Abulia: A case of Powassan Encephalitis Nilufer Yalcin, MD
05:30 PM - 06:30 PM EDT	Abstract	4-016 - West Nile encephalitis in a patient with initially negative CSF serology. Paul Sanmartin, MD
05:30 PM - 06:30 PM EDT	Abstract	4-017 - A Bird Whisperer’s Tale: The unique occurrence of stroke as a precursor to diagnosing West Nile Meningoencephalitis. Sneha Jacob, MD
05:30 PM - 06:30 PM EDT	Abstract	4-018 - Case Series: Congenital Zika Virus Infection associated with Epileptic Spasms Mayela Marie Diaz Diaz, MD
05:30 PM - 06:30 PM EDT	Abstract	4-019 - The Diagnosis of Pseudorabies Virus Encephalitis and Endophthalmitis by Next Generation Sequencing in Two Chinese Pork Retailers Lei Liu, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	4-020 - An unusual case of feline-transmitted Rabies: A Diagnostic and Preventative Approach. Freddy Escobar-Montealegre
05:30 PM - 06:30 PM EDT	Abstract	4-021 - An Uncommon Case of Treatment-Responsive SSPE Kate W. Hocquard, MD
05:30 PM - 06:30 PM EDT	Abstract	4-022 - West Nile Virus Neuroinvasive Disease Associated with Rituximab Therapy Micaela R. Owens, DO
05:30 PM - 06:30 PM EDT	Abstract	4-023 - A Quality Improvement Project Studying the Integration of a Proposed Diagnostic Algorithm on Inpatient Encephalitis into the Electronic Medical Record and its Impact on Length of Hospital Stay Tyler Kaplan, MD
05:30 PM - 06:30 PM EDT	Abstract	4-024 - A simple bioinformatics approach to disentangle the etiology and prognosis of CNS infections Kevin Tan, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-025 - Evaluation of BioFire Film Array Meningitis/ Encephalitis (ME) panel in testing of CSF specimen of patients of meningoencephalitis in Indian scenario Anshu Rohatgi, MD, DM, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-026 - Progressive Multifocal Leukoencephalopathy in an Immunocompetent Patient: A Rare Case with Radiologic-Pathologic Correlation Faisal Fecto, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	4-027 - A Case of Hepatitis E Transverse Myelitis Michael Doyle, MRCPI
05:30 PM - 06:30 PM EDT	Abstract	4-028 - Neuroinvasive West Nile Virus: a Case Series in Nebraska Matthew Purbaugh, MD
05:30 PM - 06:30 PM EDT	Abstract	4-029 - West Nile Virus Encephalitis Associated with Intraventricular Diffusion Restriction Neil K. Shetty, MD
05:30 PM - 06:30 PM EDT	Abstract	4-030 - A Case of Presumed Post-Transplant West Nile Virus Encephalitis without CSF Pleocytosis or IgM Positivity Neil K. Shetty, MD
05:30 PM - 06:30 PM EDT	Abstract	4-031 - Cerebrovascular manifestations of herpes simplex virus infection of the central nervous system: a systematic review Larissa I. Sellner, MD
05:30 PM - 06:30 PM EDT	Abstract	4-032 - Super Refractory Status Epilepticus Secondary to La Crosse Virus Encephalitis: A Case Report Leighton Mohl, MD
05:30 PM - 06:30 PM EDT	Abstract	4-033 - Unusual movement disorders and atypical MRI findings in patients with West Nile Encephalitis: A case series of two patients with evidence of clinical and imaging resolution with IVIG Irfan S. Sheikh, MD
05:30 PM - 06:30 PM EDT	Abstract	4-034 - Elsberg Syndrome, The Often Missed Other Cauda Equina Lalanthica Yogendran, MD
05:30 PM - 06:30 PM EDT	Abstract	4-035 - A 59-year-old Immunocompetent Man with Rapid Onset of Truncal Ataxia: A Case of Acute Cerebellitis Secondary to Varicella Zoster Virus. Cassandra P. Cross, MD
05:30 PM - 06:30 PM EDT	Abstract	4-036 - Oculomeningoencephalomyeloradiculitis: A case of fulminant varicella zoster infection in the setting of systemic lupus erythematosus Christopher Perrone, MD
05:30 PM - 06:30 PM EDT	Abstract	4-037 - A Novel Case of Herpes Simplex Encephalitis Complicated by Cerebral Venous Thrombosis Preston J. Eibling, MD
05:30 PM - 06:30 PM EDT	Abstract	4-038 - Neuroinvasive Spectrum of West Nile Virus. Meghana S. Kinariwala, MD
05:30 PM - 06:30 PM EDT	Abstract	4-039 - Post-operative HSV-2 Encephalitis Following Temporal Lobe Resection for Glioblastoma Multiforme Prompan Mingbunjerdsuk, MD
05:30 PM - 06:30 PM EDT	Abstract	4-040 - Acute Myositis in Three Adult Men with Rapid Resolution Laura Danielson, MD
05:30 PM - 06:30 PM EDT	Abstract	4-041 - West Nile Radiculomyelitis Mariana Vinokur, DO
05:30 PM - 06:30 PM EDT	Abstract	4-042 - Measles encephalitis without CSF pleocytosis and typical rash: a case report Hyung Seok Ahn, MD
05:30 PM - 06:30 PM EDT	Abstract	4-043 - Potassium Bromide: The First Successful Treatment of Epilepsy Teng J. Peng, MD
05:30 PM - 06:30 PM EDT	Abstract	4-044 - John Yerbury Dent and Apomorphine: an unfinished history
05:30 PM - 06:30 PM EDT	Abstract	4-045 - Women in History: Neuromuscular Medicine Angela Aziz-Donnelly, MD
05:30 PM - 06:30 PM EDT	Abstract	4-046 - Marie-Foix Syndrome: A Classical Crossed Pontine Syndrome? Guillermo R. Delgado-Garcia, MD, MSc
05:30 PM - 06:30 PM EDT	Abstract	4-047 - Conceptualizing Consciousness as Arousal+Awareness – Historical Parallels from Indian Philosophy Anand Venkatraman, MBBS
05:30 PM - 06:30 PM EDT	Abstract	4-048 - Babinski’s sign from the evolutional point of view "Why would you think that the big toe is related to your brain?" Nada A. Elsaid
05:30 PM - 06:30 PM EDT	Abstract	4-049 - The History of Neurological Serendipities Taha Nisar, MD
05:30 PM - 06:30 PM EDT	Abstract	4-050 - Ophelia’s syndrome revisited.
05:30 PM - 06:30 PM EDT	Abstract	4-051 - Wenceslao López Albo: the unsuspected influence of Cajal and Charcot on Monterrey, México Sergio A. Castillo-Torres, MD
05:30 PM - 06:30 PM EDT	Abstract	4-052 - Headaches in Ulysses Grant Sweta Sengupta, MD
05:30 PM - 06:30 PM EDT	Abstract	4-053 - Parallels to the Modern Understanding of Speech Production in Indian Philosophical History Anand Venkatraman, MBBS
05:30 PM - 06:30 PM EDT	Abstract	4-054 - Gender Disparity Between Neurologists in Brazil: Is It Really Decreasing? Vanessa Dias Veloso, MD
05:30 PM - 06:30 PM EDT	Abstract	4-055 - An 8,000-year History of Use and Abuse of Opium and Opioids: How That Matters For A Successful Control Of The Epidemic ? Sankar Bandyopadhyay, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-056 - A History of Dihydroergotamine in Migraine Sutapa Ray, PhD
05:30 PM - 06:30 PM EDT	Abstract	4-057 - Torres Homem and the Book “Lessons about Nervous System Diseases” of 1878 Ylmar Correa Neto, MD
05:30 PM - 06:30 PM EDT	Abstract	4-058 - Sir Roger Bannister: The Fastest and Famed Neurologist Jordan Mayberry, MD
05:30 PM - 06:30 PM EDT	Abstract	4-059 - Charcot's 1886 Preface to Sœur Jeanne des Anges : Autobiographie d'une hysterique possédée: An English Rendition
05:30 PM - 06:30 PM EDT	Abstract	4-060 - Hypogonadism, alopecia and neurological manifestations: evolving syndromes from an old association. Ali H. Abusrair, MD
05:30 PM - 06:30 PM EDT	Abstract	4-061 - S. Weir Mitchell, Successes and Failures of the Father of American Neurology Abraham Kalikstein, MD
05:30 PM - 06:30 PM EDT	Abstract	4-062 - Neurological Illness on the Supreme Court Eric S. Farbman, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-063 - Reimbursement Does Not Cover Inpatient Costs for tPA-Managed Patients As tPA Cost Has Continued to Rise Cathy A. Sila, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-064 - Implementation of an electronic medical record-enhanced dashboard to optimize pre-rounding for residents on the Stroke Neurology service Kevin F. O'Connor, Jr., MD
05:30 PM - 06:30 PM EDT	Abstract	4-065 - Collaborative Care in Stroke Centers: Role of Neurologists in Implanting Loop Recorders for Detection of Atrial Fibrillation Nabeel Herial, MD, MPH, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-066 - Transition Preparedness: a Pilot Study in Texas Children’s Hospital Muscular Dystrophy Care Clinic JaMis M. Jackson, MD
05:30 PM - 06:30 PM EDT	Abstract	4-067 - Epilepsy: Transition from Pediatric to Adult Care. Recommendations of the Ontario Epilepsy Implementation Task Force Danielle M. Andrade, MD
05:30 PM - 06:30 PM EDT	Abstract	4-068 - Implementing Cognitive Behavior Screening in a Hispanic Cohort with Amyotrophic Lateral Sclerosis Bhavesh Trikamji, MD
05:30 PM - 06:30 PM EDT	Abstract	4-069 - The AAN Live Well, Lead Well Program: Promoting Wellness through Leadership Heidi B. Schwarz, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-070 - A retrospective descriptive study to evaluate physician education on driving practices of patients who develop a neurological condition Emily Elliott, DO
05:30 PM - 06:30 PM EDT	Abstract	4-071 - Documentation of Code Status in Hospitalized Patients: A Pilot Quality Improvement Project Parneet K. Grewal, MD
05:30 PM - 06:30 PM EDT	Abstract	4-072 - Implementation of Standard Note Templates Captures True Level of Service (LOS) Coding Kavit Shah, MD
05:30 PM - 06:30 PM EDT	Abstract	4-073 - Does CMS GMLOS In the Neurological ICU Represent Reality in Academic Medical Centers? Mohammad Hajighasemi-Ossareh, MD
05:30 PM - 06:30 PM EDT	Abstract	4-074 - The Handoff Experience Nicholas S. Streicher, MD
05:30 PM - 06:30 PM EDT	Abstract	4-075 - Improving Hospital Discharge Time: An In-depth Analysis Derek Yuan, MD
05:30 PM - 06:30 PM EDT	Abstract	4-076 - Comparing Patient Perceptions on Multiple Sclerosis Management and Care – A Sub-analysis of Geographic Differences Mitzi J. Williams, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	4-077 - RESIDENT DOCUMENTATION PRACTICES AND NEUROHOSPITALIST GROUP REVENUE Brandon S. Pope, MD
05:30 PM - 06:30 PM EDT	Abstract	4-078 - Effects of Guideline on Prevalence of Cerebral Sinus Venous Thrombosis (CSVT) before and after 2011: Call to Action Smit D. Patel, MD, MPH
05:30 PM - 06:30 PM EDT	Abstract	4-079 - Burnout among practicing neurologists in Massachusetts Connie K. Wu, MD
05:30 PM - 06:30 PM EDT	Abstract	4-080 - Impact of Transthoracic Echocardiogram on Length of Stay and Hospital Charges in Ischemic Stroke and Transient Ischemic Attack Patients in United States: Analysis of Nationwide Inpatient Sample 2006-2014 Huy Q. Nguyen, MD
05:30 PM - 06:30 PM EDT	Abstract	4-081 - Lack of childcare restricts work related travel for physician moms Yasmeen Rauf, MBBS
05:30 PM - 06:30 PM EDT	Abstract	13-001 - A Randomized Trial of Telemedicine for Migraine Management Deborah I. Friedman, MD, MPH, FAAN
05:30 PM - 06:30 PM EDT	Abstract	13-002 - Predictors of Non-Adherence with Acute Migraine Medications Abigail Lofchie, MD
05:30 PM - 06:30 PM EDT	Abstract	13-003 - Rates of Associated Health Conditions in Those with Migraine vs. Non-migraine Controls: Results from the 2017 Migraine in America Symptoms and Treatment (MAST) Study Dawn C. Buse, PhD
05:30 PM - 06:30 PM EDT	Abstract	13-004 - Undiagnosed Chronic Migraine Is Associated With Higher Economic Burden Compared With Diagnosed Chronic Migraine: Results From a Claims-Based Retrospective Study
05:30 PM - 06:30 PM EDT	Abstract	13-005 - Poor Acute Treatment Optimization and Frequent Nausea in Episodic Migraine (EM) are Associated with New Onset Chronic Migraine (CM): Results from 2017 Migraine in America Symptoms and Treatment (MAST) Study Todd J. Schwedt, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	13-006 - OnabotulinumtoxinA wear-off phenomenon in the treatment of chronic migraine Alina Masters-Israilov, MD
05:30 PM - 06:30 PM EDT	Abstract	13-007 - 'Sleep Disturbance and Environmental Reactivity as Potential Mechanisms for Comorbidity of Mood and Anxiety Disorders with Migraine
05:30 PM - 06:30 PM EDT	Abstract	13-008 - Methylation Analyses of Stress-Modified Genes in Migraine Agustin Oterino Duran, MD
05:30 PM - 06:30 PM EDT	Abstract	13-009 - Healthcare Expenditure in Migraine Compared to Other Leading Causes of Disability: Adequate or Not? Leonhard Schaetz
05:30 PM - 06:30 PM EDT	Abstract	13-010 - Message Framing to Determine Best Methods for Discussing Migraine Behavioral Treatments with Persons with Migraine. Adama Jalloh
05:30 PM - 06:30 PM EDT	Abstract	13-011 - A Randomized Controlled Trial to Assess the Effect of Telephone Based Motivational Interviewing on the Initiation and Adherence to Behavioral Therapy for Migraine Mia T. Minen, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	13-012 - Exploring Natural Cohorts of Chronic Migraine Phenotype Yohannes W. Woldeamanuel, MD
05:30 PM - 06:30 PM EDT	Abstract	13-013 - Risk of Worse Short-term Outcomes Associated with hospitalization for migraine and co-morbid psychiatric illness: A Nationwide Population-Based Cohort Study Chirag N. Savani, MD
05:30 PM - 06:30 PM EDT	Abstract	13-014 - Angiotensin Receptor Blockers and ACE Inhibitors for Migraine Prophylaxis - A Systematic Review
05:30 PM - 06:30 PM EDT	Abstract	13-015 - Effect of Galcanezumab on Severity of Headache and Associated Symptoms of Migraine in Phase 3 Trials in Patients with Episodic or Chronic Migraine
05:30 PM - 06:30 PM EDT	Abstract	13-016 - Migraine and Cluster Headache Classification Using a Supervised Machine Learning Approach: A Multimodal MRI Study Roberta Messina, MD, PhD
05:30 PM - 06:30 PM EDT	Abstract	13-017 - Acute Anti-Migraine Prescription Varies According to Baseline Cardiovascular Risk and Clinical Characteristics: A Real-World Evidence Study Hu Li
05:30 PM - 06:30 PM EDT	Abstract	13-018 - Work Activities Associated with Migraine: Results from Migraine in America Symptoms and Treatment (MAST) Study Aftab Alam
05:30 PM - 06:30 PM EDT	Abstract	13-019 - Triptan Use and Discontinuation in a Representative Sample of Persons With Migraine: Results From Migraine in America Symptoms and Treatment (MAST) Study Aftab Alam
05:30 PM - 06:30 PM EDT	Abstract	13-020 - Prophylactic Use of SNRIs to Treat Pediatric Migraine via Reduction of Comorbid Anxiety and Depression Sarah J. McAlister
05:30 PM - 06:30 PM EDT	Abstract	13-021 - Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene?Related Peptide Receptor
05:30 PM - 06:30 PM EDT	Abstract	13-022 - Response to Lasmiditan for Acute Treatment of Migraine Based on Prior Response to Triptan Therapy Kerry L. Knievel, DO
05:30 PM - 06:30 PM EDT	Abstract	13-023 - Impact of OnabotulinumtoxinA on Quality of Life, Health Resource Utilization, and Work Productivity in People With Chronic Migraine: Interim Results From a Prospective, Observational Study (PREDICT) Goran Davidovic, MD
05:30 PM - 06:30 PM EDT	Abstract	13-024 - Eptinezumab Increases Days Free from Canonical Migraine-Associated Symptoms Within 1 Month of Treatment in Patients with Chronic Migraine Jack D. Schim, MD, FAAN
05:30 PM - 06:30 PM EDT	Abstract	13-025 - Does the presence of Cranial Autonomic Symptoms in Chronic Migraine Patients Predict Efficacy of Botox Injections? Nina Y. Riggins, MD, FAAN

Faculty Disclosures
Werner J. Becker, MD	Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Discussion moderator / speaker with Pfizer. Dr. Becker has a non-compensated relationship as a Board Member with Migraine Canada that is relevant to AAN interests or activities. Dr. Becker has a non-compensated relationship as a Board Member with Pain Society of Alberta that is relevant to AAN interests or activities.
Felix Benninger, MD	Dr. Benninger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurohelp.
Meetu Bhogal, MSc	No disclosure on file
Maria Pyle	Ms. Pyle has nothing to disclose.
Ayman E. Hassan, MD, FAAN	Dr. Hassan has nothing to disclose.
	No disclosure on file
Jonathan J. Sackett	No disclosure on file
Theodore Larson	Theodore Larson has nothing to disclose.
Emmanuel O. Akano, MD	Dr. Akano has nothing to disclose.
Rachel J. Saunders-Pullman, MD	The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.
Enrique Alvarez, MD, PhD	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Sanjeev V. Kothare, MD, FAAN	Dr. Kothare has nothing to disclose.
Harini Sarva, MD, FAAN	Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuroderm. Dr. Sarva has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Insightec. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Sun Pharma. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. The institution of Dr. Sarva has received research support from National Institute of Aging. The institution of Dr. Sarva has received research support from Michael J Fox Foundation. The institution of Dr. Sarva has received research support from Novo Nordisk. The institution of Dr. Sarva has received research support from Bukwang. The institution of Dr. Sarva has received research support from Bial. The institution of Dr. Sarva has received research support from Cerevance. The institution of Dr. Sarva has received research support from UCB. The institution of Dr. Sarva has received research support from MeiraGTX. The institution of Dr. Sarva has received research support from Biohaven. The institution of Dr. Sarva has received research support from Vima.
Eliza M. Gordon-Lipkin, MD	No disclosure on file
Bette DeMasters, MD	No disclosure on file
Leah R. Hanson, PhD	The institution of Dr. Hanson has received research support from NIA. The institution of Dr. Hanson has received research support from Merck Foundation. The institution of Dr. Hanson has received research support from Eagle Pharmaceuticals. The institution of Dr. Hanson has received research support from Research Grow Lab. The institution of Dr. Hanson has received research support from State of Minnesota. Dr. Hanson has received intellectual property interests from a discovery or technology relating to health care.
Hooman Kamel, MD	Dr. Kamel has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Kamel has received personal compensation in the range of $50,000-$99,999 for serving as a Endpoint adjudication committee with Boehringer-Ingelheim.
Mark F. Gordon, MD, FAAN	Dr. Gordon has received personal compensation for serving as an employee of Teva. Dr. Gordon has stock in Teva.
Fadar O. Otite, MD	Dr. Otite has nothing to disclose.
Michael Potchen	Michael Potchen has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Jackson & Campbell, P.C.. Michael Potchen has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Rotezel & Andress.
Marisel Vazquez, MD	Dr. Vazquez has nothing to disclose.
Jeffrey L. Bennett, MD, PhD, FAAN	Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immpact Bio. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIAC. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Bennett has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vindico. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Touch IME. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient LLC. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marie Bush. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marks Gray. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Knight, Nicastro, MacKay. The institution of Dr. Bennett has received research support from Alexion. The institution of Dr. Bennett has received research support from Genentech. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Mia T. Minen, MD, FAAN	The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Kevin M. Barrett, MD, FAAN	Dr. Barrett has nothing to disclose.
Wissam G. Deeb, MD	Dr. Deeb has a non-compensated relationship as a Board member with Davis Phinney Foundation that is relevant to AAN interests or activities.
Bassem I. Yamout, MD, FAAN	Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Benjamin H. Brinkmann, PhD	Dr. Brinkmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Brinkmann has stock in Cadence Neuroscience. The institution of Dr. Brinkmann has received research support from Epilepsy Foundation of America. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from UNEEG A/S. The institution of Dr. Brinkmann has received research support from Seer Medical Pty. The institution of Dr. Brinkmann has received research support from Neurelis Inc. Dr. Brinkmann has received intellectual property interests from a discovery or technology relating to health care.
Joy R. Esterlitz	No disclosure on file
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Charles H. Adler, MD, PhD, FAAN	Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Anna Marisa Cervantes-Arslanian, MD, FAAN	Dr. Cervantes-Arslanian has nothing to disclose.
Edward J. Fine, MD, FAAN	Dr. Fine has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Friends of PALS (People with ALS.
Robert J. Fox, MD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Jayashree Sundararajan, MD	Dr. Sundararajan has nothing to disclose.
Ram Mohan R. Sankaraneni, MD, FANA, FAES, FAAN	Dr. Sankaraneni has nothing to disclose.
Amy A. Pruitt, MD, FAAN	Dr. Pruitt has nothing to disclose.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Edgar Samaniego, MD, FAAN	Dr. Samaniego has received personal compensation for serving as an employee of University of Iowa. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Terumo Neuro. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rapid Medical. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for J&J Neuro. Dr. Samaniego has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Metronic. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as a Consultant for iSchemaView. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Society of Neurointerventional Surgery. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neurointerventional Surgery.
Brian Litt, MD	Dr. Litt has received personal compensation in the range of $0-$499 for serving as a Consultant for Beacon Neurosystems. Dr. Litt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UNEEG. Dr. Litt has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Epiminder. Dr. Litt has stock in Orph AI. Dr. Litt has stock in Hyperfine. Dr. Litt has stock in Detect. Dr. Litt has stock in Butterfly. Dr. Litt has stock in Identifeye. Dr. Litt has stock in Protein Evolution. The institution of Dr. Litt has received research support from Mirowski Foundation. The institution of Dr. Litt has received research support from Jonathan and Bonnie Rothberg. The institution of Dr. Litt has received research support from Neil and Barbara Smit. Dr. Litt has received intellectual property interests from a discovery or technology relating to health care.
Eduard Bercovici, MD	No disclosure on file
Heather Jordan, MPH, CPH, MCHES	No disclosure on file
Nicholas L. Zalewski, MD	Dr. Zalewski has nothing to disclose.
Peter Goadsby, MD, PhD, FRS	Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kallyope. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seaport Therapeutics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr Reddy's. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from NIHR. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities.
David E. Newman-Toker, MD, PhD, FAAN	The institution of Dr. Newman-Toker has received research support from NIH, AHRQ, AHA, Moore Foundation. Dr. Newman-Toker has received intellectual property interests from a discovery or technology relating to health care.
Neha Prakash, MD	The institution of Dr. Prakash has received research support from UCB Biosciences Inc.. The institution of Dr. Prakash has received research support from Parkinson Foundation.
Carlos Ynigo D. Lopez, MD	Dr. Lopez has nothing to disclose.
Mark Hallett, MD, FAAN	Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a Past-President with Functional Neurological Disorder Society that is relevant to AAN interests or activities.
Salvador Cruz-Flores, MD, FAAN	The institution of Dr. Cruz-Flores has received research support from University of Texas System.
Francesca Sangalli	No disclosure on file
Jinny O. Tavee, MD	Dr. Tavee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Tavee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Tavee has received research support from Woolsey. The institution of Dr. Tavee has received research support from Milken Foundation. The institution of Dr. Tavee has received research support from CSL Behring. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as a Article author with Medlink.
Marina K. Alvim	Dr. Alvim has nothing to disclose.
Myla D. Goldman, MD, MSc, FAAN	Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis Pharmceuticals. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniska. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics Ltd., . Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Goldman has received personal compensation in the range of $0-$499 for serving as a Grant Review Committee Member with Department of Defense.
Aaron E. Miller, MD, FAAN	Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Elizabeth Seng, PhD	Dr. Seng has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Seng has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Seng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Seng has received research support from NCCIH. Dr. Seng has received research support from Cystic Fibrosis Foundation. The institution of Dr. Seng has received research support from American Heart Association.
Jimmy R. Fulgham, MD	No disclosure on file
Marcia E. Morita-Sherman, MD	An immediate family member of Dr. Morita-Sherman has received personal compensation for serving as an employee of Forrester Research. Dr. Morita-Sherman has received personal compensation for serving as an employee of Eisai Inc.. An immediate family member of Dr. Morita-Sherman has stock in Forrester Research. The institution of Dr. Morita-Sherman has received research support from Cleveland Clinic.
Mered Parnes, MD	Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Parnes has received research support from NIH. The institution of Dr. Parnes has received research support from Alexion.
Kartavya Sharma, MD	Dr. Sharma has nothing to disclose.
Namita Goyal, MD, FAAN	Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Souffle. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Goyal has received research support from Fulcrum. The institution of Dr. Goyal has received research support from Healey Platform. The institution of Dr. Goyal has received research support from Medicinova. The institution of Dr. Goyal has received research support from Transposon. The institution of Dr. Goyal has received research support from Abcuro. The institution of Dr. Goyal has received research support from Calico. The institution of Dr. Goyal has received research support from Clene. The institution of Dr. Goyal has received research support from Janssen. The institution of Dr. Goyal has received research support from PepGen. The institution of Dr. Goyal has received research support from PTC. The institution of Dr. Goyal has received research support from Roche. The institution of Dr. Goyal has received research support from Sanofi. The institution of Dr. Goyal has received research support from Prilenia. The institution of Dr. Goyal has received research support from RAPA. The institution of Dr. Goyal has received research support from Avidity. Dr. Goyal has received publishing royalties from a publication relating to health care.
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Charles J. Bae, MD	Dr. Bae has nothing to disclose.
Neeta Garg, MD	Dr. Garg has nothing to disclose.
Elham Bayat, MD	Dr. Bayat has nothing to disclose.
Seol-Hee Baek, MD	Dr. Baek has nothing to disclose.
Joseph E. Safdieh, MD, FAAN	Dr. Safdieh has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Safdieh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, P.C.. Dr. Safdieh has received publishing royalties from a publication relating to health care.
Jeffrey Rosenfeld, MD, PhD, FAAN	Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ML Biosolutions. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MT Pharma America. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroSense. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexion. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurizon. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serano/EMD. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anelixis. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcuraStem. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroSense. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MT Pharma America. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Strongbridge Pharma. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Rosenfeld has received research support from MT Pharma. The institution of Dr. Rosenfeld has received research support from Alexion. The institution of Dr. Rosenfeld has received research support from Healey ALS Trial Center Mass General.
Adeline Vanderver, MD, FAAN	An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
Mandip S. Dhamoon, MD, MPH	Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Faegre Baker Daniels LLP. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wellstar Health System Inc. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Fabiani Cohen & Hall, LLP. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kramer, Dillof, Livingston & Moore. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Robins Kaplan. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Parker Waichman LLP. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Heidell, Pittoni, Murphy & Bach, LLP.
John D. Steffens, MD	Dr. Steffens has nothing to disclose.
Rima Dafer, MD	Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Dafer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Anderson, Rasor, and partners.
Jaime Toro, MD, FAAN	Dr. Toro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Watch Neurology .
Sabrina Paganoni, MD, PhD	Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jannsen. Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Paganoni has received personal compensation in the range of $0-$499 for serving as a Consultant for Sola. Dr. Paganoni has received personal compensation in the range of $0-$499 for serving as a Consultant for Frequency Therapeutics. The institution of Dr. Paganoni has received research support from Amylyx. The institution of Dr. Paganoni has received research support from Revalesio. The institution of Dr. Paganoni has received research support from Alector. The institution of Dr. Paganoni has received research support from UCB. The institution of Dr. Paganoni has received research support from Biohaven. The institution of Dr. Paganoni has received research support from Clene. The institution of Dr. Paganoni has received research support from Prilenia. The institution of Dr. Paganoni has received research support from Seelos. The institution of Dr. Paganoni has received research support from Calico. The institution of Dr. Paganoni has received research support from Denali. The institution of Dr. Paganoni has received research support from Anelixis. The institution of Dr. Paganoni has received research support from Cytokinetics.
Mahan Chehrenama, DO	No disclosure on file
Andrew Zillgitt, DO	Dr. Zillgitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Zillgitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Zillgitt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB. Dr. Zillgitt has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst. Dr. Zillgitt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Zillgitt has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Lifescience.
Erika Shelton	No disclosure on file
Tamara M. Pringsheim, MD, FAAN	The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
Todd J. Schwedt, MD, FAAN	Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Schwedt has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Schwedt has stock in Aural Analytics. Dr. Schwedt has stock in Nocira. Dr. Schwedt has stock in Allevalux. The institution of Dr. Schwedt has received research support from National Institutes of Health. The institution of Dr. Schwedt has received research support from United States Department of Defense. The institution of Dr. Schwedt has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Schwedt has received research support from SPARK Neuro. The institution of Dr. Schwedt has received research support from Henry Jackson Foundation. The institution of Dr. Schwedt has received research support from Pfizer. The institution of Dr. Schwedt has received research support from National Headache Foundation. The institution of Dr. Schwedt has received research support from American Heart Association. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received publishing royalties from a publication relating to health care.
Douglas C. Wallace	No disclosure on file
Raul G. Nogueira, MD	Dr. Nogueira has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, and Synchron (consulting fees) as well as for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze ( stock options). Dr. Nogueira has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firms. Dr. Nogueira has received stock or an ownership interest from Viz-AI, Perfuze, Cerebrotech, Reist/Q'Apel Medical, Truvic, and Viseon. The institution of Dr. Nogueira has received research support from Cerenovus.
Nina Y. Riggins, MD, FAAN	Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Gerson Lehrman Group . Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal Pharmaceuticals. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeurologyLive. The institution of Dr. Riggins has received research support from ElectroCore (GammaCore). The institution of Dr. Riggins has received research support from Miles for Migraine. The institution of Dr. Riggins has received research support from Eli Lilly. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has a non-compensated relationship as a PI on research study with TheraSpecs that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Advisory Board with NeurologyLive that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Member of the Board with Miles for Migraine that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI in the study which used sphenocath device with Dolor Technologies that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI with Theranica that is relevant to AAN interests or activities.
Peter W. Kaplan, MBBS, FRCP, FAAN	Dr. Kaplan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for DNP Epiwatch. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for IFCN. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Kaplan has received publishing royalties from a publication relating to health care.
George Grossberg, MD	Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioXcel. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Karuna. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maplight Therapeutics. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Grossberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anavex. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Newron. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oligomerix. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quince. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka. The institution of Dr. Grossberg has received research support from NIA. The institution of Dr. Grossberg has received research support from Functional Neuromodulation .
Sven G. Meuth	Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Jordan Mayberry, MD	Dr. Mayberry has nothing to disclose.
Derek Yuan, MD	Dr. Yuan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Yuan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer.
Daniella Miller, MD	Dr. Miller has nothing to disclose.
Fernando X. Cuascut Lassus, MD	Dr. Cuascut Lassus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Cuascut Lassus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Cuascut Lassus has received personal compensation in the range of $500-$4,999 for serving as a Speaker with MSAA.
Jeffrey Ruta, MD	Dr. Ruta has nothing to disclose.
Lucas Alessandro, Sr., MD	Dr. Alessandro has nothing to disclose.
Yuri Falzone	Yuri Falzone has nothing to disclose.
Jose E. Cavazos, MD, PhD	Dr. Cavazos has received stock or an ownership interest from Brain Sentinel . The institution of Dr. Cavazos has received research support from NIH.
Bruce A. Cree, MD, PhD, MAS, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Ursula Boschert Shafaatian	Ursula Boschert has nothing to disclose.
Troy Lund	No disclosure on file
Christina Lineback, MD	Dr. Lineback has nothing to disclose.
Wisam Elmalik, MD	No disclosure on file
Michael S. Okun, MD, FAAN	Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Teresa V. Corona Vazquez, MD	Dr. Corona Vazquez has received research support from Consejo Nacional de Ciencia y Tecnologia.
David W. Dodick, MD, FAAN	Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical ��ɫ�� Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with ��ɫ�� that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Rocio C. Garcia Santibanez, MD, FAAN	Dr. Garcia Santibanez has nothing to disclose.
Tahseen Mozaffar, MD, FAAN	Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Lily Wong-Kisiel, MD, FAAN	Dr. Wong-Kisiel has nothing to disclose.
Chafic Y. Karam, MD	Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alnylam. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied therapeutics. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intellia. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex.
Kavit Shah, MD	Dr. Shah has nothing to disclose.
Shumaila Sultan, MD, FAAN	Dr. Sultan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN	Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharma. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Genomate Health. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Alpheus medical. The institution of Dr. Mechtler has received research support from Shiratronics. The institution of Dr. Mechtler has received research support from Abbvie Inc. The institution of Dr. Mechtler has received research support from Amgen. The institution of Dr. Mechtler has received research support from Eli Lilly Company. The institution of Dr. Mechtler has received research support from H. Lundbeck HS. The institution of Dr. Mechtler has received research support from Pfizer. Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Ownership interest with Neurology Practce Consortium GPO. Dr. Mechtler has a non-compensated relationship as a Board member with International Headache Society that is relevant to AAN interests or activities.
Amy Pappas, DO	Dr. Pappas has nothing to disclose.
Maria G. Cersosimo, MD	No disclosure on file
Kavita Nair, PhD, FAAN	Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH Lifesciences. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Patient Experience. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MHJ Life Sciences. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ICER. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS. The institution of Dr. Nair has received research support from Sanofi Genzyme. The institution of Dr. Nair has received research support from Kyverna Therapeutcis. Dr. Nair has a non-compensated relationship as a Board Member with Center for Improving Value in Healthcare that is relevant to AAN interests or activities.
Dinesh V. Jillella, MD	Dr. Jillella has nothing to disclose.
Stefan Sillau	Stefan Sillau has nothing to disclose.
Catherine Miller	Catherine Miller has received personal compensation for serving as an employee of Biogen. Catherine Miller has received stock or an ownership interest from Biogen.
Laura Danielson, MD	Dr. Danielson has nothing to disclose.
Jordan J. Cole, MD	The institution of Dr. Cole has received research support from Child Neurology Career Development Program K12 (through NINDS, 5K12NS098482-07). Dr. Cole has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with American Epilepsy Society.
Lenka Hvizdosova	No disclosure on file
Marie Wencel, CCRP	Ms. Wencel has nothing to disclose.
Lynn Do, PharmD	Dr. Do has received personal compensation for serving as an employee of Eli Lilly.
Margaret M. Swanberg, DO	Dr. Swanberg has nothing to disclose.
Jose Rivera, MD	No disclosure on file
Cecilia Fernandes, MD	No disclosure on file
Diana Tzeng, MD	Dr. Tzeng has nothing to disclose.
Zivar Hajiyeva, MD	No disclosure on file
Krista Schroeder	Krista Schroeder has received personal compensation for serving as an employee of Eli Lilly and Company.
Carrie M. Hersh, DO, MSc, FAAN	Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech_GN41791. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb . Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Hersh has received research support from Biogen. The institution of Dr. Hersh has received research support from Novartis. The institution of Dr. Hersh has received research support from Genentech_GN41791. The institution of Dr. Hersh has received research support from PCORI. The institution of Dr. Hersh has received research support from Bristol Myers Squibb.
Clover Youn, MD	Dr. Youn has nothing to disclose.
Le Hua, MD, FAAN	Dr. Hua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Hua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapuetics. The institution of Dr. Hua has received research support from Genentech.
Connie K. Wu, MD	Dr. Wu has nothing to disclose.
Steven Frucht, MD	Dr. Frucht has nothing to disclose.
Leticia Tornes, MD, FAAN	Dr. Tornes has nothing to disclose.
Mauro Zaffaroni	No disclosure on file
Shelly K. Weiss, MD	No disclosure on file
Robert A. Brown, PhD	Dr. Brown has received stock or an ownership interest from ShadowLab Research Inc.. Dr. Brown has received intellectual property interests from a discovery or technology relating to health care. Dr. Brown has a non-compensated relationship as a consultant with the Population Council that is relevant to AAN interests or activities.
Mitchell Silver, MD	Dr. Silver has nothing to disclose.
Virginia Meca Lallana	Virginia Meca Lallana has nothing to disclose.
Angela M. Hawkins, RN	No disclosure on file
Fabian Sierra Morales, MD	The institution of Dr. Sierra Morales has received research support from Rush Equity office .
Roman Rubio	Roman Rubio has received personal compensation for serving as an employee of Revance.
Shashishekha J. Lamdhade, MD	No disclosure on file
Mariana Espinosa-Polanco	No disclosure on file
John W. Rose, MD, FAAN	The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Sarosh R. Irani, MD, PhD, FRCP, FEAN	Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AZ, Roche, Cerebral therapeutics, Biogen, Amgen, Argenex, Clarivate, IQVIA, BioHaven therapeutics.. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care.
Lisa Mosconi	No disclosure on file
Henri D. Becker, MD	No disclosure on file
Andrew Solomon, MD, FAAN	Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche . Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiniksa Pharmaceuticals . Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Solomon has received research support from Bristol Meyers Squibb.
S. A. Josephson, MD, FAAN	Dr. Josephson has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Josephson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw Hill---Harrison's Principles of Internal Medicine. Dr. Josephson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Josephson has received research support from NINDS. Dr. Josephson has received publishing royalties from a publication relating to health care. Dr. Josephson has received publishing royalties from a publication relating to health care.
Shannon Anderson, PA, DAAN	Mrs. Anderson has nothing to disclose.
J. David Avila, MD, FAAN	Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Avila has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
Churl-Su Kwon, MBBS	Dr. Kwon has nothing to disclose.
Jeffrey M. Chavin, MD, FAAN	Dr. Chavin has received personal compensation for serving as an employee of Sanofi. Dr. Chavin has stock in Sanofi.
Dawn C. Buse, PhD	Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
H. A. Jinnah, MD, PhD, FAAN	Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takaha/Ene. Dr. Jinnah has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Jinnah has received research support from Addex. The institution of Dr. Jinnah has received research support from Aeon. The institution of Dr. Jinnah has received research support from Revance. The institution of Dr. Jinnah has received research support from Jazz.
Marisa P. McGinley, DO	Dr. McGinley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. McGinley has received research support from Biogen. The institution of Dr. McGinley has received research support from Genentech. The institution of Dr. McGinley has received research support from NIH. The institution of Dr. McGinley has received research support from AHRQ. The institution of Dr. McGinley has received research support from EMD Serono.
Alexandra Boubour	Ms. Boubour has received research support from The Fulbright Program.
Julie C. Uchitel	No disclosure on file
Audrey Halpern, MD	Dr. Halpern has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for abbvie.
Shaun Ajinkya, MD	No disclosure on file
Lakshman N. Arcot Jayagopal, MD	Dr. Arcot Jayagopal has nothing to disclose.
Sanskriti Sasikumar, MD	Dr. Sasikumar has nothing to disclose.
William I. Hong, MD	No disclosure on file
Katherine Shulman, NP	No disclosure on file
Hunter Edwards, DO	No disclosure on file
Marianne Ulcickas Yood, DSc	No disclosure on file
Alberto Lozano Ros	No disclosure on file
Ana Graf, MD	No disclosure on file
Alessandra Adamo	No disclosure on file
Shitiz K. Sriwastava, MBBS	Dr. Sriwastava has nothing to disclose.
Joan Jasien, MD	No disclosure on file
Eunjin Kwon, MD	No disclosure on file
Joseph J. Melvin, DO	Dr. Melvin has received personal compensation in the range of $100,000-$499,999 for serving as a Physican with Tower health.
Firas A. Taha, MD	No disclosure on file
Kathrin Husmann, MD	No disclosure on file
Eric Segal, MD	Dr. Segal has received personal compensation for serving as an employee of Lundbeck. Dr. Segal has received personal compensation for serving as an employee of Eisai. Dr. Segal has received personal compensation for serving as an employee of Neurelis. Dr. Segal has received personal compensation for serving as an employee of Zogenix. Dr. Segal has received personal compensation for serving as an employee of Aquestive. Dr. Segal has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwhich Bioscience. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwhich Bioscience. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
Ester Carreon Guarnizo	Ester Carreon Guarnizo has nothing to disclose.
Neda Sattarnezhad Oskouei, MD	Dr. Sattarnezhad Oskouei has received research support from National Institutes of Health (NIH). Dr. Sattarnezhad Oskouei has received research support from National Institute of Allergy and Infectious Diseases (NIAID).
Erin Smith, MD	Dr. Smith has nothing to disclose.
Larissa Felt	No disclosure on file
Alex Exuzides	Alex Exuzides has nothing to disclose.
Robert W. Hurst, MD	No disclosure on file
Hema Viswanathan	Ms. Viswanathan has received personal compensation for serving as an employee of Allergan plc. Ms. Viswanathan has received personal compensation for serving as an employee of Precision Medicine Group. Ms. Viswanathan has received stock or an ownership interest from Allergan plc. Ms. Viswanathan has received stock or an ownership interest from Precision Medicine Group.
Ahmed Saied	Mr. Saied has nothing to disclose.
Tyler Kaplan, MD	Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono . Dr. Kaplan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave Biosciences. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Kaplan has received personal compensation in the range of $100,000-$499,999 for serving as a Speaker with EMD Serono. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker with Amgen. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker with TG Therapeutis. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker with Biogen.
Shahnaz Miri, MD	Dr. Miri has received intellectual property interests from a discovery or technology relating to health care.
Loulwah Mukharesh, MD	Dr. Mukharesh has nothing to disclose.
Mahdieh Hosseini, MD	No disclosure on file
Sherri A. Braksick, MD, FAAN	Dr. Braksick has nothing to disclose.
G. P. Gliebus, MD, FAAN	Dr. Gliebus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai.
Tony Alvaro, MBBS, FRACP	No disclosure on file
Laurie Wagner	Laurie Wagner has nothing to disclose.
Yanan Wang	No disclosure on file
Mary S. Feldman, DO, FAAN	Dr. Feldman has nothing to disclose.
Jonathan R. Galli, MD	Dr. Galli has nothing to disclose.
Robin Warner, DO	Dr. Warner has nothing to disclose.
Mohamed Taha, MD	Dr. Taha has nothing to disclose.
Alejandro Thomson, MD	Dr. Thomson has nothing to disclose.
Tracey H. Fan, DO	Dr. Fan has nothing to disclose.
May A. Kim-Tenser, MD, MHA, FAHA	Dr. Kim-Tenser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi.
Danmeng Wei, MBBS	No disclosure on file
Fulvio R. Gil, MD	No disclosure on file
Christopher Perrone, MD	Dr. Perrone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono.
Yohannes W. Woldeamanuel, MD	Dr. Woldeamanuel has received personal compensation in the range of $0-$499 for serving as a Consultant for Atheneum. Dr. Woldeamanuel has received personal compensation in the range of $0-$499 for serving as a Consultant for Research Square. The institution of Dr. Woldeamanuel has received research support from NINDS.
Pei-Ran Ho	No disclosure on file
Smathorn Thakolwiboon, MD	Dr. Thakolwiboon has nothing to disclose.
Anil Ramineni, MD	Dr. Ramineni has nothing to disclose.
Eleanor V. Thomas, MD, PhD	Dr. Thomas has nothing to disclose.
Janet F. Waters, MD, FAAN	An immediate family member of Dr. Waters has received personal compensation for serving as an employee of Haemonetics. An immediate family member of Dr. Waters has received personal compensation for serving as an employee of Vitalant. An immediate family member of Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haemonetics. An immediate family member of Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vitalant. An immediate family member of Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Vitalant. An immediate family member of Dr. Waters has received publishing royalties from a publication relating to health care.
Jason H. Karlawish, MD	No disclosure on file
Maria Zurru	No disclosure on file
Cara Jacob, MD	No disclosure on file
Marcelo Rocha, MD, PhD	The institution of Dr. Rocha has received research support from NIH.
Nan Zhang	Nan Zhang has nothing to disclose.
Catherine Hassett, MD	Dr. Hassett has nothing to disclose.
Jaime G. Gallego, MD	No disclosure on file
Jessica Langbaum, PhD	Dr. Langbaum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Langbaum has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Denovo Biopharma. Dr. Langbaum has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Langbaum has received research support from Eli Lilly.
Kevin F. O'Connor, Jr., MD	Dr. O'Connor has nothing to disclose.
Francisca Millan Zamora, MD	No disclosure on file
Agustin Pappolla, MD	Dr. Pappolla has nothing to disclose.
William B. Young, MD, FAAN	Dr. Young has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Young has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven Pharmaceuticals Inc. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Coalition for Headache and Migraine Patients. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Miles for Migraine. The institution of Dr. Young has received research support from Amgen. The institution of Dr. Young has received research support from Cumberland. The institution of Dr. Young has received research support from Eli Lilly. The institution of Dr. Young has received research support from Novartis. The institution of Dr. Young has received research support from PCORI. The institution of Dr. Young has received research support from Satsuma. The institution of Dr. Young has received research support from Scion. The institution of Dr. Young has received research support from Teva. The institution of Dr. Young has received research support from Zosano.
Ali A. Habib, MD	Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/ Amgen. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jansen/Johnson & Johnson. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMDSerono/Merck. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jansen/Joohnson & Johnson. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from Horizon/Amgen. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Regeneron. The institution of Dr. Habib has received research support from Arcellx. The institution of Dr. Habib has received research support from Novartis. The institution of Dr. Habib has received research support from EMDSerono/Merck. The institution of Dr. Habib has received research support from Cour Pharmaceuticals.
John-Michael Li, MD	No disclosure on file
Burcu Altunrende, MD	No disclosure on file
Cory J. Rice, MD	No disclosure on file
Nolan Campbell	Nolan Campbell has received personal compensation for serving as an employee of Biogen. Nolan Campbell has stock in Biogen.
Lakshmi Leishangthem, MD, MBBS	Dr. Leishangthem has nothing to disclose.
Ricardo D. Bernater	No disclosure on file
Olivia Begasse De Dhaem, MD	Dr. Begasse De Dhaem has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Begasse De Dhaem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for JOGO. Dr. Begasse De Dhaem has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Begasse De Dhaem has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pain Medicine Journal. Dr. Begasse De Dhaem has received publishing royalties from a publication relating to health care.
Shreya Nayak, MD	Dr. Nayak has nothing to disclose.
Adama Jalloh	No disclosure on file
Xilma R. Ortiz-Gonzalez, MD, PhD	The institution of Dr. Ortiz-Gonzalez has received research support from Robert Wood Johnson Foundation . The institution of Dr. Ortiz-Gonzalez has received research support from NINDS.
William P. Roche, MD	No disclosure on file
Brooke Lubinski	No disclosure on file
Amanda L. Piquet, MD, FAAN	The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
Ih Chang	Ih Chang has received personal compensation for serving as an employee of Cerevel. Ih Chang has received stock or an ownership interest from Cerevel Therapeutics.
Aleksej Zuzek, PhD	Dr. Zuzek has received personal compensation for serving as an employee of AbbVie Inc.. Dr. Zuzek has stock in AbbVie Inc..
Matthew T. Starr, MD	Dr. Starr has nothing to disclose.
Srinivas Shankara, PhD	Dr. Shankara has received personal compensation for serving as an employee of Sanofi.
Praveen Hariharan, MD	Dr. Hariharan has nothing to disclose.
Daniel Calame, MD, PhD	Dr. Calame has nothing to disclose.
Alex Mirzoev, MD	Dr. Mirzoev has nothing to disclose.
Sushant Puri, MBBS	Dr. Puri has nothing to disclose.
Robert Unger	No disclosure on file
Elie Sader, MD	No disclosure on file
Sanskruti Patel, MD	No disclosure on file
Liu Ming	No disclosure on file
Ghazaleh Ahmadi Jazi, MD	Dr. Ahmadi Jazi has nothing to disclose.
Mariana R. Brito, MD	No disclosure on file
Juan Marta-Enguita, MD	No disclosure on file
Houda Elloumi, PhD	No disclosure on file
Anne C. Van Cott, MD, FAAN	Dr. Van Cott has nothing to disclose.
Philippe Gailloud, MD	Dr. Gailloud has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerenovus. Dr. Gailloud has received stock or an ownership interest from ArtVentive. The institution of Dr. Gailloud has received research support from Siemens Medical.
Riley Bove, MD, FAAN	Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD-Serono. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Eli Lilly. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Roche Genentech.
Cynthia L. Comella, MD, FAAN	Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Raghav Govindarajan, MD, FAAN	Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
L D. DeWitt, MD	Dr. DeWitt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Annika Anderson	No disclosure on file
Jung Hwa Lee, MD	Dr. Lee has nothing to disclose.
Alon Seifan, MD	Dr. Seifan has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Science Officer with HB Biotech.
Matthew E. Fink, MD, FAAN	Dr. Fink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Relias LLC.
Maurice Vincent, MD, PhD	Prof. Vincent has received personal compensation for serving as an employee of Eli Lilly and Company. Prof. Vincent has stock in Eli Lilly and Company.
Roland Dominic Jamora	Roland Dominic Jamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for torrent. Roland Dominic Jamora has received research support from CCXDP.
Crystal J. Yeo, MD, PhD	Dr. Yeo has nothing to disclose.
David F. Cuellar Giraldo, Jr., MD	Dr. Cuellar Giraldo has nothing to disclose.
Alejandro Kohler	No disclosure on file
Abdullah Alshammaa, MD	Dr. Alshammaa has nothing to disclose.
Parul Goyal, MBBS	Dr. Goyal has nothing to disclose.
William D. Freeman, MD, FAAN	Dr. Freeman has nothing to disclose.
Cara E. Harth, MD, FAAN	Dr. Harth has received personal compensation in the range of $500-$4,999 for serving as a In-House Expert Reviewer with Academic Group.
John Cole, MD	Dr. Cole has nothing to disclose.
Joachim Krauss	No disclosure on file
William R. Tyor, MD, FAAN	The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH.
Lawrence J. Hirsch, MD, FAAN	Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus.
Mark Gudesblatt, MD	The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Finn Sellebjerg, MD	Dr. Sellebjerg has received personal compensation for serving as an employee of Danish Multiple Sclerosis Society. Dr. Sellebjerg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Gangsted Foundation. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Warwara Larsen Foundation. The institution of Dr. Sellebjerg has received research support from Biogen. The institution of Dr. Sellebjerg has received research support from Merck. The institution of Dr. Sellebjerg has received research support from Novartis. The institution of Dr. Sellebjerg has received research support from Sanofi Genzyme. Dr. Sellebjerg has received publishing royalties from a publication relating to health care.
Angela Aziz-Donnelly, MD	No disclosure on file
Amy C. Visser, MD	No disclosure on file
Nilufer Yalcin, MD	Dr. Yalcin has nothing to disclose.
Jonathan Cauchi, MD	Dr. Cauchi has nothing to disclose.
Bela Turk, MD	Dr. Turk has received intellectual property interests from a discovery or technology relating to health care. Dr. Turk has received publishing royalties from a publication relating to health care.
Kristen L. Zemina, MD	Dr. Zemina has nothing to disclose.
Dilip Chary	No disclosure on file
Dan Tong Jia, MD	Dr. Jia has nothing to disclose.
Carla Manterola	No disclosure on file
Parul Agarwal	Parul Agarwal has nothing to disclose.
June Halper, RN, ANP	Ms. Halper has nothing to disclose.
Deepa S. Rajan, MD, FAAN	Dr. Rajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Rajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Rajan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. The institution of Dr. Rajan has received research support from National Scleroderma Foundation. The institution of Dr. Rajan has received research support from Denali Therapeutics. The institution of Dr. Rajan has received research support from Ultragenyx . The institution of Dr. Rajan has received research support from Regenxbio. The institution of Dr. Rajan has received research support from Takeda. The institution of Dr. Rajan has received research support from Prevail Therapeutics. The institution of Dr. Rajan has received research support from Children's Neuroscience Institute. Dr. Rajan has received intellectual property interests from a discovery or technology relating to health care.
Anand Venkatraman, MBBS	No disclosure on file
Sanaz Attaripour, MD, FAAN	Dr. Attaripour has nothing to disclose.
Sean J. Pittock, MD, FAAN	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Brian G. Weinshenker, MD, FAAN	Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Ejaz Shamim, MD, MS, MBA, FAAN	The institution of Dr. Shamim has received research support from Michael J. Fox Foundation.
Dimitri Krainc, MD, PhD	Dr. Krainc has nothing to disclose.
Gonzalo J. Gomez-Arevalo	No disclosure on file
Deepti Chrusciel, MD	Dr. Chrusciel has nothing to disclose.
Avindra Nath, MD, MBBS, FAAN	The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care.
James J. Sejvar, MD, FAAN	Dr. Sejvar has nothing to disclose.
Nadia M. Celestin, BS	Miss Celestin has nothing to disclose.
Amanda C. Guidon, MD, MPH	An immediate family member of Dr. Guidon has received personal compensation for serving as an employee of GE Healthcare. Dr. Guidon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Guidon has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN - Continuum. The institution of Dr. Guidon has received research support from NINDS. Dr. Guidon has received publishing royalties from a publication relating to health care. Dr. Guidon has a non-compensated relationship as a Committee Member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Guidon has a non-compensated relationship as a Executive Committee Member with Neuromuscular Study Group that is relevant to AAN interests or activities.
Niyatee Samudra, MD	Dr. Samudra has nothing to disclose.
Takashi Tsuboi, PhD	No disclosure on file
John Corboy, MD, FAAN	Dr. Corboy has received personal compensation for serving as an employee of U of Coloado. Dr. Corboy has received personal compensation for serving as an employee of Rocky Mountain MS Center. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mylan. Dr. Corboy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Mylan. The institution of Dr. Corboy has received research support from MedDay. The institution of Dr. Corboy has received research support from Novartis. The institution of Dr. Corboy has received research support from NMSS. The institution of Dr. Corboy has received research support from PCORI. The institution of Dr. Corboy has received research support from EMD Serono.
Marie F. Grill, MD	Dr. Grill has nothing to disclose.
Joseph Jankovic, MD, FAAN	Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Lisa T. Emrick, MD	Dr. Emrick has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Arkema. The institution of Dr. Emrick has received research support from Lysogene. The institution of Dr. Emrick has received research support from PTC. The institution of Dr. Emrick has received research support from Roche. The institution of Dr. Emrick has received research support from NIH.
Katharine Alter, MD	Katharine Alter, MD has received personal compensation for serving as an employee of Paradigm Medical Communications. Katharine Alter, MD has received personal compensation for serving as an employee of Cleveland clinic foundation. Katharine Alter, MD has received personal compensation for serving as an employee of Catalyst medical . Katharine Alter, MD has received personal compensation for serving as an employee of AANEM. Katharine Alter, MD has received personal compensation for serving as an employee of Efficiwent CME. Katharine Alter, MD has received publishing royalties from a publication relating to health care.
Gregory Owens, PhD	Dr. Owens has received intellectual property interests from a discovery or technology relating to health care.
Kamakshi Lakshminarayan, MD, PhD	Dr. Lakshminarayan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT Labs. The institution of Dr. Lakshminarayan has received research support from NIH.
Onteddu Reddy	No disclosure on file
Terry R. Barclay, PhD	Dr. Barclay has nothing to disclose.
Mary A. Willis, MD, FAAN	Dr. Willis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb.
Michael D. Geschwind, MD, PhD, FAAN	Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Stefan M. Pulst, MD, FAAN	Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
Diana M. Barratt, MD, MPH, FAAN	Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Legally Pink, LLC. Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Vlantis Law, LLC. Dr. Barratt has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Traub Lieberman. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Callahan Fusco. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Chane Socarras. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Conroy Simberg. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Crandall & Katt. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kelley Kronenberg. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Plakas Mannos. Dr. Barratt has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marshall Denehey. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Pritt & Spano. Dr. Barratt has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Russo Law.
Ellen H. Grober, PhD	No disclosure on file
Alana T. Wong, PhD	No disclosure on file
Brenda L. Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Joohi Jimenez Shahed, MD, FAAN	Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Treefrog. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RebrAIn. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. The institution of Dr. Jimenez Shahed has received research support from Ono Pharmaceuticals. The institution of Dr. Jimenez Shahed has received research support from BlueRock. The institution of Dr. Jimenez Shahed has received research support from Neuron23. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with ��ɫ��. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation.
Julia O'Mahony	Ms. O'Mahony has nothing to disclose.
Sigal Melamed-Gal	No disclosure on file
Yelena G. Pyatkevich, MD	Dr. Pyatkevich has received personal compensation for serving as an employee of Takeda. Dr. Pyatkevich has stock in Takeda.
Elanagan Nagarajan, MD	Dr. Nagarajan has nothing to disclose.
Matthew Chung, MD	No disclosure on file
Walter G. Husar, MD	Dr. Husar has nothing to disclose.
Shivakrishna Kovi, MD, MBBS	Dr. Kovi has nothing to disclose.
Fedor Panov	Fedor Panov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for neuropace. Fedor Panov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for zimmer biomet.
Elia Sechi, MD	Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Magd F. Zakaria, MD	Dr. Zakaria has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Bayer, Novartis, Sanofi Genzyme, Roche and Biogen.
Jonathan W. Mink, MD, PhD, FAAN	The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS.
Vicki Shanker, MD, FAAN	Dr. Shanker has received personal compensation in the range of $0-$499 for serving as a Consultant for The Insighters.
Scott Norris, MD	The institution of Dr. Norris has received research support from NIH, DMRF, Dysphonia International.
Jennifer R. Molano, MD, FAAN	Dr. Molano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society . The institution of Dr. Molano has received research support from National Institutes of Health.
Bruno Giometto, MD	Dr. Giometto has nothing to disclose.
Margaret Adler, MD	Dr. Adler has nothing to disclose.
Christopher McDermott	The institution of Christopher McDermott has received research support from NIHR. The institution of Christopher McDermott has received research support from Motor Neurone Disease Association.
Leighton Mohl, MD	Dr. Mohl has nothing to disclose.
Saul Reyes, MD	Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIIB. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Matthias Kant	Matthias Kant has nothing to disclose.
Alicia E. Bennett, DO	Dr. Bennett has nothing to disclose.
Chirag N. Savani, MD	No disclosure on file
Varun B. Shah, MD	Dr. Shah has nothing to disclose.
Samuel Lichtman-Mikol, BA	Mr. Lichtman-Mikol has nothing to disclose.
Yin A. Liu, MD, FAAN	Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Liu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
William Kielbasa	No disclosure on file
Thomas Duginski, MD	No disclosure on file
Ling Pan, MD	No disclosure on file
Giulia Fadda, MD	Dr. Fadda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon Therapeutics. Dr. Fadda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. Fadda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fadda has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Novartis.
Michael Doyle, MRCPI	No disclosure on file
Mohammad Ghatali, MD	Dr. Ghatali has nothing to disclose.
Deborah I. Friedman, MD, MPH, FAAN	Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Friedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsone. Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology . Dr. Friedman has a non-compensated relationship as a Program Co-Chair, Scottsdale Headache Symposium with American Headache Society that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Medical Advisor with Spinal CSF Leak Foundation that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a President-elect, Board of Directors with Southern Headache Society that is relevant to AAN interests or activities.
Cumara B. O'Carroll, MD, FAAN	Dr. O'Carroll has nothing to disclose.
John Hart, MD	The institution of Dr. Hart has received research support from Department of Defense.
Brent L. Fogel, MD, PhD, FAAN	Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Ataxia Foundation. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ataxia Global Initiative. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genes. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuromarkers. The institution of Dr. Fogel has received research support from the National Institutes of Health. The institution of Dr. Fogel has received research support from the National Ataxia Foundation. The institution of an immediate family member of Dr. Fogel has received research support from the National Institutes of Health, the National Science Foundation, and the Department of Defense. The institution of Dr. Fogel has received research support from US Department of Defense .
May Han, MD	Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arena Pharmaceuticals.
Mitzi J. Williams, MD, FAAN	Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen Idec. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis Pharmaceuticals. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Williams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Williams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Williams has received publishing royalties from a publication relating to health care. Dr. Williams has received publishing royalties from a publication relating to health care. Dr. Williams has a non-compensated relationship as a National Board Member with National MS Society that is relevant to AAN interests or activities. Dr. Williams has a non-compensated relationship as a Board Trustee with Consortium of MS Centers that is relevant to AAN interests or activities. Dr. Williams has a non-compensated relationship as a Board Chair with Joi Life Foundation that is relevant to AAN interests or activities.
Reid D. Taylor, MD	Dr. Taylor has nothing to disclose.
Ahmad El Kouzi, MD, FAAN	Dr. El Kouzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Silvia Basaia	Silvia Basaia has nothing to disclose.
Erica Marini	No disclosure on file
Andrea I. Ciplea	An immediate family member of Ms. Ciplea has received personal compensation for serving as an employee of Astra Zeneca. Ms. Ciplea has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Bayer Healthcare. Ms. Ciplea has received personal compensation in the range of $0-$499 for serving as a payment of travel-related expenses with Novartis. Ms. Ciplea has received personal compensation in the range of $0-$499 for serving as a payment of congress fees with Teva.
Kristin Engelstad	No disclosure on file
Amro Stino, MD	Dr. Stino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Stino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Stino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Stino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Stino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. The institution of Dr. Stino has received research support from GBS-CIDP Foundation. The institution of Dr. Stino has received research support from Bristol Myers Squibb.
Ajaz Sheikh, MD	Dr. Sheikh has nothing to disclose.
Robin N. Dharia, MD	Dr. Dharia has nothing to disclose.
Ifat Vigiser	Ifat Vigiser has nothing to disclose.
Adam Quick, MD	The institution of Dr. Quick has received research support from NINDS. The institution of Dr. Quick has received research support from NEALS.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Daniel Vela-Duarte, MD	Dr. Vela-Duarte has nothing to disclose.
Michel T. Torbey, MD, MPH, FAAN	Dr. Torbey has nothing to disclose.
Maria Mazurkiewicz-Beldzin	Dr. Mazurkiewicz-Beldzin has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen, . Dr. Mazurkiewicz-Beldzin has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Mazurkiewicz-Beldzin has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche. Dr. Mazurkiewicz-Beldzin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Mazurkiewicz-Beldzin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Mazurkiewicz-Beldzin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Debra J. Ehrlich, MD, FAAN	Dr. Ehrlich has nothing to disclose.
Ermelinda De Meo	Ms. De Meo has nothing to disclose.
Neil A. Busis, MD, FAAN	Dr. Busis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ��ɫ��. Dr. Busis has received personal compensation in the range of $0-$499 for serving as a Consultant for American Medical Association. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Busis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Clinical Practice.
Bruce I. Ovbiagele, MD, MSc, FAAN	Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Mudassir Farooqui, MD	Dr. Farooqui has nothing to disclose.
Benjamin Turner, MD, MBBS	No disclosure on file
Eric Gutflais, MD	No disclosure on file
Stephen W. English, MD	Dr. English has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brainomix.
Alina Masters-Israilov, MD	Dr. Masters-Israilov has received publishing royalties from a publication relating to health care.
Julia T. Bu, MD	Dr. Bu has nothing to disclose.
Yohei Harada, MD	Dr. Harada has nothing to disclose.
Magnus Spangsberg Boesen, MD	Dr. Spangsberg Boesen has nothing to disclose.
Katelyn E. Gay	Ms. Gay has received personal compensation for serving as an employee of The Emmes Company, LLC.
Melody Gilroy, BS	Ms. Gilroy has nothing to disclose.
Timothy A. Collins, MD	No disclosure on file
Preben B. Andersen	No disclosure on file
Maryam Zulfiqar, MD	Dr. Zulfiqar has nothing to disclose.
Cassandra P. Cross, MD	No disclosure on file
Adriana Carra	No disclosure on file
Tobias Sejbaek, MD, PhD	Prof. Sejbaek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Merck, NeuroXpharm, Novartis, Roche, Sandoz and Sanofi. The institution of Prof. Sejbaek has received research support from Merck, Novartis, Roche and Sanofi.
Hani Alhourani	No disclosure on file
Kathryn B. Schaubhut	No disclosure on file
James Van Etten	No disclosure on file
Michelle Kaku, MD	Dr. Kaku has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Fatcliffe Harten Galamaga LLP.
Nishi Rampal, MD	Dr. Rampal has received personal compensation for serving as an employee of Amgen. Dr. Rampal has received personal compensation for serving as an employee of Horizon Therapeutics. Dr. Rampal has stock in Amgen. Dr. Rampal has stock in Horizon Therapeutics.
Nikita Shukla, MD	The institution of Dr. Shukla has received research support from Roche.
Anders Lindholm, MD, PhD	No disclosure on file
Cristina Lopez Lopez, MD, PhD	No disclosure on file
Hang Shi, MD	Dr. Shi has nothing to disclose.
Osama M. Abu-hadid, MD	Dr. Abu-hadid has nothing to disclose.
Mohammed Al-Dulaimi, MD	Dr. Al-Dulaimi has nothing to disclose.
Joseph Snow, PhD	Dr. Snow has received research support from NIH/NIMH.
Tyler Koehn, MD	Dr. Koehn has nothing to disclose.
Ivan Cuesta Isabel, MD	No disclosure on file
Abril Marone, MD	Dr. Marone has nothing to disclose.
Thomas S. Monaghan, MD	No disclosure on file
Kathleen C. Somera-Molina, PhD	Dr. Somera-Molina has received personal compensation for serving as an employee of Biogen. Dr. Somera-Molina has received stock or an ownership interest from Biogen.
Nicholas Cothros, MD	No disclosure on file
Angela M. Curcio, MD	No disclosure on file
John Henderson	No disclosure on file
Landon Perlett, MD	No disclosure on file
Alfonso Fasano, MD, PhD, FAAN	Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. The institution of Dr. Fasano has received research support from Canadian Institutes of Health Research (CIHR). The institution of Dr. Fasano has received research support from Michael J Fox Foundation. The institution of Dr. Fasano has received research support from Bluerock Therapeutics. Dr. Fasano has received publishing royalties from a publication relating to health care. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with CenteR for Advancing Neurological Innovation to Application (CRANIA) that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with HopeNET that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Member with Tremor Research Group that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Co-Chair with Tremor Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with NPH Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with Industry Committee of the IPMDS that is relevant to AAN interests or activities.
Soe S. Mar, MD, FAAN	The institution of Dr. Mar has received research support from NIH.
Darin T. Okuda, MD, FAAN	Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Helen C. Lin, MD	Dr. Lin has received personal compensation for serving as an employee of Genentech. Dr. Lin has stock in Genentech.
Joshua Z. Willey, MD, FAAN	Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edwards Scientific. Dr. Willey has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for RECARDIO. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainQ. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of the American College of Cardiology. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Uptodate. The institution of Dr. Willey has received research support from NIH. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as a Review chapter author, MKSAP 16-20 with American College of Physicians.
Richard F. Lewis, MD	No disclosure on file
Maura R. Ruzhnikov, MD	Dr. Ruzhnikov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orchard Therapeutics. Dr. Ruzhnikov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Affinia Therapeutics. Dr. Ruzhnikov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Travere Therapeutics. Dr. Ruzhnikov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapetuics. The institution of Dr. Ruzhnikov has received research support from Grace Science Foundation. The institution of Dr. Ruzhnikov has received research support from Ionis Pharmaceuticals. The institution of Dr. Ruzhnikov has received research support from NIH. Dr. Ruzhnikov has a non-compensated relationship as a Co-founder and Secretary with Little Zebra Fund that is relevant to AAN interests or activities.
Jose G. Merino, MD, MPhil, FAHA, FAAN	The institution of Dr. Merino has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Merino has received personal compensation in the range of $500-$4,999 for serving as a StrokeNet DSMB Member with National Institute of Neurological Disorders and Stroke.
Barbara Voetsch, MD, PhD	The institution of Dr. Voetsch has received research support from NIH StrokeNet . Dr. Voetsch has received publishing royalties from a publication relating to health care. Dr. Voetsch has received personal compensation in the range of $500-$4,999 for serving as a International Stroke Conference attendee (travel-related expenses) with AHA/ASA. Dr. Voetsch has a non-compensated relationship as a member of the Massachusetts Systems of Care Workgroup with AHA/ASA that is relevant to AAN interests or activities.
Jonathan Jagid	Jonathan Jagid has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miami Dade County State Attorneys office. The institution of Jonathan Jagid has received research support from Boston Scientific.
Alberto Albanese, MD	Dr. Albanese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen pharma. Dr. Albanese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz pharms. Dr. Albanese has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Publishing Group. Dr. Albanese has a non-compensated relationship as a President with International Association on Parkinsonism and Related Disorders that is relevant to AAN interests or activities.
Susanne Ostrowitzki, MD, PhD	No disclosure on file
Muhammad H. Jaffer, MD	Dr. Jaffer has nothing to disclose.
Juan Pablo Cuello	Juan Pablo Cuello has nothing to disclose.
Kiran Thakur, MD, FAAN	Dr. Thakur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio.
Hunaid Hasan, MD	No disclosure on file
Jill M. Olson, MD	No disclosure on file
Hyeon Jin Kim, MD	No disclosure on file
Fernando Romero Delgado	No disclosure on file
Jonathan Ciron, MD	Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS - Celgene. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Harold H. Morris III, MD, FAAN	No disclosure on file
Juan C. Bulacio, MD	No disclosure on file
Jason H. Margolesky, MD, FAAN	Dr. Margolesky has nothing to disclose.
Cecilia Pita	Cecilia Pita has nothing to disclose.
Damien Biotti	Damien Biotti has nothing to disclose.
Ihtesham A. Qureshi, MD	No disclosure on file
Monisha Sachdev	No disclosure on file
Marcella A. Wozniak, MD, PhD	Dr. Wozniak has nothing to disclose.
Maureen Handoko-Yang, MD	Dr. Handoko has nothing to disclose.
Guojun N. Zhang, MD	Dr. Zhang has nothing to disclose.
Edward J. Espineli, MD	No disclosure on file
Robert Myers, DO	No disclosure on file
Amanda Rogers, MD	An immediate family member of Dr. Rogers has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medpace.
Fernando Duarte Caron	No disclosure on file
Larissa I. Sellner, MD	No disclosure on file
Antonia L. Gragg, PA	No disclosure on file
Amr H. Ewida, MD	Dr. Ewida has nothing to disclose.
Matthew J. Mandel, MD	Dr. Mandel has received personal compensation for serving as an employee of EMD Serono.
Yasmeen Rauf, MBBS	Dr. Rauf has nothing to disclose.
Hamidreza Saber, MD	No disclosure on file
Jillian Smith	Jillian Smith has received personal compensation for serving as an employee of Roche Products Ltd. Jillian Smith has stock in Roche Holdings. Jillian Smith has received intellectual property interests from a discovery or technology relating to health care.
Patrick Acuna	Mr. Acuna has nothing to disclose.
Neil Minton	Neil Minton has received personal compensation for serving as an employee of Bristol Myers Squibb. Neil Minton has received stock or an ownership interest from Bristol Myers Squibb.
Alyssa Kriegermeier	No disclosure on file
Valeriya Levitan, MD	Dr. Levitan has nothing to disclose.
Mihir Kakara, MD	Dr. Kakara has nothing to disclose.
Sara Dawit, MD	Dr. Dawit has nothing to disclose.
Alexander M. Lopez	No disclosure on file
Laura K. Stein, MD, MPH	The institution of Dr. Stein has received research support from American Heart Association.
Steven R. Dunham, Jr., MD	Dr. Dunham has nothing to disclose.
Mohammed A. Almuqbil, MD, FAAN	No disclosure on file
Davide Martino, MD, PhD	Dr. Martino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Martino has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merz Pharma Canada Ltd..
Jens Schjodt-Eriksen	No disclosure on file
Michael A. Ament, MD	No disclosure on file
Heidi B. Schwarz, MD, FAAN	Dr. Schwarz has received personal compensation for serving as an employee of University of Rochester Medical Center. Dr. Schwarz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBSCO. Dr. Schwarz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepost. Dr. Schwarz has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Law Firms.
Aarti Sarwal, MD, FAAN	Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stimdia, Inc. Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Sheinkei. Dr. Sarwal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society of Neuroimaging . The institution of Dr. Sarwal has received research support from Butterfly, Inc. The institution of Dr. Sarwal has received research support from Bard. The institution of Dr. Sarwal has received research support from Biogen. The institution of Dr. Sarwal has received research support from Novartis. The institution of Dr. Sarwal has received research support from CVR Global. The institution of Dr. Sarwal has received research support from NIH/NIA R01 AG066910-01 . The institution of Dr. Sarwal has received research support from Image Monitoring. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Faculty, CME courses with Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Intensive Care Society. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Indian Society of Critical Care. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a speaker/Faculty for Annual meeting, travel compensation with European Society of Intensive Care Medicine. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ISICEM. Dr. Sarwal has a non-compensated relationship as a Social Media Editor with Neurocritical Care that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Secretary with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a President with Association of Indian Neurologists in America that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Member, Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Section Chair, Neurosciences Section with Society of Critical Care Medicine that is relevant to AAN interests or activities.
Tatiana Zaldivar Vaillant, MD	No disclosure on file
Tracey Cho, MD, FAAN	Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of an immediate family member of Dr. Cho has received research support from NIH. Dr. Cho has received publishing royalties from a publication relating to health care.
Allison Brashear, MD, MBA, FAAN	Dr. Brashear has received personal compensation for serving as an employee of McKnight Brain Res Found. Dr. Brashear has received personal compensation for serving as an employee of American Board of Psychiatry and Neurology. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Brashear has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation i. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Care Directions- start up . Dr. Brashear has stock in Caredirections . The institution of Dr. Brashear has received research support from NINDS. Dr. Brashear has received publishing royalties from a publication relating to health care. Dr. Brashear has received personal compensation in the range of $500-$4,999 for serving as a Special government employee and study section reviewer with NIH. Dr. Brashear has received personal compensation in the range of $0-$499 for serving as a Adminstrative board -travel reimbursement with AAMC.
Melissa Armstrong, MD, MSc, FAAN, FAAN	The institution of Dr. Armstrong has received research support from National Institutes of Health. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. The institution of Dr. Armstrong has received research support from The Michael J. Fox Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has received personal compensation in the range of $500-$4,999 for serving as a DSMB member with National Institutes of Health. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Richard S. Isaacson, MD, FAAN	Dr. Isaacson has stock in Retain Health. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.
Stacy A. Rudnicki, MD, FAAN	Dr. Rudnicki has received personal compensation for serving as an employee of Cytokinetics. Dr. Rudnicki has stock in Cytokinetics.
Joseph R. Lacy, MD	No disclosure on file
Ulrich Hofstadt-van Oy, MD	No disclosure on file
Seyed A. Fatemi, MD, MBA	Dr. Fatemi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for RCO law. The institution of Dr. Fatemi has received research support from Minoryx. The institution of Dr. Fatemi has received research support from Viking Therapeutics. The institution of Dr. Fatemi has received research support from Swanbio Therapeutics . The institution of Dr. Fatemi has received research support from Autobahn Therapeutics. The institution of Dr. Fatemi has received research support from Nuvelution. The institution of Dr. Fatemi has received research support from NIH. The institution of Dr. Fatemi has received research support from A Cure for Ellie Foundation. The institution of Dr. Fatemi has received research support from Brian's Hope Foundation . Dr. Fatemi has received intellectual property interests from a discovery or technology relating to health care. Dr. Fatemi has a non-compensated relationship as a Director (Board member) with ALDConnect that is relevant to AAN interests or activities.
Shreyas Gangadhara, MD, FAAN	Dr. Gangadhara has nothing to disclose.
Lisseth E. Burbano, MD, PhD	Ms. Burbano has received research support from The ��ɫ��.
Julia Klein, NP	An immediate family member of Ms. Klein has received personal compensation for serving as an employee of Amgen. An immediate family member of Ms. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Damon P. Cardenas, PhD	No disclosure on file
Anne Marie Conway, RN, MHA	No disclosure on file
Chandrashekhar Agrawal, MD	No disclosure on file
Michelle P. Lin, CRC	Dr. Lin has nothing to disclose.
Chetan P. Gandhy, MD	No disclosure on file
Maya Zeineddine	No disclosure on file
Yasser Kabbani, MD	No disclosure on file
Joshua Tobin, MD, FAAN	An immediate family member of Dr. Tobin has received personal compensation for serving as an employee of Amgen. Dr. Tobin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tobin has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie.
Pradeep Banerjee, PhD	No disclosure on file
Michelle Shapiro, MD	Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Shapiro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
Juha M. Savola, MD, PhD	Dr. Savola has received personal compensation for serving as an employee of Teva Pharmaceuticals. Dr. Savola has received intellectual property interests from a discovery or technology relating to health care.
Atif Zafar, MD	Dr. Zafar has nothing to disclose.
Virti D. Shah, Sr., MD, MBBS	No disclosure on file
Eric D. Marsh, MD, PhD	Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmacuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from NIH. The institution of Dr. Marsh has received research support from Rett Syndrome Research Trust. The institution of Dr. Marsh has received research support from International Rett Syndrome Foundation. The institution of Dr. Marsh has received research support from Eagles Autism Challenge. The institution of Dr. Marsh has received research support from LouLou Foundation. The institution of Dr. Marsh has received research support from International CDKL5 Resarch Foundation. The institution of Dr. Marsh has received research support from Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from Marinus. The institution of Dr. Marsh has received research support from Stoke Therapeutics. The institution of Dr. Marsh has received research support from Takeda Pharmaceuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Grant Review with NIH. Dr. Marsh has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Witness with Department of Human Services. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Medscape.
Hisham G. Elkhider, MD	Dr. Elkhider has nothing to disclose.
Douglas Ney, MD, FAAN	The institution of Dr. Ney has received research support from Orbus Therapeutics. The institution of Dr. Ney has received research support from Denovo Biopharma.
Ashley Helseth, MD, PhD	No disclosure on file
Benjamin C. Cox, MD	The institution of Dr. Cox has received research support from American Epilepsy Society. The institution of Dr. Cox has received research support from Brain and Behavior Research Foundation.
Mayela Marie Diaz Diaz, MD	No disclosure on file
Joao L. Durães, MD	No disclosure on file
Leonhard Schaetz	No disclosure on file
Natasha Mupambo, MBBS	No disclosure on file
Irfan Qureshi, MD	Dr. Qureshi has received personal compensation for serving as an employee of Biohaven. Dr. Qureshi has stock in Biohaven Pharmaceuticals.
Kelly-Ann Patrice, MBBS	Dr. Patrice has nothing to disclose.
Ye Hu, MD	Dr. Hu has nothing to disclose.
Puneet Opal, MD, PhD	Dr. Opal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for reata. Dr. Opal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACTN. Dr. Opal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JCI. The institution of Dr. Opal has received research support from NIH. Dr. Opal has received intellectual property interests from a discovery or technology relating to health care.
Francesca Ammoscato	No disclosure on file
Jose Manuel Garcia Dominguez	Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Dominic Thyagarajan, MD	No disclosure on file
James R. Ghattas, DO	No disclosure on file
Arens Taga, MD	Dr. Taga has nothing to disclose.
Sophie Lan-Linh Duong, MD	No disclosure on file
Fabio Adrian Barroso, MD	Fabio Adrian Barroso, MD has nothing to disclose.
Derek T. Soon, MBBS, PhD	Dr. Soon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Legal Clinic.
Shailee S. Shah, MD	Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Shah has received publishing royalties from a publication relating to health care.
Sushil S. Lakhani, MD	Dr. Lakhani has nothing to disclose.
Kathryn Fitzgerald, PhD	Dr. Fitzgerald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Setpoint Medical. The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Aparna Vaddiparti, MD	Dr. Vaddiparti has nothing to disclose.
Devin J. Burke, MD	Dr. Burke has nothing to disclose.
Ryan P. Barmore, MD	No disclosure on file
Ivan Kotchetkov, MD	No disclosure on file
Antje Neubert	No disclosure on file
Jonathan W. Sahawneh	No disclosure on file
Aliona Cucovici	Dr. Cucovici has nothing to disclose.
Nikolai Gil D. Reyes, MD	Dr. Reyes has nothing to disclose.
Dongya Huang, MD	No disclosure on file
Nour Baki, MD	No disclosure on file
Claudia Prada	No disclosure on file
Amanda Glickman	Ms. Glickman has nothing to disclose.
Mangala Gopal, MD	Dr. Gopal has nothing to disclose.
Emily Caesar	No disclosure on file
Florian Lipsmeier	No disclosure on file
Eda Turanli	The institution of Eda Turanli has received research support from Scientific and Technological Research Council of Turkey (TÜBITAK). The institution of Eda Turanli has received research support from Turkish MS Society. The institution of Eda Turanli has received research support from Acibadem University Scientific Research Projects Commission . The institution of Eda Turanli has received research support from Istanbul University Scientific Research Projects Commission .
Nidhi Kapoor, MD, MBBS	Dr. Kapoor has nothing to disclose.
Lalanthica Yogendran, MD	The institution of Dr. Yogendran has received research support from Incyte. The institution of Dr. Yogendran has received research support from Dana Farber . The institution of Dr. Yogendran has received research support from FALK Catalyst. Dr. Yogendran has received personal compensation in the range of $0-$499 for serving as a speaker at community conference with Parkinson Support and Wellness. Dr. Yogendran has received personal compensation in the range of $500-$4,999 for serving as a speaker at local conference with University of Cincinnati.
Sneha Jacob, MD	Dr. Jacob has nothing to disclose.
Vanja C. Douglas, MD, FAAN	Dr. Douglas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms. Dr. Douglas has received publishing royalties from a publication relating to health care. Dr. Douglas has received publishing royalties from a publication relating to health care.
Jack D. Schim, MD, FAAN	Dr. Schim has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aeon, Abbvie, Amgen, Biohaven, electroCore, Impel, Lilly, Lundbeck, Novartis, Promius, Revance, Teva, Upsher-Smith. Dr. Schim has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan, Amgen, Biohaven, electroCore, Lilly, Lundbeck, Novartis, Promius, Teva, Theranica, Upsher-Smith.
Nada G. Abou Fayssal, MD, FAAN	Dr. Abou Fayssal has nothing to disclose.
Peter R. Camfield, MD	No disclosure on file
Benjamin R. Miller, MD	The institution of Dr. Miller has received research support from StrokeNET.
Joel Raskin	No disclosure on file
Murtaza Khan, MD	Dr. Khan has nothing to disclose.
Niccolò Mencacci	No disclosure on file
Samuel Tomlinson	No disclosure on file
Valentina Poretto, MD	Dr. Poretto has nothing to disclose.
David A. Discua	No disclosure on file
Joela T. Mathews, MRPSGB	Miss Mathews has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Miss Mathews has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Miss Mathews has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celegene.
Morten B. Blinkenberg, MD, PhD	The institution of Morten Bjorn Blinkenberg, MD, PhD has received research support from Danish MS Society.
Roohi Katyal, MD	Dr. Katyal has nothing to disclose.
Sergio A. Castillo-Torres, MD	No disclosure on file
Nicole Calakos, MD	No disclosure on file
Aliza Brown, PhD	Dr. Brown has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NuvOx Pharma.
Sarah R. Risen, MD	Dr. Risen has nothing to disclose.
Shailesh Male, MD	Dr. Male has nothing to disclose.
Eyal Muscal	Eyal Muscal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sobi. An immediate family member of Eyal Muscal has stock in pfizer.
Kim Burchiel	Kim Burchiel has nothing to disclose.
Elan Guterman, MD	Dr. Guterman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Guterman has stock in REMO Health. The institution of Dr. Guterman has received research support from NIH. The institution of Dr. Guterman has received research support from AAN.
Michael J. Persenaire, MD	Dr. Persenaire has nothing to disclose.
Tamra I. Ranasinghe, MD	Dr. Ranasinghe has nothing to disclose.
Reina Fuji	No disclosure on file
Danielle Takacs, MD	Dr. Takacs has received publishing royalties from a publication relating to health care.
Maria Gaughan, MBBS	Dr. Gaughan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Gaughan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Gaughan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Gaughan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck.
Daniel Garbin Di Luca, MD	Dr. Garbin Di Luca has nothing to disclose.
Kathryn T. Fong, MD	Dr. Fong has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fong has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fong has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Fong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics.
Ka-Ho Wong	The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Suma Babu, MD, MPH	The institution of Dr. Babu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. The institution of Dr. Babu has received personal compensation in the range of $0-$499 for serving as a Consultant for Specific Biologics. The institution of Dr. Babu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure Therapeutics. The institution of Dr. Babu has received research support from Biogen. The institution of Dr. Babu has received research support from Ionis. The institution of Dr. Babu has received research support from OrphAI therapeutics. The institution of Dr. Babu has received research support from Denali Therapeutics. The institution of Dr. Babu has received research support from Tiziana. Dr. Babu has a non-compensated relationship as a Appointed Member of the Committee on ALS: Accelerating Treatments and Improving Quality of Life with National Academies of Sciences, Engineering and Medicine that is relevant to AAN interests or activities.
Leena E. Youssefian, MD	No disclosure on file
Rae E. Bacharach, DO	Dr. Bacharach has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��.
Sandra Thiel	Ms. Thiel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer Healthcare .
Scott D. Newsome, DO, FAAN	Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from Lundbeck. The institution of Dr. Newsome has received research support from Sanofi. The institution of Dr. Newsome has received research support from Kyverna Therapeutics. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Maria I. Reyes-Mantilla, MD	Dr. Reyes-Mantilla has nothing to disclose.
Joseph C. McCall, MD	No disclosure on file
Bhavana U. Patel, DO	The institution of Dr. Patel has received research support from National Institute on Aging. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Question writer with ��ɫ��.
Nicholas J. Everage	No disclosure on file
Noah Lechtzin, MD	No disclosure on file
Vladimir Skljarevski	No disclosure on file
Lobat Hashemi	No disclosure on file
Jerome Hanna	No disclosure on file
Stanley I. Rapoport, MD	No disclosure on file
Dhasakumar S. Navaratnam, MD, PhD	The institution of Dr. Navaratnam has received research support from NIH. The institution of Dr. Navaratnam has received research support from AHRA. Dr. Navaratnam has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with NIH.
Jennifer Wong	No disclosure on file
Jacob L. Van Orman, MD	Dr. Van Orman has nothing to disclose.
Susan M. Bowyer, PhD	Dr. Bowyer has nothing to disclose.
Samuel A. Frank, MD, FAAN	Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Cerevel.
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Daniel O. Claassen, MD, FAAN	Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics . Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI.
Dusan Stefoski, MD, FAAN	No disclosure on file
Joseph M. Ferrara, MD, FAAN	No disclosure on file
Saeed A. Bohlega, MD	No disclosure on file
Jennifer Simpson, MD	Dr. Simpson has nothing to disclose.
Ashish Gupta, MD	No disclosure on file
Hyung Seok Ahn, MD	No disclosure on file
Sonia S. Bellara, MBBS	Dr. Bellara has nothing to disclose.
Robert Romanelli	No disclosure on file
Hu Li	No disclosure on file
Yatin Sagvekar	No disclosure on file
Eric Pearlman, MD	Dr. Pearlman has received personal compensation for serving as an employee of Eli Lilly and Co. Dr. Pearlman has received stock or an ownership interest from Eli Lilly and Co.
Ronald Postuma, MD	Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH.
Keith R. Edwards, MD, FAAN	No disclosure on file
Camilla Cividini, MSc	Ms. Cividini has nothing to disclose.
Michael Comisac III	Mr. Comisac has nothing to disclose.
Henry L. Paulson, MD, PhD, FAAN	Dr. Paulson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Exicure. The institution of Dr. Paulson has received research support from National Institutes of Health. Dr. Paulson has a non-compensated relationship as a Member, Nominating committee with American Neurological Association that is relevant to AAN interests or activities.
E. W. Massey, MD, FAAN	No disclosure on file
George J. Hutton, MD, FAAN	Dr. Hutton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Autoimmunity Biologic Solutions, Inc.. The institution of Dr. Hutton has received research support from Biogen. The institution of Dr. Hutton has received research support from Genentech. The institution of Dr. Hutton has received research support from Genzyme.
Dawn W. Langdon, PhD	Prof. Langdon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Prof. Langdon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Prof. Langdon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Prof. Langdon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celgene. Prof. Langdon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Prof. Langdon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. The institution of Prof. Langdon has received research support from Merck. The institution of Prof. Langdon has received research support from Novartis. The institution of Prof. Langdon has received research support from MS Society (UK). The institution of Prof. Langdon has received research support from Multiple Sclerosis Trust (UK).
Ramon R. Diaz-Arrastia, MD, PhD, FAAN	Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Terry D. Heiman-Patterson, MD	Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation.
Rakesh Khatri, MD, FAAN	Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Alpha insight . Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Survey company .
Barry A. Singer, MD	Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TG Therapeutics. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb (Celgene). Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Vanda. An immediate family member of Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Singer has received research support from Novartis. The institution of Dr. Singer has received research support from Sanofi. The institution of Dr. Singer has received research support from TG Therapeutics. The institution of Dr. Singer has received research support from Bristol Myers Squibb.
Ylmar Correa Neto, MD	No disclosure on file
Sandra D'Alfonso	No disclosure on file
Sanjay Mittal, MD	Dr. Mittal has nothing to disclose.
Kristen M. Krysko, MD	Dr. Krysko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Krysko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Krysko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Krysko has received research support from MS Society of Canda. The institution of Dr. Krysko has received research support from Roche.
Massimiliano Copetti	No disclosure on file
Ram N. Narayan, MD, FAAN	Dr. Narayan has nothing to disclose.
Yin-Hsiu Chien	Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Avexis/Norvatis. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Yin-Hsiu Chien has received research support from Sanofi Genzyme.
Mohammad Rauf A. Chaudhry, MD	Dr. Chaudhry has nothing to disclose.
Veronica Castelnovo, MSc	Dr. Castelnovo has nothing to disclose.
Siena Duarte, MD, MAS	Dr. Duarte has received personal compensation for serving as an employee of Johns Hopkins University. Dr. Duarte has received personal compensation for serving as an employee of University of California, San Francisco.
Jonas Graf	No disclosure on file
Douglas L. Arnold, MD, FAAN	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Gavin Giovannoni, MD	Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Alexander G. Khandji, MD	No disclosure on file
Lakshmi Warrior, MD, FAAN	Dr. Warrior has nothing to disclose.
Kenji Sekiguchi, MD, PhD	Dr. Sekiguchi has nothing to disclose.
Archana Hinduja, MD	Dr. Hinduja has nothing to disclose.
Atul T. Patel	Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IPSEN. Atul T. Patel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for IPSEN. The institution of Atul T. Patel has received research support from Abbvie. The institution of Atul T. Patel has received research support from IPSEN.
Alberto J. Espay, MD, FAAN	Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Brant Oliver	Brant Oliver has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for @ Point of Care. The institution of Brant Oliver has received research support from Biogen.
Qing Wang	Qing Wang has nothing to disclose.
Krishna Mourya Galla, MD	No disclosure on file
David Wormser	No disclosure on file
Daniela Stokmaier	Daniela Stokmaier has received personal compensation for serving as an employee of Roche.
Chen Ye	No disclosure on file
Micah Etter, MD	Dr. Etter has nothing to disclose.
Zheng Ren	Zheng Ren has received personal compensation for serving as an employee of Biogen.
Derek Bauer, MD	No disclosure on file
Preston J. Eibling, MD	No disclosure on file
Adam Dickey, MD, PhD	No disclosure on file
Ann M. Mayo, PhD	No disclosure on file
Lauren Jackson, MD	Dr. Jackson has nothing to disclose.
Matthew R. Burns, MD, PhD	The institution of Dr. Burns has received research support from NIH. The institution of Dr. Burns has received research support from Mcknight Brain Institute.
Jose Meca Lallana, MD	Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers-Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Meca Lallana has received research support from Merck. The institution of Dr. Meca Lallana has received research support from Novartis. The institution of Dr. Meca Lallana has received research support from Roche. The institution of Dr. Meca Lallana has received research support from Sanofi. The institution of Dr. Meca Lallana has received research support from Biogen.
Christina Maxwell, PhD	Dr. Maxwell has received personal compensation for serving as an employee of Sanofi. Dr. Maxwell has stock in Sanofi.
Ali G. Hamedani, MD, MHS	Dr. Hamedani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Hamedani has received personal compensation in the range of $0-$499 for serving as a Consultant for LoQus23. The institution of Dr. Hamedani has received research support from NIH. The institution of Dr. Hamedani has received research support from Biogen. The institution of Dr. Hamedani has received research support from Biohaven.
Ibrahim Migdady, MD	Dr. Migdady has nothing to disclose.
Aldo Mendez Ruiz, MD	No disclosure on file
Keithan Sivakumar, MD	Dr. Sivakumar has nothing to disclose.
Guillermo R. Delgado-Garcia, MD, MSc	Dr. Delgado-Garcia has received research support from Consejo Nacional de Ciencia y Tecnologia (Mexico). Dr. Delgado-Garcia has received research support from Consejo Nacional de Ciencia y Tecnologia (Mexico). Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Team Member with Neurology Resident & Fellow Section that is relevant to AAN interests or activities. Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Board Member with Brain and Life en Espanol that is relevant to AAN interests or activities. Dr. Delgado-Garcia has a non-compensated relationship as a Editorial Board Member with Neurology Clinical Practice that is relevant to AAN interests or activities.
Veronica Campanille, MD	No disclosure on file
Muhammad Z. Memon, MD	Dr. Memon has nothing to disclose.
Chen Chen, MD	No disclosure on file
Sarah J. McAlister	No disclosure on file
Diana Wei, MD	No disclosure on file
Mariana Vinokur, DO	Dr. Vinokur has nothing to disclose.
Whitley W. Aamodt, MD	Dr. Aamodt has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Steven C. Swavely, MD	No disclosure on file
Teng J. Peng, MD	Dr. Peng has nothing to disclose.
Jeremy M. Shefner, MD, PhD, FAAN	Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Uniqure. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Shefner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cytokinetics. Dr. Shefner has received personal compensation in the range of $0-$499 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for annexon. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurosense. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuvivo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nura BIo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for swanbio. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vertex. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Shefner has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Shefner has received research support from NIH. The institution of Dr. Shefner has received research support from Mitsubishi Tanabe Pharma America. The institution of Dr. Shefner has received research support from Amylyx. The institution of Dr. Shefner has received research support from BIogen. The institution of Dr. Shefner has received research support from Cytokinetics. The institution of Dr. Shefner has received research support from IONIS. The institution of Dr. Shefner has received research support from Healey Center for ALS. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a grant review chair with DOD- General Dynamics.
Kottil W. Rammohan, MD	Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. The institution of Dr. Rammohan has received research support from Genentech. The institution of Dr. Rammohan has received research support from Genzyme. The institution of Dr. Rammohan has received research support from EMD Serono. The institution of Dr. Rammohan has received research support from Alexion.
Gustavo J. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Bettina M. Cockroft, MD, MBA	No disclosure on file
Sandra Vanotti, MD	No disclosure on file
Gioacchino Tedeschi, MD	Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Mushtaq H. Qureshi, MD	No disclosure on file
Darine Kassar, MD	Dr. Kassar has nothing to disclose.
Antonios Bayas	No disclosure on file
Jasem Y. Al-Hashel, MD	Dr. Al-Hashel has nothing to disclose.
Stephanie Grover, MSc, CCRP	No disclosure on file
Savary Om	No disclosure on file
Abraham Kalikstein, MD	Dr. Kalikstein has nothing to disclose.
Mu Ji Hwang, MD	Dr. Hwang has nothing to disclose.
Ekaterina Volkova-Volkmar	No disclosure on file
Yonas E. Geda, MD	The institution of Dr. Geda has received research support from NIH.
Suzanne Hendrix, PhD	Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has or had stock in Pentara.
Thomas Leist, MD, PhD, FAAN	Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Leist has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seono. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Wittness with DHHS HRSA.
Anahita F. Deboo, MD	Dr. Deboo has nothing to disclose.
Paul Orchard	No disclosure on file
Alberto Maud, MD	Dr. Maud has nothing to disclose.
Gisella Gargiulo Monachelli, MD, PhD	No disclosure on file
Antonio Uccelli, MD	An immediate family member of Dr. Uccelli has received personal compensation for serving as an employee of Biogen. The institution of Dr. Uccelli has received research support from Merck. The institution of Dr. Uccelli has received research support from Roche.
Elena Bravver, MD	No disclosure on file
Sana Syed, MD	Dr. Syed has received personal compensation for serving as an employee of Sanofi US.
George R. Wilmot, MD, PhD	Dr. Wilmot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar Therapeutics. The institution of Dr. Wilmot has received research support from Friedrich Ataxia Research Alliance. The institution of Dr. Wilmot has received research support from National Ataxia Foundation. The institution of Dr. Wilmot has received research support from NIH. The institution of Dr. Wilmot has received research support from Reata. The institution of Dr. Wilmot has received research support from Biohaven Pharmaceuticals.
Imama A. Naqvi, MD	Dr. Naqvi has nothing to disclose.
Leonardo Almeida	No disclosure on file
Rod Middleton	The institution of Mr. Middleton has received research support from MS Society.
Petr Hlustik, MD, PhD	The institution of Prof. Hlustik has received research support from Czech Health Research Council (AZV CR).
Norman W. Barton, MD, PhD	Dr. Barton has received personal compensation for serving as an employee of Takeda Pharmaceutical Co. LTD. Dr. Barton has received stock or an ownership interest from Takeda Pharmaceutical Co. LTD.
Elisabeth M. Wood, MSCGC	No disclosure on file
Brian C. Healy	The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Shahram Majidi, MD	Dr. Majidi has nothing to disclose.
Ismael Calandri, MD	Dr. Calandri has nothing to disclose.
Abigail Lofchie, MD	No disclosure on file
Brian Westerhuis, MD	Dr. Westerhuis has nothing to disclose.
Jenna A. Brunn, MD	Dr. Brunn has nothing to disclose.
Pierre Tariot	Pierre Tariot has received personal compensation for serving as an employee of Banner Alzheimer's Institute. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for WebMD. Pierre Tariot has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arcadia. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioXcel. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eNOVA. Pierre Tariot has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos. Pierre Tariot has received intellectual property interests from a discovery or technology relating to health care.
E. Ann Yeh, MD, MA, FRCPC	Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to AAN interests or activities.
Faisal Fecto, MD, PhD	The institution of Dr. Fecto has received research support from NINDS.
Allison Wright Willis, MD	Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pharmacoepidemiology and Drug Safety. Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Wright Willis has received research support from NIH. The institution of Dr. Wright Willis has received research support from NIA. The institution of Dr. Wright Willis has received research support from Biogen. The institution of Dr. Wright Willis has received research support from Parkinson Foundation. The institution of Dr. Wright Willis has received research support from Arcadia.
Melissa M. Cortez, DO	The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Dysautonomia International. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project.
M. M. Paz Soldan, MD, PhD	Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Fady I. Malik	No disclosure on file
Lesley Schofield	No disclosure on file
Abhimanyu Mahajan, MD, MHS, FAAN	Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima Therapeutics, Inc.. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Mahajan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie . Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Adaptive Biosciences . Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement disorders clinical practice. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Texas Alzheimer's Research And Care Consortium .
David M. Greer, MD, FAAN	Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to AAN interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to AAN interests or activities.
Roy H. Hamilton, MD, MS, FANA, FAAN	Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highland Instruments. Dr. Hamilton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognito Therapeutics. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation. The institution of Dr. Hamilton has received research support from NIH. The institution of Dr. Hamilton has received research support from Department of Defense. The institution of Dr. Hamilton has received research support from Chan Zuckerberg Initiative.
Derek W. Stitt, MD	Dr. Stitt has nothing to disclose.
Elizabeth A. Coon, MD, FAAN	Dr. Coon has received publishing royalties from a publication relating to health care. Dr. Coon has a non-compensated relationship as a Non-Voting Member of the Board of Directors with UCNS that is relevant to AAN interests or activities.
Michelle Fabian, MD, FAAN	Dr. Fabian has nothing to disclose.
Jean Godin, MD, MBA	No disclosure on file
Giulietta Riboldi, MD	The institution of Dr. Riboldi has received research support from Prevail Therapeutics.
Toby A. Ferguson, MD	Dr. Ferguson has received personal compensation for serving as an employee of Biogen. Dr. Ferguson has received stock or an ownership interest from Biogen.
Shannon Y. Chiu, MD, MSc	Dr. Chiu has received research support from NIH.
Ammar Al-Chalabi, PhD, FRCP DipStat	The institution of Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for OrionPharma. The institution of Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics Inc. The institution of Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma. The institution of Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. The institution of Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for My Name'5 Doddie Foundation. The institution of Dr. Al-Chalabi has received research support from Medical Research Council. The institution of Dr. Al-Chalabi has received research support from NIHR. The institution of Dr. Al-Chalabi has received research support from European Commission. The institution of Dr. Al-Chalabi has received research support from MND Association. The institution of Dr. Al-Chalabi has received research support from My Name'5 Doddie Foundation. Dr. Al-Chalabi has received publishing royalties from a publication relating to health care. Dr. Al-Chalabi has received publishing royalties from a publication relating to health care. Dr. Al-Chalabi has a non-compensated relationship as a SAB Member and Executive Member with TRICALS that is relevant to AAN interests or activities.
Neil K. Shetty, MD	No disclosure on file
Prompan Mingbunjerdsuk, MD	No disclosure on file
Mohammad Hajighasemi-Ossareh, MD	No disclosure on file
Rajiv Patni, MD	No disclosure on file
Mithat Kasap	No disclosure on file
Mauricio F. Villamar, MD, FAAN	Dr. Villamar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Villamar has or had stock in Ceribell.Dr. Villamar has received research support from Brown Physicians Inc.. Dr. Villamar has a non-compensated relationship as a Member of Editorial Board with Neurology: Clinical Practice that is relevant to AAN interests or activities. Dr. Villamar has a non-compensated relationship as a Member of Editorial Board with The Neurohospitalist that is relevant to AAN interests or activities. Dr. Villamar has a non-compensated relationship as a Co-Chair - Quality Improvement Committee with American Clinical Neurophysiology Society that is relevant to AAN interests or activities. Dr. Villamar has a non-compensated relationship as a Co-Leader, Practice and Compensation Survey Working Group with The Neurohospitalist Society that is relevant to AAN interests or activities.
Herve Jullien De Pommerol	No disclosure on file
Parneet K. Grewal, MD	The institution of Dr. Grewal has received research support from Bristol Myer Squibb Foundation. The institution of Dr. Grewal has received research support from IPSEN Global.
Heather Lau, MD	Dr. Lau has received personal compensation for serving as an employee of Ultragenyx. Dr. Lau has or had stock in Ultragenyx.
Alexander J. Gill, MD, PhD	Dr. Gill has received personal compensation for serving as an employee of Novartis Pharmaceuticals Corporation. Dr. Gill has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medical Logix, LLC. Dr. Gill has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Health Union, LLC . Dr. Gill has received research support from National Multiple Sclerosis Society. Dr. Gill has a non-compensated relationship as a President, Treasurer, and Member of Board of Directors with Autoimmune Neurology Research Consortium, Inc. that is relevant to AAN interests or activities.
Hae Young Baang, MD	Dr. Baang has nothing to disclose.
Casey Engel	Casey Engel has nothing to disclose.
Zakia Jabarkheel	No disclosure on file
Amit Bar-Or, MD, FRCPC	Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Richard A. Bernstein, MD	No disclosure on file
Tobias Kurth, MD, ScD, FAAN	Dr. Kurth has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TotalEnergies. Dr. Kurth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly & Company. Dr. Kurth has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ. Dr. Kurth has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. The institution of Dr. Kurth has received research support from German Joint Committee. The institution of Dr. Kurth has received research support from Ministry of Health.
Cristina Moglia	Cristina Moglia has nothing to disclose.
Ruth-Ann Marrie, MD, PhD	The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
Angela Vincent, MBBS, MSc	Angela Vincent, MBBS, MSc has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Lundbeck Foundation. Angela Vincent, MBBS, MSc has received intellectual property interests from a discovery or technology relating to health care.
Yang Mao-Draayer, MD	Dr. Mao-Draayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen Idec. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizone. Dr. Mao-Draayer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen Idec. The institution of Dr. Mao-Draayer has received research support from NIH .
Aparna Wagle-Shukla, MD, FAAN	Dr. Wagle-Shukla has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Encora. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Tremor research group. The institution of Dr. Wagle-Shukla has received research support from NIH. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as a reviewer with NIH.
Kyle B. Womack, MD	The institution of Dr. Womack has received research support from NIH. The institution of Dr. Womack has received research support from Janssen.
Gerald Raymond, MD	Dr. Raymond has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Bluebird bio. Dr. Raymond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Raymond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Travere. Dr. Raymond has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with Dept of HHS.
Kevin M. Biglan, MD	Dr. Biglan has received personal compensation for serving as an employee of Eli Lilly. Dr. Biglan has received stock or an ownership interest from Eli Lilly.
Christopher Gomez, MD, PhD	Dr. Gomez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Gomez has received research support from Nih.
Vikram Shakkottai, MD, PhD	The institution of Dr. Shakkottai has received research support from National Institutes of Health. Dr. Shakkottai has received publishing royalties from a publication relating to health care.
Andrew A. Wolff, MD	No disclosure on file
Marius Ringelstein	Marius Ringelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Marius Ringelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Muriel Stoppe	Muriel Stoppe has nothing to disclose.
Elizabeth Poole	No disclosure on file
Daniel Diehl, MD	No disclosure on file
Mallikarjuna Rettiganti, PhD	Dr. Rettiganti has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Rettiganti has received stock or an ownership interest from Eli Lilly and Company.
Ruo-Yah Lai	Ms. Lai has nothing to disclose.
Kevin Tan, MD, FAAN	Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck.
Orhan Aktas, MD	Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubish Tanake. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon. The institution of Dr. Aktas has received research support from German Research Foundation. The institution of Dr. Aktas has received research support from German Ministry of Science. The institution of Dr. Aktas has received research support from Neuromyelitis optica Study Group (NEMOS).
Maurizio Leone, MD	Dr. Leone has nothing to disclose.
Nathalie Sambuchi	No disclosure on file
Luisa H. Klotz, MD	Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Klotz has received research support from Immunic AG. The institution of Dr. Klotz has received research support from Merck.
Andrew Chan	The institution of Andrew Chan has received research support from UCB. The institution of Andrew Chan has received research support from Biogen. The institution of Andrew Chan has received research support from Sanofi Genzyme.
Sam S. Handshoe	Dr. Handshoe has nothing to disclose.
Cassandra J. Milling, MD	No disclosure on file
Angela R. Sung, MD	No disclosure on file
Matthew C. Agan, MD	No disclosure on file
JinSeok Park, MD, PhD	No disclosure on file
Phuong Nguyen	No disclosure on file
Caroline Geremakis	No disclosure on file
Henry J. Kaminski, MD, FAAN	Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta Bio. The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canopy Immunotherapeutics. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curie.bio. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kaminski has received personal compensation in the range of $0-$499 for serving as a Consultant for Care Constitution. Dr. Kaminski has stock in mimivax. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
Senda Ajroud-Driss, MD, FAAN	Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astrazeneca. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Ajroud-Driss has received research support from NIH. The institution of Dr. Ajroud-Driss has received research support from University of Minesota/FDA. The institution of Dr. Ajroud-Driss has received research support from Edgewise Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Biogen. The institution of Dr. Ajroud-Driss has received research support from Woolsey Pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Uniqure Biopharma. The institution of Dr. Ajroud-Driss has received research support from Coya Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Novartis. The institution of Dr. Ajroud-Driss has received research support from Alnylam pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Healey and AMG center for ALS . The institution of Dr. Ajroud-Driss has received research support from les Turner ALS Foundation. The institution of Dr. Ajroud-Driss has received research support from Hopewell. The institution of Dr. Ajroud-Driss has received research support from Peripheral neuropathy foundation. Dr. Ajroud-Driss has received publishing royalties from a publication relating to health care.
Eric S. Farbman, MD, FAAN	Dr. Farbman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Farbman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Farbman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda.
Vittorio Martinelli	Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Ken Uchino, MD	Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Dietrich Haubenberger, MD, FAAN	Dr. Haubenberger has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Haubenberger has stock in Neurocrine Biosciences. Dr. Haubenberger has a non-compensated relationship as a Member of the Board with American Society for Experimental Neurotherapeutics that is relevant to AAN interests or activities.
Osman Farooq, MD	Dr. Farooq has nothing to disclose.
Eric McConathey	No disclosure on file
Navya Joseph, MD	Dr. Joseph has nothing to disclose.
Christy Smith	No disclosure on file
Allycia MacDonald, MBBS	No disclosure on file
Yajun Cheng	No disclosure on file
Samyuktha Ravi	No disclosure on file
Stuart H. Isaacson, MD, FAAN	The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Christine Lebrun Frenay, MD, FAAN	Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Richard L. Skolasky, BA	No disclosure on file
Chandrabhaga Miskin, MD	No disclosure on file
Benjamin T. Barnes, MD	Dr. Barnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Barnes has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Kristopher Southard, MD	Dr. Southard has nothing to disclose.
Rafeed Alkawadri	No disclosure on file
Hannah R. Cooper	Ms. Cooper has nothing to disclose.
Chelsea S. Kidwell, MD	No disclosure on file
Andrew P. Duker, MD	No disclosure on file
Aziz I. Shaibani, MD, FAAN	Dr. Shaibani has nothing to disclose.
Analia Calle	Analia Calle has nothing to disclose.
Rocio Hernandez Clares, MD, PhD	No disclosure on file
Devangi S. Mehta, PhD	No disclosure on file
Thyagarajan Subramanian, MD, MBBS, FAAN	Dr. Subramanian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Subramanian has received research support from National Institutes of Health. The institution of Dr. Subramanian has received research support from Ann and Phillip Gladfetler III Foundation. The institution of Dr. Subramanian has received research support from Department of Defense . Dr. Subramanian has received publishing royalties from a publication relating to health care. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with National Institutes of Health.
Diana Z. Li, MD	Dr. Li has nothing to disclose.
Mohamed Nasser, MD	Dr. Nasser has nothing to disclose.
Jeff Rodgers	Jeff Rodgers has nothing to disclose.
Molly B. Ungrady	No disclosure on file
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Rajesh Pahwa, MD, FAAN	Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB. The institution of Dr. Pahwa has received research support from Ono. The institution of Dr. Pahwa has received research support from Intra-cellular Therapies. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Michael J Fox Foundation . The institution of Dr. Pahwa has received research support from Neuron 23. The institution of Dr. Pahwa has received research support from Roche.
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Ling Zheng, MBBS, PhD	No disclosure on file
Christian Krarup, MD, DMSc, FRcP, FAAN	Dr. Krarup has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Shire/Takeda. Dr. Krarup has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shire/Takeda. Dr. Krarup has received publishing royalties from a publication relating to health care.
Diogo C. Haussen, MD	Dr. Haussen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stryker. Dr. Haussen has received stock or an ownership interest from Viz AI.
Kiel Woodward, MD	Dr. Woodward has nothing to disclose.
Faranak Najibi, MD	No disclosure on file
Carlos Santiago Claverie, MD	No disclosure on file
Guido D. Vazquez II, PhD	Dr. Vazquez has nothing to disclose.
Tudor G. Jovin, MD	Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Contego Medical. Dr. Jovin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Several law firms. Dr. Jovin has stock in Corindus. Dr. Jovin has stock in Methinks. Dr. Jovin has stock in Viz.ai. Dr. Jovin has stock in Route92. Dr. Jovin has stock in FreeOx Biotech. Dr. Jovin has stock in Galaxy. Dr. Jovin has stock in Kandu. The institution of Dr. Jovin has received research support from Stryker. The institution of Dr. Jovin has received research support from Medtronic.
Ned C. Sacktor, MD, FAAN	No disclosure on file
Jessica D. Lee, MD, FAAN	Dr. Lee has received personal compensation for serving as an employee of ��ɫ��. The institution of Dr. Lee has received research support from Janssen.
Robert L. Sufit, MD	No disclosure on file
Tjalf Ziemssen, MD, FAAN	Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Jeremiah M. Scharf, MD, PhD	The institution of Dr. Scharf has received research support from the TLC Foundation for Body-Focused Repetitive Behaviors. Dr. Scharf has received personal compensation in the range of $500-$4,999 for serving as a Speaker for a TAA/CDC Family Day Symposium with the Tourette Association of America. Dr. Scharf has a non-compensated relationship as a Scientific Advisory Board Member with the Tourette Association of America that is relevant to AAN interests or activities.
Rodolfo Savica, MD, PhD, FAAN	The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Mohanad A. AlGaeed, MD	Dr. AlGaeed has nothing to disclose.
Justin S. Yu	No disclosure on file
Mohamad Abdalkader	Mohamad Abdalkader has nothing to disclose.
Rami Fakih, MD	Dr. Fakih has nothing to disclose.
Saranya Khurana	No disclosure on file
Felipe Vial, MD	No disclosure on file
Ioannis Karakis, MD, FAAN	Dr. Karakis has received personal compensation for serving as an employee of Emory University School of Medicine. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Karakis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GSK. Dr. Karakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epitel. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hill Ward Henderson.
Lisa Wolfe, MD	No disclosure on file
A. Blake Buletko, MD	Dr. Buletko has nothing to disclose.
Arastoo Vossough, MD	Dr. Vossough has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Syneos Health. Dr. Vossough has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for DeepSight. Dr. Vossough has received publishing royalties from a publication relating to health care.
Gracia C. Mui, MD	Dr. Mui has nothing to disclose.
Frank Bittner, DO	Dr. Bittner has nothing to disclose.
Ebru Nur Yavuz, MD	No disclosure on file
Rock A. Heyman, MD	Dr. Heyman has nothing to disclose.
Wendy Su, PhD	No disclosure on file
Lucy Zhang, MD	Dr. Zhang has nothing to disclose.
Andrea Loggini, MD, MPH MBA	Dr. Loggini has nothing to disclose.
Sarah Woidill	Sarah Woidill has nothing to disclose.
Joyce En-Hua Wang	No disclosure on file
Benjamin Atchie	No disclosure on file
Esau G. Mbewe	Esau G. Mbewe has received research support from Research was supported by the National Institute Of Neurological Disorders And Stroke of the National Institutes of Health under Award Number K23NS117310. .
Christina Minkoff, CCC/SLP	No disclosure on file
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN	An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities.
Joel Gutierrez, MD	Dr. Gutierrez has nothing to disclose.
Jorge D. Correale, MD	Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Matthew Rizzo, MD, FAAN	The institution of Dr. Rizzo has received research support from NIH.
John N. Caviness, MD, FAAN	Dr. Caviness has nothing to disclose.
Jason S. Hawley, MD	Dr. Hawley has nothing to disclose.
Danielle M. Andrade, MD	The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Dr. Andrade has received research support from Epilepsy Canada. The institution of Dr. Andrade has received research support from SynGAP Research Fund. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Former Chair of task force on Transition with International League Against Epilepsy that is relevant to AAN interests or activities. Dr. Andrade has a non-compensated relationship as a President with Canadian League Against Epilepsy that is relevant to AAN interests or activities.
Amy T. Waldman, MD	Dr. Waldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio. An immediate family member of Dr. Waldman has or had stock in Pfizer. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Roche/Genentech. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. The institution of Dr. Waldman has received research support from Calico. Dr. Waldman has received publishing royalties from a publication relating to health care. Dr. Waldman has received publishing royalties from a publication relating to health care.
Jay Pathmanathan, MD, PhD	No disclosure on file
Sankar Bandyopadhyay, MD, FAAN	Dr. Bandyopadhyay has nothing to disclose.
Ashish Pradhan, MD	Dr. Pradhan has received personal compensation for serving as an employee of Genentech. Dr. Pradhan has received stock or an ownership interest from Genetech.
Cynthia X. Wang, MD	Dr. Wang has nothing to disclose.
Angelica M. Lee, DO	Dr. Lee has nothing to disclose.
Ana M. Morales Ortiz	No disclosure on file
Fuad-al Ali, MD	No disclosure on file
Kanika Sharma, MD	Dr. Sharma has nothing to disclose.
Anand R. Shewale	Anand R. Shewale has received personal compensation for serving as an employee of AbbVie. Anand R. Shewale has stock in AbbVie.
Shyam Majmundar, MD	Dr. Majmundar has nothing to disclose.
Gary L. Pattee, MD	The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA pharmaceuticals. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MTPA pharmaceiticals. The institution of Dr. Pattee has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for General Dynamics US military. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka pharmaceuticals.
Cindy Zadikoff, MD	Dr. Zadikoff has received personal compensation for serving as an employee of AbbVie.
Piotr Bzdyra, MD	No disclosure on file
Reyna M. Duron, MD	No disclosure on file
Divya Madathiparambil	No disclosure on file
Hwai Y. Ooi, MD	Dr. Ooi has nothing to disclose.
Natalie Moreo, MD	Dr. Moreo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PRIME ��ɫ��, LLC. Dr. Moreo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Moreo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apollo Medical Communications. The institution of Dr. Moreo has received research support from InnoCare. The institution of Dr. Moreo has received research support from Novartis .
Janice Rodriguez Hernandez, MD	No disclosure on file
Sweta Sengupta, MD	No disclosure on file
Ryan B. Ghusayni, MD	No disclosure on file
Bianca Barcelo, MD	No disclosure on file
Zachary Satin	No disclosure on file
Cathy A. Sila, MD, FAAN	Dr. Sila has nothing to disclose.
Russell E. Bartt, MD, FAAN	Dr. Bartt has nothing to disclose.
Giancarlo Logroscino, MD, PhD, FAAN	Dr. Logroscino has nothing to disclose.
Carlos A. Pardo-Villamizar, MD	The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Agustin Oterino Duran, MD	No disclosure on file
Josephine F. Huang, MD	Dr. Huang has nothing to disclose.
Paul Mehta	Paul Mehta has nothing to disclose.
Alessandro Orlando, MPH	No disclosure on file
Isabella Herman, MD	Dr. Herman has nothing to disclose.
Ehad Afreen, MD	Dr. Afreen has nothing to disclose.
Irfan S. Sheikh, MD	Dr. Sheikh has nothing to disclose.
Sharon E. Whiting, MBBS, FR	Dr. Whiting has nothing to disclose.
Mona Al Banna, MB BCh BAO	Dr. Al Banna has nothing to disclose.
JaMis M. Jackson, MD	No disclosure on file
Christine Meadows, MD	Dr. Meadows has nothing to disclose.
Alexandra Buda	Ms. Buda has nothing to disclose.
Michele Tagliati, MD, FAAN	Dr. Tagliati has received publishing royalties from a publication relating to health care.
Charles H. Tegeler, MD	Dr. Tegeler has nothing to disclose.
Marufjon Salokhiddinov, MD	No disclosure on file
Jennifer Keller, PhD	No disclosure on file
Owen Dean	No disclosure on file
Tehniyat Baig, MD	Ms. Baig has nothing to disclose.
Tom Petro	No disclosure on file
John H. Sladky, MD, FAAN	Dr. Sladky has nothing to disclose.
Fabrizio Giuliani, MD	Dr. Giuliani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Giuliani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffman-LaRoche. The institution of Dr. Giuliani has received research support from Canadian Institute of Health Research. The institution of Dr. Giuliani has received research support from University of Alberta Hospital Foundation. The institution of Dr. Giuliani has received research support from Hoffman-LaRoche. The institution of Dr. Giuliani has received research support from Novartis.
Nabeel Herial, MD, MPH, FAAN	Dr. Herial has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic.
Zongqi Xia, MD, PhD	The institution of Dr. Xia has received research support from National Institute of Health. The institution of Dr. Xia has received research support from Genentech/Roche.
Matthew Swan, MD, FAAN	The institution of Dr. Swan has received research support from Biogen. The institution of Dr. Swan has received research support from Sage Therapeutics. The institution of Dr. Swan has received research support from Parkinson's Foundation. The institution of Dr. Swan has received research support from Photopharmics. The institution of Dr. Swan has received research support from Denali Therapeutics. The institution of Dr. Swan has received research support from NOEMA Pharma.
Jung E Park, MD, PhD	No disclosure on file
Felippe Borlot, MD	Dr. Borlot has nothing to disclose.
Pattamon Panyakaew, MD	No disclosure on file
Erin Deegan, MD	No disclosure on file
Tara M. Biller, NP	No disclosure on file
Stefania De Trane	Stefania De Trane has nothing to disclose.
Sajid Suriya, MD	Dr. Suriya has nothing to disclose.
Asad Ikram, MD, MBBS	Dr. Ikram has nothing to disclose.
Mefkure Eraksoy, MD	Dr. Eraksoy has nothing to disclose.
Ashutosh P. Jadhav, MD, FAAN	Dr. Jadhav has nothing to disclose.
Recai Turkoglu	Recai Turkoglu has nothing to disclose.
Harold Koendgen, MD	Dr. Koendgen has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. Koendgen has received stock or an ownership interest from F. Hoffmann-La Roche Ltd .
Benjamin Emanuel, DO	Dr. Emanuel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Reback McAndrews Blessey.
Zeynep Caliskan	No disclosure on file
Smit D. Patel, MD, MPH	Dr. Patel has nothing to disclose.
Nada A. Elsaid	Mrs. Elsaid has nothing to disclose.
Shayna Zanker	No disclosure on file
Jose Maria Cabrera Maqueda	Mr. Cabrera Maqueda has nothing to disclose.
Cindy Gonzalez	No disclosure on file
Rachel Darling	No disclosure on file
Pelekelo Kabundula	Pelekelo Kabundula has nothing to disclose.
Fred D. Lublin, MD, FAAN	Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
David M. Biondi, DO, FAAN	Dr. Biondi has received personal compensation for serving as an employee of Cohen Veterans Bioscience, Inc. Dr. Biondi has received personal compensation for serving as an employee of Alder Biopharmaceuticals, Inc. Dr. Biondi has received stock or an ownership interest from Johnson & Johnson . The institution of Dr. Biondi has received research support from US Department of Defense .
James F. Meschia, MD, FAAN	The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Ruggero Capra, MD	Dr. Capra has nothing to disclose.
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Jolanta Marszalek, MD	No disclosure on file
Marie Slegr, MD	No disclosure on file
Ivan M. Pavkovic, MD	No disclosure on file
Morgan Jordan, DO	Dr. Jordan has nothing to disclose.
Arif Husain, DO	No disclosure on file
Katarzyna Kotulska-Jozwiak	No disclosure on file
Aksel Siva, MD	Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Monika Gora	No disclosure on file
Jessica Rice, MD	Dr. Rice has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Pharmaceuticals.
Rabia Yasin, MD	Dr. Yasin has nothing to disclose.
Eoghan P. Deasy, MBBS	No disclosure on file
Anudeep Yelam, MD	Dr. yelam has nothing to disclose.
O. C. Snead III, MD, FAAN	Dr. Snead has nothing to disclose.
Barbara P. Karp, MD, FAAN	Dr. Karp has nothing to disclose.
Ilya Kister, MD, FAAN	Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Angelo Ghezzi, MD	No disclosure on file
Joan Miravite, DNP, RN, FNP-BC, FAAN, FAANP, DAAN	Dr. Miravite has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Miravite has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Miravite has a non-compensated relationship as a Board Member with Association of Movement Disorder Advanced Practice Providers that is relevant to AAN interests or activities.
Kerry L. Knievel, DO	Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Knievel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . The institution of Dr. Knievel has received research support from Abbvie .
Rohit A. Marawar, MD, FAAN	Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Jane Khalife, MD	Dr. Khalife has nothing to disclose.
Jaime Raymond	Jaime Raymond has nothing to disclose.
Carlos N. Ketzoian, MD	No disclosure on file
Morten Blaabjerg, MD	Dr. Blaabjerg has nothing to disclose.
Erin C. Conrad, MD	Dr. Conrad has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epiminder. Dr. Conrad has stock in Humana. Dr. Conrad has stock in Lilly Eli. Dr. Conrad has stock in Medtronic. Dr. Conrad has stock in Merck. Dr. Conrad has stock in Nevro. Dr. Conrad has stock in Sanofi. Dr. Conrad has stock in United Health Group.
Tracy Kornafel	Tracy Kornafel has nothing to disclose.
Malene Landbo Børresen	No disclosure on file
Leanne Munsie	Leanne Munsie has received personal compensation for serving as an employee of Eli Lilly and Company. Leanne Munsie has received stock or an ownership interest from Eli Lilly and Company.
Nneka S. Amadife, MD	No disclosure on file
Rosario Vasta, MD	Dr. Vasta has nothing to disclose.
Arwa Adib	No disclosure on file
Madison Clague	No disclosure on file
Farrukh Javed, MD	Dr. Javed has nothing to disclose.
Isela S. Hernandez	Miss Hernandez has nothing to disclose.
Camilo Garcia	No disclosure on file
Dina Jacobs, MD	Dr. Jacobs has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/EMD Serono. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharmaceuticals. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi . Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for William Blair &Company . Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi . The institution of Dr. Jacobs has received research support from Roche/Genentech .
Jonathan D. Glass, MD	Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apic Bio. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CIRM. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bryan Cave Leighton Paisner. The institution of Dr. Glass has received research support from NIH. The institution of Dr. Glass has received research support from ALS Assoiciation. The institution of Dr. Glass has received research support from Muscular Dystrophy Assoication.
Ricardo C. Reisin, MD	Dr. Reisin has nothing to disclose.
Eric Rosenthal, MD	Dr. Rosenthal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma, Inc. . Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell, Inc. . The institution of Dr. Rosenthal has received research support from Sage Therapeutics. Dr. Rosenthal has received intellectual property interests from a discovery or technology relating to health care.
Domingo O. Garcea, MD	No disclosure on file
Joachim M. Baehring, MD, FAAN	Dr. Baehring has nothing to disclose.
M. B. Westover, MD, PhD	Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
Anjali Gera, MD	Dr. Gera has nothing to disclose.
Vincent H. Bargnes III	Mr. Bargnes has received research support from Harry Dent Family Foundation.
Karl A. Kasischke, MD	No disclosure on file
Jimmy Suh, MD	Dr. Suh has received publishing royalties from a publication relating to health care.
Ryan J. McGinn, MD	No disclosure on file
Hassan Aboul Nour, MD	Dr. Aboul Nour has nothing to disclose.
Ali Ebrahim, MD	Dr. Ebrahim has nothing to disclose.
Pieter B. De Best	No disclosure on file
Sara Cabras	No disclosure on file
Sara McCurdy Murphy	No disclosure on file
Steve Niemcryk	No disclosure on file
Netta Levin, MD, PhD	Dr. Levin has nothing to disclose.
Gloria Von Geldern, MD, FAAN	The institution of Dr. Von Geldern has received research support from Novartis. The institution of Dr. Von Geldern has received research support from Contineum Therapeutics. Dr. Von Geldern has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH, NINDS. Dr. Von Geldern has a non-compensated relationship as a editorial board member with MS and Related Disorders Journal that is relevant to AAN interests or activities.
Nutan Sharma, MD, PhD, FAAN	Dr. Sharma has nothing to disclose.
Alexandra Urban, MD, FAAN	Dr. Urban has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuropace. Dr. Urban has received personal compensation in the range of $0-$499 for serving as a Consultant for LivaNova.
Katherine A. Riester, MPH	No disclosure on file
Umberto Manera, MD	Dr. Manera has nothing to disclose.
David P. Lerner, MD	Dr. Lerner has received publishing royalties from a publication relating to health care.
Pablo Shubaroff	No disclosure on file
Susan King	No disclosure on file
Alejandro R. Marfil-Rivera, MD	Dr. Marfil-Rivera has nothing to disclose.
Sudhakar Tummala, MD, FAAN	Dr. Tummala has nothing to disclose.
Camilo Toro, MD, FAAN	Dr. Toro has received personal compensation in the range of $100,000-$499,999 for serving as a TORO with NIH/IRP.
Gianni Soraru	No disclosure on file
Brian Kopell	No disclosure on file
Ann Murray, MD	Dr. Murray has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Murray has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic .
Sabahattin Saip	Sabahattin Saip has nothing to disclose.
Taskin Duman	Dr. Duman has nothing to disclose.
Samantha J. LoRusso, MD	Dr. LoRusso has nothing to disclose.
Dejan Jakimovski, MD, PhD	Dr. Jakimovski has nothing to disclose.
Asya I. Wallach, MD	Dr. Wallach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Wallach has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen.
Rohit Gummi, MD	Dr. Gummi has nothing to disclose.
Amit S. Singh, MD	Dr. Singh has nothing to disclose.
Susie I. Ro, MD, FAAN	No disclosure on file
Jeenendra P. Singhvi, MD, FAAN	Dr. Singhvi has nothing to disclose.
Andrew Buchanan	No disclosure on file
George Nune, MD	Dr. Nune has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Local residental real estate company.
Jocelyn Montalvo, MD	Dr. Montalvo has nothing to disclose.
Jessica Gonzalez Montes, MD	No disclosure on file
Abigail M. Taylor, PA	Ms. Taylor has nothing to disclose.
George K. Vilanilam, MBBS	Dr. Vilanilam has nothing to disclose.
Saji Bushnaq, MD	No disclosure on file
Solmaz Asnafi, MD	No disclosure on file
Stacy Cusack	No disclosure on file
Franco E. Appiani, MD	Dr. Appiani has nothing to disclose.
Luisa A. Diaz-Arias, MD	Dr. Diaz-Arias has nothing to disclose.
Melanie Guenette	No disclosure on file
Nobutaka Hattori, MD, PhD, FANA	Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PARKINSON Laboratories Co., Ltd. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin Co., Ltd. . Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEIJIN PHARMA LIMITED.. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sumitomo Dainippon Pharma Co., Ltd.. Prof. Hattori has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharmaceutical Co., Ltd.. Prof. Hattori has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyowa Kirin Co., Ltd. . Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie GK. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai Co., Ltd. . Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka Holdings Co.,Ltd.. Prof. Hattori has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Ono Pharmaceutical Co., Ltd.. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai Co., Ltd. . Prof. Hattori has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sumitomo Dainippon Pharma Co., Ltd.. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda Pharma Co., Ltd.. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharma K.K.. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for DAIICHI SANKYO Co., Ltd.. Prof. Hattori has received stock or an ownership interest from PARKINSON Laboratories Co., Ltd. The institution of Prof. Hattori has received research support from Japan Society for the Promotion of Science (JSPS). The institution of Prof. Hattori has received research support from Japan Agency for Medical Research and Development (AMED). The institution of Prof. Hattori has received research support from Japan Science and Technology Agency, Health Labour Sciences Research Grant. The institution of Prof. Hattori has received research support from Japan Science and Technology Agency (JST). The institution of Prof. Hattori has received research support from Kyowa Kirin Co.,Ltd.. The institution of Prof. Hattori has received research support from Medtronic, Inc.. The institution of Prof. Hattori has received research support from Boston Scientific Corporation. The institution of Prof. Hattori has received research support from TEIJIN PHARMA LIMITED.. The institution of Prof. Hattori has received research support from AbbVie GK. The institution of Prof. Hattori has received research support from FP Pharmaceutical Corporation. The institution of Prof. Hattori has received research support from Dai-Nippon Sumitomo Pharma Co.,Ltd. The institution of Prof. Hattori has received research support from Nihon Medi-physics Co.,Ltd.,. The institution of Prof. Hattori has received research support from Eisai Co.,Ltd. . The institution of Prof. Hattori has received research support from Kirin Holdings Company, Limited. The institution of Prof. Hattori has received research support from Mitsubishi UFJ Trust and Banking Corporation. The institution of Prof. Hattori has received research support from GLORY LTD.. The institution of Prof. Hattori has received research support from Nippon Life Insurance Company. The institution of Prof. Hattori has received research support from Otsuka Pharmaceutical, Co.,Ltd. The institution of Prof. Hattori has received research support from AbbVie GK,. The institution of Prof. Hattori has received research support from Meiji Seika Pharma Co., Ltd.. The institution of Prof. Hattori has received research support from Ono Pharmaceutical Co., Ltd.. The institution of Prof. Hattori has received research support from FUJIFILM Wako Pure Chemical Corporation. The institution of Prof. Hattori has received research support from Sunwels,Inc.. The institution of Prof. Hattori has received research support from OHARA Pharmaceutical Co.,Ltd.. The institution of Prof. Hattori has received research support from PARKINSON Laboratories Co., Ltd.. The institution of Prof. Hattori has received research support from Ono Pharmaceutical Co., Ltd.. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving as a Team Leader with RIKEN Center for Brain Science. Prof. Hattori has received personal compensation in the range of $500-$4,999 for serving as a Program officer with AMED: Japan Agency for Medical Research and Development.
Corey C. Ford, MD, PhD, FAAN	No disclosure on file
Mohamad A. Mikati, MD	No disclosure on file
Philip De Jager, MD, PhD	Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from puretech.
Jeremy Moeller, MD, FAAN	Dr. Moeller has received publishing royalties from a publication relating to health care.
Oscar S. Gershanik, MD	No disclosure on file
Berge A. Minassian, MD	Dr. Minassian has nothing to disclose.
Matthew S. Robbins, MD, FAAN	Dr. Robbins has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Robbins has received publishing royalties from a publication relating to health care. Dr. Robbins has a non-compensated relationship as a Board of Directors member, ��ɫ�� Program speaker with American Headache Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Board of Directors member, ��ɫ�� Program speaker with New York State Neurological Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Editorial Board Member with Continuum, ��ɫ�� that is relevant to AAN interests or activities.
Ali Saber Tehrani, MD	Dr. Saber Tehrani has nothing to disclose.
Jacquelyne Kane, MD	No disclosure on file
Roger Cady, MD	Dr. Cady has received personal compensation for serving as an employee of Lundbeck. Dr. Cady has stock in Alder Biopharmaceutical.
Michael Shaw	Mr. Shaw has nothing to disclose.
Catalina Bensi	No disclosure on file
Eric Kassel, PharmD	No disclosure on file
Sen Sheng, MD	Dr. Sheng has nothing to disclose.
Lindsay M. Malatesta, MD	No disclosure on file
Goran Davidovic, MD	No disclosure on file
Paul M. Elsbernd, MD	Dr. Elsbernd has nothing to disclose.
Sabrina Marangoni	No disclosure on file
Mireya M. Bolo-Diaz, MD	No disclosure on file
Paul Sanmartin, MD	No disclosure on file
Anem Kohli, MBBS	No disclosure on file
Meghan Hubert, MD	No disclosure on file
Ozlem Yildiz, PhD	Dr. Yildiz has nothing to disclose.
Rajeeev Ranjan	No disclosure on file
David Dunigan	No disclosure on file
Moein Amin, MD	Dr. Amin has nothing to disclose.
Min Young Chun, MD	Dr. Chun has nothing to disclose.
Vanessa Dias Veloso, MD	Dr. Dias Veloso has nothing to disclose.
Kayla B. Coutts, PT	No disclosure on file
Jennifer M. Kwon, MD, FAAN	Dr. Kwon has nothing to disclose.
John K. Fink, MD	No disclosure on file
Marc Gotkine, MD	No disclosure on file
Johann Sellner, MD, FAAN	Dr. Sellner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Boehringer, Celgene, Immunic, Merck, Novartis, Roche, Sanofi. Dr. Sellner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion, Biogen, Immunic, Merck, Novartis, Roche, Sanofi. Dr. Sellner has received personal compensation in the range of $0-$499 for serving as a Reviewer with Ethics Committtee.
Jacqueline Montes, PT, EdD, NCS	Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA.
Rodney D. Bell, MD	Dr. Bell has received publishing royalties from a publication relating to health care.
Annette Wundes, MD, FAAN	The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Daniel J. MacGowan, MD, FAAN	No disclosure on file
Laszlo Sztriha, MD, PhD	No disclosure on file
Anand V. Patel, MD	Dr. Patel has nothing to disclose.
Ayush Batra, MD	Dr. Batra has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Batra has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogenerator Ventures. Dr. Batra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avania. The institution of Dr. Batra has received research support from GeNeuro SA. The institution of Dr. Batra has received research support from National Institutes of Health. Dr. Batra has received publishing royalties from a publication relating to health care.
Carolina B. Maciel, MD, MSCR, FAAN	Dr. Maciel has received research support from American Heart Association. Dr. Maciel has received research support from National Institute of Health.
Muhammad Affan, MD	Dr. Affan has nothing to disclose.
Kaycee Sink, MD	No disclosure on file
David Clayton	David Clayton has received personal compensation for serving as an employee of Genentech/Roche. David Clayton has received stock or an ownership interest from Roche. An immediate family member of David Clayton has received publishing royalties from a publication relating to health care.
Jared Srinivasan	No disclosure on file
Lin Zhang, FRACP	No disclosure on file
Zachary Cross	No disclosure on file
Tasneem F. Hasan, MD	Dr. Hasan has nothing to disclose.
Nassim Zanganeh, MS	No disclosure on file
Timo Grimmer, MD	Dr. Grimmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie, Alector, Anavex, Biogen, Eli Lilly, Functional Neuromodulation, Grifols, Iqvia, Noselab, Novo Nordisk, NuiCare, Orphanzyme, Roche Diagnostics, Roche Pharma, UCB, and Vivoryon. Dr. Grimmer has received personal compensation in the range of $500-$4,999 for serving as a lecturer with Grifols, Medical Tribune, Novo Nordisk, Roche Pharma, and Schwabe.
Gen Li	No disclosure on file
Orly Moshe-Lilie, MD	No disclosure on file
Mary Kay Floeter, MD, PhD	No disclosure on file
Kumar Rajamani, MD, FAAN	Dr. Rajamani has nothing to disclose.
Devon Conway, MD	Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Conway has received research support from Novartis. The institution of Dr. Conway has received research support from BMS. The institution of Dr. Conway has received research support from Biogen.
Hyang Woon Lee	No disclosure on file
Jens Kuhle, MD	Dr. Kuhle has nothing to disclose.
Terrie Livingston, PharmD	Ms. Livingston has received personal compensation for serving as an employee of Octave Bioscience. Ms. Livingston has received personal compensation for serving as an employee of EMD Serono. Ms. Livingston has stock in Biogen. Ms. Livingston has stock in Octave Bioscience.
Gabrielle Macaron, MD	Dr. Macaron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD-Serono. Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MedEdge. Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Macaron has received research support from National MS Society/International Progressive Multiple Sclerosis Alliance .
Michael R. Wagner, MD	No disclosure on file
Paul M. Miller	No disclosure on file
Steven Gangloff, MD	Dr. Gangloff has nothing to disclose.
Harathi Bandaru, MD	Dr. Bandaru has nothing to disclose.
Sergei Yakushin	No disclosure on file
Syeda Maria Muzammil, MD	Dr. Muzammil has nothing to disclose.
Neal J. Baumbach, MD	No disclosure on file
Amena Smith, MD	No disclosure on file
Henrik Boye Jensen, MD	Henrik Boye Jensen, MD has nothing to disclose.
Luis Paixao, BMBCh, MSc	No disclosure on file
Apameh Salari, MD	Dr. Salari has nothing to disclose.
Thomas G. Brott, MD, FAAN	Dr. Brott has nothing to disclose.
Bjorn E. Oskarsson, MD, FAAN	Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. The institution of Dr. Oskarsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AnnJi. The institution of Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Oskarsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tsumura. The institution of Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MediciNova. The institution of Dr. Oskarsson has received research support from Biogen. The institution of Dr. Oskarsson has received research support from Medicinova. The institution of Dr. Oskarsson has received research support from Cytokinetics. The institution of Dr. Oskarsson has received research support from Calico. The institution of Dr. Oskarsson has received research support from Mitsubishi. The institution of Dr. Oskarsson has received research support from Tsumura. The institution of Dr. Oskarsson has received research support from Sanofi. The institution of Dr. Oskarsson has received research support from AZTherapeutics. The institution of Dr. Oskarsson has received research support from Orion. The institution of Dr. Oskarsson has received research support from Esaii.
Peter H. King, MD	The institution of Dr. King has received research support from Department of Veterans Affairs. The institution of Dr. King has received research support from NIH.
Fred Rincon, MD	Dr. Rincon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroCrit, LLC. Dr. Rincon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for NeuroCrit LLC.
Jacqueline Palace	Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, AMgen, UCB, Roche, Novartis, Amplo, Alexion, . Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Amgen. Dr. Palace has or had stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,. argenx, amgen. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care.
Jesper Hagemeier	No disclosure on file
Ashley Jones	No disclosure on file
Brandi L. Vollmer, MPH	Ms. Vollmer has nothing to disclose.
Judith D. Steinberg, MD	No disclosure on file
Alain Z. Lekoubou Looti, MD	Dr. Lekoubou Looti has nothing to disclose.
Muniza Sheikh	Ms. Sheikh has received personal compensation for serving as an employee of The Emmes Company.
Mariano Marrodan, MD	Dr. Marrodan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Marrodan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck, Astra Zeneca, Gador, Biogen, Roche and Novartis.
Kalyan Yarraguntla, MD	Dr. Yarraguntla has nothing to disclose.
Nataliya Pyatka, MD	Dr. Pyatka has nothing to disclose.
Saif A. Bushnaq, MD	Dr. Bushnaq has nothing to disclose.
Elif Everest, PhD	Ms. Everest has received personal compensation in the range of $50,000-$99,999 for serving as a postdoctoral visiting fellow with National Institutes of Health.
Annett Petersen, MD	No disclosure on file
Suzanne N. Christie, MD	No disclosure on file
Husitha Reddy Vanguru, MBBS	Dr. Vanguru has nothing to disclose.
Raghav Malik	No disclosure on file
Nesreen Jaafar, MD	Dr. Jaafar has nothing to disclose.
Janet Greenwood	Janet Greenwood has stock in Neuropace .
Susan B. Bressman, MD, FAAN	The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Leon S. Dure, MD	Dr. Dure has nothing to disclose.
Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN	Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Karen C. Albright, DO, DO, PhD, MS, MPH	Dr. Albright has nothing to disclose.
Timothy E. Lotze, MD, FAAN	Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Klaus Schmierer, MD, PhD	Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AXDEV. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MedScape. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDiem. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for F. Hoffmann-La Roche AG. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Jiwon Oh, MD, FAAN	Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from Roche.
Deepti Zutshi, MD, FAAN	Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Anthony Noto, MD	Dr. Noto has nothing to disclose.
Sandeep S. Rana, MD, FAAN	Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSI. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmawrite. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
D Kevin Horton	No disclosure on file
Isobel A. Hawes	Ms. Hawes has nothing to disclose.
Olwen Murphy, MD	Dr. Murphy has nothing to disclose.
Khodayar Farahmand	Mr. Farahmand has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
Louise Lombard	Louise Lombard has received personal compensation for serving as an employee of Eli Lilly.
Melih Tutuncu, MD	Dr. Tutuncu has nothing to disclose.
Debra Levin, MA, CCC-SLP	No disclosure on file
Joel S. Perlmutter, MD, FAAN	Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for CHDI. Dr. Perlmutter has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Parkinson Study Group. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wood, Cooper and Peterson, LLC . Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Simmons and Simmons LLP . The institution of Dr. Perlmutter has received research support from NIH. The institution of Dr. Perlmutter has received research support from American Parkinson Disease Association (Advanced Research Center at Washington University). The institution of Dr. Perlmutter has received research support from CHDI. The institution of Dr. Perlmutter has received research support from Huntington Disease Society of America. The institution of Dr. Perlmutter has received research support from University of Western Toronto. The institution of Dr. Perlmutter has received research support from Barnes-Jewish Hospital Foundation. The institution of Dr. Perlmutter has received research support from Michael J Fox Foundation. The institution of Dr. Perlmutter has received research support from UCSD. The institution of Dr. Perlmutter has received research support from Paula & Rodger Riney FUnd. The institution of Dr. Perlmutter has received research support from Jo Oertli Fund. The institution of Dr. Perlmutter has received research support from Murphy FUnd. The institution of Dr. Perlmutter has received research support from Fixel Fund. The institution of Dr. Perlmutter has received research support from N Grant WIlliams Fund. The institution of Dr. Perlmutter has received research support from Pohlman Fund. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a lecturer with Boston University. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a external advisor with Stanford University. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a visiting professor with Beth Israel Hospital. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a visiting professor with U Pennsylvania.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Carlos Singer, MD	Dr. Singer has nothing to disclose.
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Merry Chen, MD	Dr. Chen has nothing to disclose.
Gyanendra Kumar, MD, FAAN	Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Medical Consultant with Arizona Medical Board.
Bhavesh Trikamji, MD	Dr. Trikamji has nothing to disclose.
Guy T. Helman	No disclosure on file
Taha Nisar, MD	Dr. Nisar has nothing to disclose.
Ursula Utz	Ursula Utz has nothing to disclose.
Christopher Salvatore	No disclosure on file
Monica K. Johnson, MD	Dr. Johnson has a non-compensated relationship as a Advisory Board Member with LiveOn OPO that is relevant to AAN interests or activities.
Danielle R. Brigham, MD	No disclosure on file
Giuseppina Pilloni, PhD	Dr. Pilloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceragem.
Irina Agarkova	No disclosure on file
Maria Mateo-Casas	No disclosure on file
Mario Javier Halfon	No disclosure on file
Susan Warner	No disclosure on file
Rebecca V. Zhang	No disclosure on file
Imad M. Najm, MD	Dr. Najm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc. Dr. Najm has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Inc. Dr. Najm has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai Inc.
Christopher McGuigan, MD	An immediate family member of Prof. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. McGuigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Prof. McGuigan has received research support from Novartis.
Diana Dimitrova, PhD	No disclosure on file
Luisa Maria Villar Guimerans, MD	No disclosure on file
Carolyn Cronin, MD, PhD, FAAN	Dr. Cronin has nothing to disclose.
Tarun Girotra, MD	Dr. Girotra has nothing to disclose.
Michael E. Theriault, MD	No disclosure on file
Christine Lu, MD	No disclosure on file
Omar Sherbini	No disclosure on file
Evan Riddle, PhD	Dr. Riddle has received personal compensation for serving as an employee of Biogen. Dr. Riddle has received stock or an ownership interest from Biogen.
Joseph C. Perumpillichira, MD, PhD, DM	No disclosure on file
Christa Habela, MD	The institution of Dr. Habela has received research support from NINDS. Dr. Habela has received publishing royalties from a publication relating to health care.
Supriya Kairamkonda, MD	No disclosure on file
Brendan Clark	No disclosure on file
Per Soelberg Sorensen	No disclosure on file
Vissia Viglietta, MD	No disclosure on file
Joseph D. Burns, MD	Dr. Burns has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Minjee Kim, MD	The institution of Dr. Kim has received research support from Genentech, Inc.. The institution of Dr. Kim has received research support from National Institute on Aging.
Machteld E. Hillen, MD, FAAN	The institution of Dr. Hillen has received research support from Genentech.
Marijean Buhse	Marijean Buhse has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Chelsea S. Chen	Ms. Chen has nothing to disclose.
Huan G. Huynh, MD	No disclosure on file
Fonda Liu	No disclosure on file
Brittany A. Charsar, MD, PhD	No disclosure on file
Jose R. Rodriguez, MD	No disclosure on file
Sutapa Ray, PhD	Dr. Ray has received personal compensation for serving as an employee of Impel Pharmaceuticals. Dr. Ray has stock in Impel Pharmaceuticals.
Muhammad Muzzammil Edhi, MBBS	Dr. Edhi has nothing to disclose.
Meghana S. Kinariwala, MD	Dr. Srinivas has nothing to disclose.
Mohammed Alhaidar, MD	Dr. Alhaidar has nothing to disclose.
Micaela R. Owens, DO	Dr. Owens has nothing to disclose.
Panna L. Bhattacharyya, MD, MBBS	No disclosure on file
Juan Sebastian Diaz, MD	No disclosure on file
Paul Ardayfio	Paul Ardayfio has received personal compensation for serving as an employee of Eli Lilly and Co.. Paul Ardayfio has stock in Eli Lilly and Co.
Pallavi Pemmireddy	No disclosure on file
Gregory L. Barkley, MD	No disclosure on file
Merit E. Cudkowicz, MD, MSC, FAAN	Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for cytokinetics. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for immunitypharm. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for transposon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vectorY. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inflectis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ono. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for otsuka. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for coya. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ac immune. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for pontifax. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inflectis. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for ab science. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for aclipse. Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Locust Walk. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pasithea. Dr. Cudkowicz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Praxis Precision Medicine. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology . The institution of Dr. Cudkowicz has received research support from NINDS. The institution of Dr. Cudkowicz has received research support from ALSFAC. The institution of Dr. Cudkowicz has received research support from UCB ra. The institution of Dr. Cudkowicz has received research support from Biohaven. The institution of Dr. Cudkowicz has received research support from Clene nanomedicine. The institution of Dr. Cudkowicz has received research support from prilenia. The institution of Dr. Cudkowicz has received research support from ALS one. The institution of Dr. Cudkowicz has received research support from Seelos. The institution of Dr. Cudkowicz has received research support from Calico. The institution of Dr. Cudkowicz has received research support from denali. The institution of Dr. Cudkowicz has received research support from ITB. The institution of Dr. Cudkowicz has received research support from PharmAust. The institution of Dr. Cudkowicz has received research support from woolsley. Dr. Cudkowicz has received research support from lilly. The institution of Dr. Cudkowicz has received research support from J& J. Dr. Cudkowicz has received publishing royalties from a publication relating to health care.
Nathalie Jette, MD, MSc, FRCPC, FAAN	Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES.
Julia Kramer-Golinkoff	No disclosure on file
Theresa A. Zesiewicz, MD	Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Andrea Calvo, MD, PhD, FAAN	Dr. Calvo has nothing to disclose.
Zachary Simmons, MD, FAAN	Dr. Simmons has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insmed. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Simmons has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Simmons has received research support from MGH. The institution of Dr. Simmons has received research support from Clene. The institution of Dr. Simmons has received research support from NIH via MGH. The institution of Dr. Simmons has received research support from Aburo. The institution of Dr. Simmons has received research support from NIH subaward via Univ of Pennsylvania.
Caitlin Bell	No disclosure on file
Michael Rabbia	No disclosure on file
Emily Elliott, DO	Dr. Elliott has nothing to disclose.
Aftab Alam	No disclosure on file
Fan Wu, PhD	No disclosure on file
Dhara Murray-Frank, MD	Dr. Murray-Frank has nothing to disclose.
Laura A. Adang, MD	Dr. Adang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orchard Therapeutics.
Shayan Ul Haque, MD, MBBS	No disclosure on file
Freddy Escobar-Montealegre	No disclosure on file
Sophia Yang, MD	No disclosure on file
Rashid A. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Gabriela A. Bou, MD	Dr. Bou has nothing to disclose.
Ariana Gopal	No disclosure on file
Gilbert J. L'Italien	Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Petr Kanovsky, PhD	Dr. Kanovsky has nothing to disclose.
Robert A. Bermel, MD, FAAN	Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Halley A. Alexander, MD	Dr. Alexander has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Alexander has received research support from National Center for Advancing Translational Sciences, National Institute of Health, Grant KL2TR001421.
Lauren D. Weaver, MD	No disclosure on file
Haydee Del Calvo	No disclosure on file
Shayan A. Gates, DO	No disclosure on file
Morgan M. Heinzelmann-Weisbaum, MD	Dr. Heinzelmann-Weisbaum has nothing to disclose.
Bayan Moustafa, DO	Dr. Moustafa has nothing to disclose.
Victor Saunders, MD	No disclosure on file
Sandra McDonald, NP	No disclosure on file
Bennett L. Lavenstein, MD, FAAN	No disclosure on file
Saud Sadiq, BS, FAAN	Ms. Brewi has nothing to disclose.
Sandra Vukusic, MD	The institution of Dr. Vukusic has received research support from Biogen. The institution of Dr. Vukusic has received research support from Janssen. The institution of Dr. Vukusic has received research support from Merck. The institution of Dr. Vukusic has received research support from Novartis. The institution of Dr. Vukusic has received research support from Roche.
Joan M. Ohayon	Joan M. Ohayon has nothing to disclose.
Stephen N. Scelsa, MD	No disclosure on file
Abel Wu, MD	No disclosure on file
Brian J. Villafuerte Trisolini, MD	Dr. Villafuerte Trisolini has nothing to disclose.
Natalie Thom	Ms. Thom has nothing to disclose.
Preeth Manu, MD	No disclosure on file
Alexander J. Bader, MD	No disclosure on file
Robert A. Hauser, MD, MBA, FAAN	Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Robert Cowan, MD, FAAN	Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for lundbeck. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biohavenn. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbviie. Dr. Cowan has stock in Percept. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received publishing royalties from a publication relating to health care.
Sachin Kedar, MD, FAAN	Dr. Kedar has nothing to disclose.
Ralf Gold, MD	Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Michael Dobbs, MD	Dr. Dobbs has received publishing royalties from a publication relating to health care.
Laxman Bahroo, DO, FAAN	Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ipsen. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Dr. Bahroo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Acorda. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amneal. Dr. Bahroo has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Bahroo has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Neurocrine. Dr. Bahroo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Bahroo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Bahroo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz.
Christine I. Dali, MD	Dr. Dali has received personal compensation for serving as an employee of Orphazyme A/S .
Hussam A. Yacoub, DO	Dr. Yacoub has nothing to disclose.
Brian Berman, MD, MS, FAAN	The institution of Dr. Berman has received research support from Dystonia Medical Research Foundation. The institution of Dr. Berman has received research support from National Institutes of Health. The institution of Dr. Berman has received research support from Neurocrine Biosciences. The institution of Dr. Berman has received research support from Benign Essential Blepharospasm Research Foundation. The institution of Dr. Berman has received research support from National Institutes of Health.
Eric Lancaster, MD, PhD	Dr. Lancaster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merck. Dr. Lancaster has received intellectual property interests from a discovery or technology relating to health care. Dr. Lancaster has received personal compensation in the range of $50,000-$99,999 for serving as a Expert and Witness with US Vaccine Injury Compensation Program.
Kazuko Hasegawa, MD	Dr. Hasegawa has nothing to disclose.
Benjamin M. Greenberg, MD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Timothy L. Vollmer, MD, FAAN	The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Stephen B. Shrewsbury, MD	Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Bernadette Boden-Albala, DrPH	Ms. Boden-Albala has received research support from NIH.
Madison L. Wolfe	No disclosure on file
Andrew Garrett, DO	No disclosure on file
Swati Pradeep, MD	Dr. Pradeep has nothing to disclose.
Louise Mason	No disclosure on file
Amputch Karukote, MD	Dr. Karukote has nothing to disclose.
Jerry S. Wolinsky, MD, FAAN	Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
J. Theodore Phillips, MD, PhD, FAAN	No disclosure on file
Lin Zhang, MD, PhD, FAAN	Dr. Zhang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for supernus. Dr. Zhang has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for supernus. The institution of Dr. Zhang has received research support from Michael J. Fox Foundation.
Dhimant Dani, MD	Dr. Dani has nothing to disclose.
Jelena M. Pavlovic, MD, PhD	Dr. Pavlovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven.
Asako Takanohashi, PhD, DVM	Dr. Takanohashi has nothing to disclose.
Van Hellerslia, PharmD	No disclosure on file
Mario E. Ricciardi, Sr., MD	Dr. Ricciardi has nothing to disclose.
Mark S. Quigg, MD	Dr. Quigg has received personal compensation for serving as an employee of Natus. Dr. Quigg has received personal compensation for serving as an employee of Neurocrine. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebral Therapeutics. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerebral Therapeutics. Dr. Quigg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Finnigen and Harrison. Dr. Quigg has received research support from NIH. Dr. Quigg has received publishing royalties from a publication relating to health care.
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Michael L. Reed, PhD	The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities.
Alfredo Thomson, MD	Dr. Thomson has nothing to disclose.
Guerry M. Peavy, PhD	Dr. Peavy has stock in MRK. Dr. Peavy has stock in ABT. Dr. Peavy has stock in JNJ. Dr. Peavy has stock in ABBV. The institution of an immediate family member of Dr. Peavy has received research support from NIH. The institution of Dr. Peavy has received research support from NIH.
Raju Kapoor, MD	No disclosure on file
Anshu Rohatgi, MD, DM, FAAN	No disclosure on file
Noreen Bukhari-Parlakturk, MD, PhD	No disclosure on file
Andrew Ng, MD	No disclosure on file
Jeremy Wong, MD	Dr. Wong has nothing to disclose.
Ruiqing Sun, MD, PhD	Dr. Sun has nothing to disclose.
Serena Galosi, MD	No disclosure on file
Yash Shah, MD, MBBS, MPH	Dr. Shah has nothing to disclose.
David Gozal	No disclosure on file
Julien Valverde Twiggs	No disclosure on file
Elahe Bordbar, MD	Dr. Bordbar has nothing to disclose.
Yoni Goldstein	No disclosure on file
William Ondo, MD	Dr. Ondo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. The institution of Dr. Ondo has received research support from Cerevel. The institution of Dr. Ondo has received research support from SCION. The institution of Dr. Ondo has received research support from Harmony. Dr. Ondo has received publishing royalties from a publication relating to health care.
Peter Siao Tick Chong, MD	No disclosure on file
Camila Pupe, MD	Dr. Pupe has nothing to disclose.
Fernando L. Pagan, MD, FAAN	Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US World Meds. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Parkinsonism and related Disorders. Dr. Pagan has stock in Keiferx. The institution of Dr. Pagan has received research support from US World Meds. The institution of Dr. Pagan has received research support from Novartis.
Ashwini K. Rao	No disclosure on file
Jeffrey M. Katz, MD	Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Katz Medical Consulting. The institution of Dr. Katz has received research support from Medtronic.
Melinda Magyari, MD	Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Magyari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Magyari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. The institution of Dr. Magyari has received research support from The Danish MS Society. The institution of Dr. Magyari has received research support from Biogen. The institution of Dr. Magyari has received research support from Novartis. The institution of Dr. Magyari has received research support from Roche. The institution of Dr. Magyari has received research support from Merck. The institution of Dr. Magyari has received research support from Sanofi.
Neal S. Parikh, MD	Dr. Parikh has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Parikh has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for cases of neurological illness. Dr. Parikh has stock in Alnylam Pharmaceuticals. The institution of Dr. Parikh has received research support from Leon Levy Foundation. The institution of Dr. Parikh has received research support from Florence Gould Foundation. The institution of Dr. Parikh has received research support from NY State Empire Clinical Research Investigator Program. The institution of Dr. Parikh has received research support from NIA. The institution of Dr. Parikh has received research support from Medtronic.
Emily S. Riser, MD	Dr. Riser has nothing to disclose.
Michal Vytopil, MD	Dr. Vytopil has nothing to disclose.
Eliezer Sternberg, MD	No disclosure on file
Mohamad Orabi, MD	No disclosure on file
Rajanigandhi Hanumanthu, MD	No disclosure on file
Paul B. Hart	Mr. Hart has nothing to disclose.
Martin A. Myers, MD	No disclosure on file
Chizoba Ezepue, MD	No disclosure on file
Roberto Alvarez Lafuente	No disclosure on file
Sylvia Josephy, MD	Dr. Josephy has nothing to disclose.
Amy Postelnik, MD	No disclosure on file
Anna D. Hohler, MD, FAAN	Dr. Hohler has nothing to disclose.
Michael McDermott	No disclosure on file
Helmut Butzkueven, MD, MBBS	Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Paulo P. Fontoura, MD, PhD, FAAN	Dr. Fontoura has received personal compensation for serving as an employee of F. Hoffmann La Roche. Dr. Fontoura has stock in Roche Pharmaceuticals.
Alexander Sherman	The institution of Mr. Sherman has received research support from The ALS Association. The institution of Mr. Sherman has received research support from NIH. The institution of Mr. Sherman has received research support from FDA. The institution of Mr. Sherman has received research support from Biogen. The institution of Mr. Sherman has received research support from Amylyx Pharmaceuticals. The institution of Mr. Sherman has received research support from Mitsubishi-Tanabe Pharma America. Mr. Sherman has a non-compensated relationship as a Member, Board of Directors with ALD Connect that is relevant to AAN interests or activities.
Augusto A. Miravalle, MD, FAAN	Dr. Miravalle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Miravalle has received research support from Genzyme. The institution of Dr. Miravalle has received research support from EMD Serono. The institution of Dr. Miravalle has received research support from Alexion.
Evanthia Bernitsas, MD, FAAN	Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Anindita Deb, MD, FAAN	Dr. Deb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altec.
Eric J. Mallack, MD	Dr. Mallack has received research support from NINDS.
Shumei Man, MD, PhD	No disclosure on file
Luiz De Souza, MD	No disclosure on file
Ekenedilichukwu C. Nwoye, MD	No disclosure on file
Paula K. Lee, MD	No disclosure on file
Wilson D. Heredia, MD	Dr. Heredia has nothing to disclose.
Alexandre Mason Sharma, MD	Dr. Mason Sharma has nothing to disclose.
Michlene Passeri, MD	Dr. Passeri has nothing to disclose.
Chan Young Lee, MD	No disclosure on file
Grace Kim	Mr. Kim has nothing to disclose.
Jin Jing	No disclosure on file
Haleigh C. Harris	No disclosure on file
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Charles W. Brock, MD	No disclosure on file
Steven J. Kittner, MD, MPH	The institution of Dr. Kittner has received research support from NINDS.
Mark F. Lew, MD, FAAN	Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for kyowa. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for neurocrine. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RegenXBio. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyowa. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Lew has received research support from MJFF. Dr. Lew has received research support from NIH.
Adriano Chio, MD, FAAN	Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Anto Bagic, MD, PhD	Dr. Bagic has nothing to disclose.
Tamir S. Ben-Hur, MD, PhD	The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI Pharma. The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kadimastem. The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sipnose. The institution of Dr. Ben-Hur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regenera Pharma. The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medasense. Dr. Ben-Hur has received stock or an ownership interest from Sipnose. Dr. Ben-Hur has received stock or an ownership interest from Kadimastem. Dr. Ben-Hur has received stock or an ownership interest from MAPI Pharma. Dr. Ben-Hur has received intellectual property interests from a discovery or technology relating to health care.
Alejandra Duque Ramirez, MD	Dr. Duque Ramirez has nothing to disclose.
Nicholas Calvo, MD	No disclosure on file
Manuel Nunez, PharmD	No disclosure on file
Klaus Tiel-Wilck, MD	No disclosure on file
Gabriela Tuttrup, MD	Dr. Tuttrup has nothing to disclose.
John Furey	Mr. Furey has nothing to disclose.
Rajeev Ojha, MD	Dr. Ojha has nothing to disclose.
Andrea Falini	No disclosure on file
Kelly D. Foote, MD	Kelly D. Foote, MD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axio/Neurocrine Biosciences.
Karla P. Figueroa	Ms. Figueroa has nothing to disclose.
Giulia Longoni, MD	Dr. Longoni has nothing to disclose.
Michael J. Lyerly, MD, FAAN	Dr. Lyerly has nothing to disclose.
Michael Ko, MD	No disclosure on file
Maria Wieman, MPH	No disclosure on file
Deborah Raymond	The institution of Ms. Raymond has received research support from NIH.
Gregg G. Blevins, MD, FRCP(C)	Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffman La-roche. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen Idec. The institution of Dr. Blevins has received research support from Novartis. Dr. Blevins has received research support from Hoffman La-Roche. The institution of Dr. Blevins has received research support from EMD Serono. Dr. Blevins has received research support from Biogen Idec. The institution of Dr. Blevins has received research support from MS society of Canada. The institution of Dr. Blevins has received research support from Canadian Institutes of Health Research .
Lucia Moiola, MD, PhD	Dr. Moiola has nothing to disclose.
Gregg D. Meekins, MD, FAAN	No disclosure on file
Sydney Cash, MD	Dr. Cash has received stock or an ownership interest from Beacon Biosignals.
Maysaa M. Basha, MD, FAAN	Dr. Basha has nothing to disclose.
Sepideh Mokhtari, MD	Dr. Mokhtari has nothing to disclose.
Shaista Alam, MD	Dr. Alam has nothing to disclose.
Gabriella Sahyoun	No disclosure on file
Shunji Toya	Shunji Toya has received personal compensation for serving as an employee of Sumitomo Dainippon Pharma Co., Ltd..
Katherine A. Zarroli, MD	Dr. Zarroli has nothing to disclose.
James Huynh, MD	Dr. Huynh has nothing to disclose.
Michelle Patel	No disclosure on file
Kelly L. Polito, MD	No disclosure on file
David Rahimian, MD	No disclosure on file
Francesco Gavazzi, MD, MD, PhD	The institution of Dr. Gavazzi has received research support from NIH. The institution of Dr. Gavazzi has received research support from NIH, NINDS. The institution of Dr. Gavazzi has received research support from IONIS Pharmaceuticals.
Rodny Munoz-Perez II, MD	No disclosure on file
Kristen T. Ashourian	No disclosure on file
John E. Greenlee, MD, FAAN	Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
Daniel D. Truong, MD, FAAN	The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Truong has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Truong has received research support from Abbvie. The institution of Dr. Truong has received research support from Aeon. The institution of Dr. Truong has received research support from Biogen. The institution of Dr. Truong has received research support from Bukwang. The institution of Dr. Truong has received research support from Cerevel. The institution of Dr. Truong has received research support from Eli Lilly. The institution of Dr. Truong has received research support from Enterin. The institution of Dr. Truong has received research support from Ipsen. The institution of Dr. Truong has received research support from Lundbeck. The institution of Dr. Truong has received research support from Neurocrine. The institution of Dr. Truong has received research support from Neuroderm. The institution of Dr. Truong has received research support from Parkinson Foundation. The institution of Dr. Truong has received research support from Prilenia. The institution of Dr. Truong has received research support from Revance. The institution of Dr. Truong has received research support from Sunovion. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has a non-compensated relationship as a President with International Association for Parkinsonism and Related Disorders that is relevant to AAN interests or activities.
David Rog, MBBS	Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Rog has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rog has received research support from Merck. The institution of Dr. Rog has received research support from Novartis. The institution of Dr. Rog has received research support from TG Therapeutics. Dr. Rog has received research support from Janssen-Cilag.
Frederick A. Schmitt, PhD	The institution of Dr. Schmitt has received research support from NIH.
Frank Hoffmann, MD	Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Talecris. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Florian Then Bergh, MD	Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Actelion. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Fresenius. Dr. Then Bergh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Then Bergh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. The institution of Dr. Then Bergh has received research support from Actelion. The institution of Dr. Then Bergh has received research support from Novartis. The institution of Dr. Then Bergh has received research support from DFG (German Science Fund). The institution of Dr. Then Bergh has received research support from Fresenius. The institution of Dr. Then Bergh has received research support from Diamed. Dr. Then Bergh has received personal compensation in the range of $10,000-$49,999 for serving as a Member of the Institutional Ethics Board with University of Leipzig, Medical Faculty.
Carlo Colosimo, MD	No disclosure on file
Sylvia R. Delgado, MD, FAAN	The institution of Dr. Delgado has received research support from Novartis. The institution of Dr. Delgado has received research support from EMD Serono.
Mauricio F. Farez, MD	Dr. Farez has received personal compensation for serving as an employee of Entelai. Dr. Farez has stock in Entelai. The institution of Dr. Farez has received research support from Fundación Sadosky.
Clemens Warnke	The institution of Clemens Warnke has received research support from Novartis. The institution of Clemens Warnke has received research support from Alexion. The institution of Clemens Warnke has received research support from Sanofi-Genzyme. The institution of Clemens Warnke has received research support from Biogen. The institution of Clemens Warnke has received research support from Roche.
Xiangyi Meng, PhD	Dr. Meng has nothing to disclose.
Vivay Peter Misra, MD	No disclosure on file
Rachel Salazar, PT	No disclosure on file
Byung-Jo Kim	No disclosure on file
Mirla L. Avila, MD, FAAN	Dr. Avila has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Genzyme, BMS, Serono. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen, genzyme, BMS. The institution of Dr. Avila has received research support from Texas Tech.
Carol Mathews	The institution of Carol Mathews has received research support from NIH.
Nitish Harid	No disclosure on file
Sarah G. Finnegan, MD, PhD	No disclosure on file
Lisa Nassif, MD	Dr. Nassif has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Family Neurology and Neurodevelopmental Center.
Aristide Merola, MD, PhD	Dr. Merola has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Merola has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Merola has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Pooja SirDeshpande, MBBS	No disclosure on file
Shaweta Khosa	Ms. Khosa has nothing to disclose.
Emma Benn	No disclosure on file
Christopher Oakley, MD	Dr. Oakley has nothing to disclose.
Shreya Gandhy, DO	Dr. Gandhy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.
Jonathan Ratcliff	The institution of Dr. Ratcliff has received research support from Nico Corporation. The institution of Dr. Ratcliff has received research support from Sense .
Matthew Purbaugh, MD	Dr. Purbaugh has nothing to disclose.
Huy Q. Nguyen, MD	No disclosure on file
Mehdi Fanai, MD	No disclosure on file
Maria A. Garcia-Dominguez, MD	Dr. Garcia-Dominguez has nothing to disclose.
Mamta B. Singh, MD, MBBS, DM, FAAN	Dr. Singh has nothing to disclose.
Marjo Van Der Knaap, MD, PhD	The institution of Marjo Van Der Knaap, MD, PhD has received research support from Calico. The institution of Marjo Van Der Knaap, MD, PhD has received research support from Ionis.
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Orna O'Toole, MB, BCh, BAO MD	Dr. O'Toole has nothing to disclose.
Ugur Uygunoglu	Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanovel of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genveon of Turkey.
Ikjae Lee, MD	Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. The institution of Dr. Lee has received research support from NIH. The institution of Dr. Lee has received research support from Spastic Paraplegia Foundation.
Dustin Chernick, PhD	No disclosure on file
Richard W. Hughes, MBBS	Dr. Hughes has received personal compensation for serving as an employee of Biogen. Dr. Hughes has stock in Biogen.
Nicolas Currier	No disclosure on file
Daniel A. Crespo, MD	Dr. Crespo has nothing to disclose.
Annika Ehrlich, DNP, FNP-C, AQH, CNRN	Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Pharmaceuticals. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmamark. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Focus MedEd. Dr. Ehrlich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eNeura. Dr. Ehrlich has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axome Therapeutics. Dr. Ehrlich has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Ehrlich has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific. Dr. Ehrlich has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neurology Advanced Practice Providers. Dr. Ehrlich has a non-compensated relationship as a Board President with Alliance for Headache Disorders Advocacy that is relevant to AAN interests or activities. Dr. Ehrlich has a non-compensated relationship as a Board President with The Headache Alliance that is relevant to AAN interests or activities. Dr. Ehrlich has a non-compensated relationship as a Advanced Practice Provider Board Liaison with American Headache Society that is relevant to AAN interests or activities.
Germano Ferreira	No disclosure on file
David Daniel, MD	Dr. Daniel has nothing to disclose.
Caroline M. Tanner, MD, PhD, FAAN	Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Cheolsu Shin, MD	No disclosure on file
Harry B. Coslett, MD, FAAN	The institution of Dr. Coslett has received research support from NIDCD, NINDS, NIA. Dr. Coslett has received publishing royalties from a publication relating to health care.
Howard L. Weiner, MD	Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Richard S. Nicholas, FRCP	Dr. Nicholas has nothing to disclose.
Panayiotis Mitsias, MD	The institution of Dr. Mitsias has received research support from European Union.
Michael R. Frankel, MD	The institution of Dr. Frankel has received research support from Nico Corporation, Inc.
Janice Y. Maldonado, MD	The institution of Dr. Maldonado has received research support from Genentech.
Daniel Bandari, MD	The institution of Dr. Bandari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Bandari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. The institution of Dr. Bandari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Bandari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD-Serono. The institution of Dr. Bandari has received research support from Genentech. The institution of Dr. Bandari has received research support from EMD-Serono.
Suzanne J. Hodgkinson, MD, MBBS, PhD, FRACP	The institution of Dr. Hodgkinson has received research support from MERCK. The institution of Dr. Hodgkinson has received research support from Atara. The institution of Dr. Hodgkinson has received research support from Biogen . The institution of Dr. Hodgkinson has received research support from Genzyme. The institution of Dr. Hodgkinson has received research support from ROCHE. The institution of Dr. Hodgkinson has received research support from Novartis.
Clara Aguirre Hernandez	Clara Aguirre Hernandez has nothing to disclose.
Navnika Gupta, MBBS	Dr. Gupta has nothing to disclose.
Jennifer Merickel	No disclosure on file
Stephen L. Hauser, MD	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Thanh Nguyen, MD	Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vesalio. Dr. Nguyen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avania. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Nguyen has received research support from Boston Medical Center. The institution of Dr. Nguyen has received research support from Society of Vascular and Interventional Neurology.
Bonnie Glanz	The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Martin Nevrly, MD	No disclosure on file
Thomas A. Berger, MD	Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Kaj Blennow	Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Julius Clinical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celdara Medical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Co-founder with Brain Biomarker Solutions.
Clarissa L. Yasuda, MD, PhD	Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Sudeepta Dandapat, MD	Dr. Dandapat has nothing to disclose.
Sung-Min Cho, DO	Dr. Cho has nothing to disclose.
Dharampreet Singh, MD	No disclosure on file
Jorge Patiño	No disclosure on file
Justine Shults	No disclosure on file
George Small, MD	Dr. Small has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Brandon S. Pope, MD	No disclosure on file
Sarah A. Levy, MD	Dr. Levy has received research support from NYU FACES.
Abigail N. Schwaede, MD	Dr. Schwaede has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Schwaede has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen .
Michelle J. Jaeggi, MD	Dr. Jaeggi has nothing to disclose.
Jiaqi Yao, MD	Dr. Yao has nothing to disclose.
Jorge Maurino	Jorge Maurino has received personal compensation for serving as an employee of Roche Pharma Spain, Medical Department.
Daniel Chasman, PhD	Daniel Chasman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Daniel Chasman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Daniel Chasman has received research support from Pfizer. Daniel Chasman has received intellectual property interests from a discovery or technology relating to health care.
Maria Laura Saladino	Maria Laura Saladino has nothing to disclose.
Kristine Yaffe, MD	Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quintiles. Dr. Yaffe has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Alector. The institution of Dr. Yaffe has received research support from NIH. The institution of Dr. Yaffe has received research support from DOD. The institution of Dr. Yaffe has received research support from Veterans Affairs.
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Bernard F. Michel, MD	No disclosure on file
Norbert Goebels, MD	Dr. Goebels has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Goebels has received research support from Sanofi-Genzyme.
Justin Y. Kwan, MD, FAAN	Dr. Kwan has received research support from National Institutes of Health. Dr. Kwan has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with National Institutes of Health.
Andrea J. Swenson, MD	An immediate family member of Dr. Swenson has received personal compensation for serving as an employee of IDT. Dr. Swenson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. An immediate family member of Dr. Swenson has received stock or an ownership interest from IDT.
Andrew Kirk, MD	No disclosure on file
Tania Kuempfel, MD	Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon.
Shifang Liu	No disclosure on file
Elisa Canu	The institution of Elisa Canu has received research support from Italian Ministry of Health .
Veronica A. Bruno, MD	Dr. Bruno has nothing to disclose.
Lisa Meng	No disclosure on file
Jeffrey M. Kornitzer, MD, FAAN	Dr. Kornitzer has nothing to disclose.
Ilana B. Katz Sand, MD	The institution of Dr. Katz Sand has received research support from National Multiple Sclerosis Society. The institution of Dr. Katz Sand has received research support from Hirschl Foundation. The institution of Dr. Katz Sand has received research support from National Institutes of Health. Dr. Katz Sand has received personal compensation in the range of $500-$4,999 for serving as a Conference presenter with ��ɫ��.
Vikram Shivkumar, MD, FAAN	Dr. Shivkumar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Addie Peretz, MD	Dr. Peretz has nothing to disclose.
Kate W. Hocquard, MD	No disclosure on file
Reed Johnson	No disclosure on file
Maria D. Zambrano Espinoza, MD	Dr. Zambrano Espinoza has nothing to disclose.
Pierpaolo Turcano, MD	Dr. Turcano has nothing to disclose.
Cosette M. Burian, PA	No disclosure on file
Doris Chen, MD	No disclosure on file
Alan K. Jacobs, MD, FAAN	Dr. Jacobs has received personal compensation for serving as an employee of Immunovant, Inc. Dr. Jacobs has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Galler Consulting.
Carrie Downey, DO	No disclosure on file
Jamison Hofer, MD	No disclosure on file
Kalyan Reddy Malgireddy, MD	No disclosure on file
Bhageeradh Mulpur, MD	Dr. Mulpur has nothing to disclose.
Shashvat Desai, MD	Dr. Desai has nothing to disclose.
Michael A. Perez, MD	Dr. Perez has nothing to disclose.
Sylvia Mwanza-Kabaghe	No disclosure on file
Haoqi Sun, PhD	Dr. Sun has nothing to disclose.
Lauren B. Krupp, MD, FAAN	Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Maria P. Amato, PhD	Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOU Careggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi genzyme. The institution of Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene BMS. The institution of Dr. Amato has received research support from Merck. The institution of Dr. Amato has received research support from Biogen. The institution of Dr. Amato has received research support from Roche.
Irene Malaty, MD, FAAN	Dr. Malaty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aevum. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. The institution of Dr. Malaty has received research support from Acadia. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
Leigh E. Charvet, PhD	Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Lei Liu, MD, PhD	Dr. Liu has nothing to disclose.
Derrick Robertson, MD	Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Greenwich Biosciences. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mallinckrodt. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PRIME CME. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McVeigh. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mccumber. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodis. The institution of Dr. Robertson has received research support from Biogen. The institution of Dr. Robertson has received research support from EMD Serono. The institution of Dr. Robertson has received research support from Jansenn. The institution of Dr. Robertson has received research support from Genentech. The institution of Dr. Robertson has received research support from Patient-Centered Outcomes Research Institute. The institution of Dr. Robertson has received research support from Novartis. The institution of Dr. Robertson has received research support from Sanofi Genzyme. The institution of Dr. Robertson has received research support from TG Therapeutics. The institution of Dr. Robertson has received research support from Prime. The institution of Dr. Robertson has received research support from Greenwich Biosciences. The institution of Dr. Robertson has received research support from Atara Biotherapeutics. The institution of Dr. Robertson has received research support from CorEvitas. The institution of Dr. Robertson has received research support from Anokion. The institution of Dr. Robertson has received research support from UCB Biosciences. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Consortium of Multiple Sclerosis Centers. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Alfred Balasa, MD	Dr. Balasa has nothing to disclose.
Alice Edwards, DO	The institution of Dr. Rutatangwa has received research support from NIH.
Ryan A. Keating, DO	Dr. Keating has nothing to disclose.
Jason Maljaars	No disclosure on file
Gaurav Thakur, DO	Dr. Thakur has nothing to disclose.
JIANI MOU	No disclosure on file
Elisa Meier-Gerdingh, MD	No disclosure on file
S H. Subramony, MBBS, FAAN	Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fallonmedica. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fulcrum. The institution of Dr. Subramony has received research support from Reata. The institution of Dr. Subramony has received research support from Retrotope. The institution of Dr. Subramony has received research support from Acceleron. The institution of Dr. Subramony has received research support from Biohaven. The institution of Dr. Subramony has received research support from Pharnext. The institution of Dr. Subramony has received research support from Fulcrum. The institution of Dr. Subramony has received research support from National Ataxia Foundation. The institution of Dr. Subramony has received research support from Friedreich Ataxia Research Alliance. The institution of Dr. Subramony has received research support from Muscular Dystrophy Association. The institution of Dr. Subramony has received research support from Univ of Rochester, MDA. The institution of Dr. Subramony has received research support from Virginia Commonwealth Univ (FDA, Wyck Foundation)). The institution of Dr. Subramony has received research support from Children's Hospital, Philadelphia (FDA). The institution of Dr. Subramony has received research support from Houston Methodist (NIH). The institution of Dr. Subramony has received research support from NIHR01 AR076060-01A1 . The institution of Dr. Subramony has received research support from NIH2R42HD089804-04 . The institution of Dr. Subramony has received research support from NIH R01 AR056973 . The institution of Dr. Subramony has received research support from FSHD Society. The institution of Dr. Subramony has received research support from AAVANTI BIO. The institution of Dr. Subramony has received research support from COHAV FL State Dept of Health. The institution of Dr. Subramony has received research support from Avidity. The institution of Dr. Subramony has received research support from PTC. The institution of Dr. Subramony has received research support from Biohaven. The institution of Dr. Subramony has received research support from Fulcrum. The institution of Dr. Subramony has received research support from Vertex. The institution of Dr. Subramony has received research support from Arthrex.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Thomas F. Scott, MD	Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme.
Benjamin R. Brooks, MD, FAAN	Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with ��ɫ�� that is relevant to AAN interests or activities.
Marc Verin	Mr. Verin has nothing to disclose.
Kerstin Hellwig	Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from BMS .
Patrick Waters, PhD	Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UBC. The institution of Dr. Waters has received research support from Guthy-Jackson Charitable Foundation. Dr. Waters has received intellectual property interests from a discovery or technology relating to health care.
Bryan Smith, MD	Dr. Smith has nothing to disclose.
Philipp Albrecht, PhD	Dr. Albrecht has received personal compensation for serving as an employee of Abbvie. Dr. Albrecht has received personal compensation for serving as an employee of Biogen. Dr. Albrecht has received personal compensation for serving as an employee of Bristol Myers Squibb. Dr. Albrecht has received personal compensation for serving as an employee of Ipsen. Dr. Albrecht has received personal compensation for serving as an employee of Merck. Dr. Albrecht has received personal compensation for serving as an employee of Merz. Dr. Albrecht has received personal compensation for serving as an employee of Novartis. Dr. Albrecht has received personal compensation for serving as an employee of Roche. Dr. Albrecht has received personal compensation for serving as an employee of Sanofi. Dr. Albrecht has received personal compensation for serving as an employee of Lilly.
Alberto Esquenazi, MD	Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen and Allergan. Dr. Esquenazi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen and Allergan. The institution of Dr. Esquenazi has received research support from Ipsen, Allergan and Merz.
Sara LaHue, MD	The institution of Dr. LaHue has received research support from National Institute on Aging . The institution of Dr. LaHue has received research support from Larry L. Hillblom Foundation . The institution of Dr. LaHue has received research support from UCSF Claude D. Pepper Older Americans Independence Center . The institution of Dr. LaHue has received research support from UCSF Bakar Aging Research Institute. The institution of Dr. LaHue has received research support from Doris Duke Foundation . The institution of Dr. LaHue has received research support from National Institute on Aging . The institution of Dr. LaHue has received research support from Longevity Impetus Grants. Dr. LaHue has received publishing royalties from a publication relating to health care.
Rosalind S. Chuang, MD	No disclosure on file
Christopher Streib, MD	Dr. Streib has nothing to disclose.
Mark C. Cascione, MD	No disclosure on file
Shivani Ghoshal, MD	Dr. Ghoshal has nothing to disclose.
Paula Barreras, MD	Dr. Barreras has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from ��ɫ��.
Marisela E. Dy-Hollins, MD, MSCR, FAAN	The institution of Dr. Dy-Hollins has received research support from CNCDP-K12.
Kwan Ng, MD, PhD	Dr. Ng has nothing to disclose.
Leslie J. Higuita, MD	Dr. Higuita has nothing to disclose.
Fernando Cendes, MD, PhD, FAAN	Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Erdem Tuzun	Erdem Tuzun has nothing to disclose.
Ricardo F. Allegri, MD, PhD, FAAN	Dr. Allegri has nothing to disclose.
Nerses Bebek, MD, PhD	Dr. Bebek has nothing to disclose.
Anne D. Yacoub, MD	Dr. Yacoub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie.
Jessica McFarlin, MD	Dr. McFarlin has received personal compensation in the range of $500-$4,999 for serving as a Volunteer Faculty with Vital Talk.
Pavel Hok, MD	Dr. Hok has nothing to disclose.
James P. Klaas, MD, FAAN	An immediate family member of Dr. Klaas has received publishing royalties from a publication relating to health care.
Murat Kurtuncu, MD	Dr. Kurtuncu has nothing to disclose.
Stephen J. Kolb, MD, PhD	Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH.
Jeffrey C. Wagner, MD	Dr. Wagner has nothing to disclose.
Heather Adams	The institution of Heather Adams has received research support from Current: NIH; Past: Abeona; Batten Research Alliance; American University Centers on Disabilities. An immediate family member of Heather Adams has received publishing royalties from a publication relating to health care. Heather Adams has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Critical Path Institute.
Murali Ramanathan, PhD	The institution of Dr. Ramanathan has received research support from DoD. Dr. Ramanathan has received publishing royalties from a publication relating to health care.
Thomas Osterholt	No disclosure on file
Justin C. McArthur, MBBS, MPH, FAAN	No disclosure on file
Murray Grossman, MD, FAAN	Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Tamara Vyshkina, PhD	No disclosure on file
Nicte Mejia, MD, MPH, FAAN	Dr. Mejia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mejia has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mejia has received research support from Biogen Foundation.
Violaine K. Harris, PhD	No disclosure on file
Sanjay P. Singh, MD, FAAN	Dr. Singh has nothing to disclose.
Bruno E. Vidal, MD	No disclosure on file
Sebina Bulic, MD	Dr. Bulic has nothing to disclose.
Alejandra Heriz	No disclosure on file
Gloria V. Lopez Cardenas, MD	No disclosure on file
Bruno Colombo	Bruno Colombo has nothing to disclose.
Mary Russo, RNCT	No disclosure on file
Teepu Siddique, MD, FAAN	No disclosure on file
Paolo M. Moretti, MD	The institution of Dr. Moretti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Inc. The institution of an immediate family member of Dr. Moretti has received research support from NIH. The institution of an immediate family member of Dr. Moretti has received research support from VHA. The institution of an immediate family member of Dr. Moretti has received research support from DOD.
Eric M. Reiman, MD	Dr. Reiman has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali, Green Valley, Zinfandel, and Takeda. Dr. Reiman has received stock or an ownership interest from Alkahest, Alzheon, Aural Analytics, Denali, and United Neuroscience.. Dr. Reiman has received intellectual property interests from a discovery or technology relating to health care. Dr. Reiman has received personal compensation in the range of $500-$4,999 for serving as a Member, National Advisory Council on Aging (NACA) with NIA.
Bradley Molyneaux, MD, PhD	Dr. Molyneaux has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Molyneaux has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Billing, Cochran, Lyles, Mauro and Ramsey. The institution of Dr. Molyneaux has received research support from NIH. Dr. Molyneaux has received publishing royalties from a publication relating to health care.
Henrik Zetterberg	Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley and Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions.
Paisith Piriyawat, MD	Dr. Piriyawat has nothing to disclose.
Wendy E. Kaye, PhD	Dr. Kaye has received personal compensation for serving as an employee of McKing Consulting Corporation. Dr. Kaye has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Association for the Protection of Human Research Participants.
Regina Berkovich, MD, PhD	The institution of Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion, Biogen, Genentec, Mallincrodt, Sanofi, Novartis, . Dr. Berkovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Genentec, Sanofi, Merck . Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion, Biogen, Sanofi, Merck, Mallincrodt . The institution of Dr. Berkovich has received research support from Biogen, Sanofi, Merck.
Cem Kucukali	No disclosure on file
Silvia Messina	No disclosure on file
Tianxia Wu	Tianxia Wu has nothing to disclose.
Amelia K. Boehme, PhD	Dr. Boehme has nothing to disclose.
Edoardo G. Spinelli, MD	Dr. Spinelli has nothing to disclose.
Tara A. Kimbrough, MD	Dr. Kimbrough has nothing to disclose.
Jack E. Riggs, MD, FAAN	No disclosure on file
Darryl C. De Vivo, MD, FAAN	Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics.
Steven Jacobson	Steven Jacobson has nothing to disclose.
Richard J. Nowak, MD	Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janseen . The institution of Dr. Nowak has received research support from UCB. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Janseen. The institution of Dr. Nowak has received research support from Immunovant . The institution of Dr. Nowak has received research support from argenx. The institution of Dr. Nowak has received research support from Amgen. Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Coleman Martin, MD	Dr. Martin has nothing to disclose.
Daniel Miller, MD	Dr. Miller has nothing to disclose.
Sanjeeva R. Onteddu, MD, FAAN	Dr. Onteddu has nothing to disclose.
Sahar Zafar, MD	Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Zafar has received research support from NIH. Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker for a lecture with Marinus.
Michael H. Rosenbloom, MD, FAAN	Dr. Rosenbloom has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Esai. Dr. Rosenbloom has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai.
Aashit K. Shah, MD, FAAN	Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma.
Mark Cohen	Mark Cohen has nothing to disclose.
Becky J. Parks, MD	Dr. Parks has received personal compensation for serving as an employee of Alexion Pharmaceuticals. An immediate family member of Dr. Parks has received personal compensation for serving as an employee of Edward P. Evans Foundation. Dr. Parks has stock in Biogen. An immediate family member of Dr. Parks has stock in Regeneron. Dr. Parks has stock in Blueprint Medicines. Dr. Parks has stock in Sanofi. An immediate family member of Dr. Parks has stock in Vertex. Dr. Parks has stock in AstraZeneca. The institution of an immediate family member of Dr. Parks has received research support from NIH/NCI. The institution of an immediate family member of Dr. Parks has received research support from Leukemia & Lymphoma Society. The institution of an immediate family member of Dr. Parks has received research support from AstraZeneca Scholar Award.
Olha Taraschenko, MD, PhD	The institution of Dr. Taraschenko has received research support from NIH. The institution of Dr. Taraschenko has received research support from DHSS LB606 Nebraska Stem Cell Grant . Dr. Taraschenko has received personal compensation in the range of $0-$499 for serving as a Speaker with AES.
Borna Bonakdarpour, MD, FAAN	Dr. Bonakdarpour has nothing to disclose.
Shefali Karkare, MD	Dr. Karkare has nothing to disclose.
Maria C. Curbelo	No disclosure on file
Esther Bui, MD	Dr. Bui has received publishing royalties from a publication relating to health care.
Jennifer R. Friedman, MD	An immediate family member of Dr. Friedman has received personal compensation in the range of $0-$499 for serving as a Consultant for Sinopia Biosciences. An immediate family member of Dr. Friedman has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Pet Dx. Dr. Friedman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Friedman has stock in Friedman Bioventure .
Krishna Nalleballe, MD, FAAN	Dr. Nalleballe has nothing to disclose.
Omar A. Danoun, MD	Dr. Danoun has nothing to disclose.
Nizar Chahin, MD	Dr. Chahin has nothing to disclose.
Bonnie E. Levin, PhD	No disclosure on file
Gian D. Pal, MD	Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CLRM Law. Dr. Pal has stock in Baudax Bio. The institution of Dr. Pal has received research support from National Institutes of Health. The institution of Dr. Pal has received research support from Parkinson's Foundation. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant with RKV Firm.
Michael Phipps, MD, MHS, FAAN	Dr. Phipps has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMJ.
Bichun Ouyang	Bichum Ouyang has nothing to disclose.
Richard Libman, MD, FAAN	Dr. Libman has nothing to disclose.
Marcela Uribe Roca	The institution of Marcela Uribe Roca has received research support from Roche.
Dianalee McKnight, PhD	Dr. McKnight has nothing to disclose.
Aysegul Gunduz	No disclosure on file
Bryan Traynor, MD	The institution of Dr. Traynor has received research support from ALS Association. The institution of Dr. Traynor has received research support from Merck. The institution of Dr. Traynor has received research support from Myasthenia Gravis Foundation. The institution of Dr. Traynor has received research support from Cerevel Therapeutics. Dr. Traynor has received intellectual property interests from a discovery or technology relating to health care.
Nicholas J. Maragakis, MD, FAAN	Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UptoDate. Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharmaceuticals. Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. An immediate family member of Dr. Maragakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for National Basketball Association. Dr. Maragakis has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Akava. An immediate family member of Dr. Maragakis has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Johns Hopkins Howard County Medical Center. Dr. Maragakis has stock in Akava. The institution of Dr. Maragakis has received research support from NIH/NINDS. The institution of Dr. Maragakis has received research support from Department of Defense. The institution of Dr. Maragakis has received research support from Maryland Stem Cell Research Fund. Dr. Maragakis has received intellectual property interests from a discovery or technology relating to health care.
Letizia Mazzini	No disclosure on file
Toni Pearson, MBBS	Dr. Pearson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Dr. Pearson has received research support from NIH.
John T. Slevin, MD, FAAN	Dr. Slevin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Slevin has received research support from Veterans Administration. The institution of Dr. Slevin has received research support from NIH. The institution of Dr. Slevin has received research support from AbbVie. The institution of Dr. Slevin has received research support from NeuroDerm. The institution of Dr. Slevin has received research support from Bukwang-Syneos. The institution of Dr. Slevin has received research support from Takeda.
Chirantan Banerjee, MD, MPH	Dr. Banerjee has nothing to disclose.
Ricardo Alonso	Ricardo Alonso has nothing to disclose.
David K. Li, MD	Dr. Li has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Academy of Health Care Learning. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Consortium of MS Centers.
Tritia R. Yamasaki, MD, PhD, FAAN	The institution of Dr. Yamasaki has received research support from Veteran's Affairs. The institution of an immediate family member of Dr. Yamasaki has received research support from Dept of Energy.
Christopher D. Stephen, MB ChB, FRCP, MSc, SM	The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
Danielle S. Shpiner, MD	An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.
Pablo Bonardo, MD	Dr. Bonardo has nothing to disclose.
Randall Edgell, MD	Dr. Edgell has nothing to disclose.
Katherine L. Possin, PhD	Dr. Possin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ClearView Healthcare Partners. The institution of Dr. Possin has received research support from Quest Diagnostics. The institution of Dr. Possin has received research support from NIH. The institution of Dr. Possin has received research support from The Global Brain Health Institute. The institution of Dr. Possin has received research support from The Rainwater Foundation.
Timothy Spelman	No disclosure on file
James D. Berry, MD MPH	Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene Nanomedicine. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma Holdings of America. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berry has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Berry has stock in ReactNeuro. The institution of Dr. Berry has received research support from Biogen. The institution of Dr. Berry has received research support from MT Pharma of America. The institution of Dr. Berry has received research support from Rapa Therapeutics. The institution of Dr. Berry has received research support from Brainstorm Cell Therapeutics. The institution of Dr. Berry has received research support from Alexion. The institution of Dr. Berry has received research support from nQ Medical. The institution of Dr. Berry has received research support from ALSA. The institution of Dr. Berry has received research support from MDA. The institution of Dr. Berry has received research support from Amylyx. The institution of Dr. Berry has received research support from Transposon. Dr. Berry has a non-compensated relationship as a Scientific Advisor with Everything ALS that is relevant to AAN interests or activities.
Golshan Fahimi, MD	Dr. Fahimi has nothing to disclose.
Maria S. Pacha	No disclosure on file
Musa Ozturk, MD	No disclosure on file
Bogdan I. Patedakis Litvinov, MD	No disclosure on file
Nicholas S. Streicher, MD	Dr. Streicher has nothing to disclose.
Kiran Talekar	An immediate family member of Kiran Talekar has received personal compensation for serving as an employee of Verismo. An immediate family member of Kiran Talekar has received personal compensation for serving as an employee of GSK Pharmaceuticals. An immediate family member of Kiran Talekar has stock in GSK. The institution of Kiran Talekar has received research support from NIH. The institution of Kiran Talekar has received research support from Gates Foundation. An immediate family member of Kiran Talekar has received intellectual property interests from a discovery or technology relating to health care.
Robert J. Thomas, MD	Dr. Thomas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Councils. Dr. Thomas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Thomas has received intellectual property interests from a discovery or technology relating to health care. Dr. Thomas has received publishing royalties from a publication relating to health care.
Lindsay A. Horton, MD	Dr. Horton has nothing to disclose.
David Bearden, MD	Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Bearden has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for law firms.
Hesham Masoud, MD	Dr. Masoud has nothing to disclose.
Genko Oyama, MD, PhD, FAAN	Dr. Oyama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Oyama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Oyama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka Pharmaceutical Co. Ltd.. Dr. Oyama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sumitomo Dainippon Pharma Co. Ltd.. Dr. Oyama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai Co., Ltd.. Dr. Oyama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda Pharmaceutical Company LTD.. Dr. Oyama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Hakko Kirin Co. Ltd.. Dr. Oyama has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie, Inc. The institution of Dr. Oyama has received research support from AbbVie, Inc. The institution of Dr. Oyama has received research support from GLORY LTD. The institution of Dr. Oyama has received research support from Kirin Company LTD. The institution of Dr. Oyama has received research support from Mitsubishi UFJ Lease & Finance Company LTD. The institution of Dr. Oyama has received research support from Sunwels Co., Ltd. The institution of Dr. Oyama has received research support from Ohara Pharmaceutical Co.,Ltd.. The institution of Dr. Oyama has received research support from PARKINSON Laboratories Co., Ltd..
Mohamed Kazamel, MD	Dr. Kazamel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam Pharamceuticals. Dr. Kazamel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea Therapeutics.
Scott Siegert	Mr. Siegert has received personal compensation for serving as an employee of Neurocrine Biosciences. Mr. Siegert has stock in Neurocrine Biosciences.
Rivka Sachdev, MD	No disclosure on file
Giorgia Querin, MD	No disclosure on file
Doreen Ho, MD	Dr. Ho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals.
Madeline C. Fields, MD	Dr. Fields has nothing to disclose.
Shahram Izadyar, MD, FAAN	The institution of Dr. Izadyar has received research support from Xenon Pharmaceuticals. An immediate family member of Dr. Izadyar has received publishing royalties from a publication relating to health care.
Maria Antonietta Mazzola, MD	Dr. Mazzola has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentec.
David Brassat, MD, PhD	No disclosure on file
Laura M. Scorr, MD	Dr. Scorr has received research support from Dystonia Medical Research Foundation.
Florian Eichler, MD	An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atlas Venture. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leal Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orchard Tx. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Therapeutics. The institution of Dr. Eichler has received research support from ASPA Therapeutics. The institution of Dr. Eichler has received research support from Abbvie. The institution of Dr. Eichler has received research support from Ionis Pharmaceuticals.
Corneliu C. Luca, MD	Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
Clara De Andres, MD	No disclosure on file
Tamara Miller, MD	Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics Therapeutics, Abbvie, Genentech. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono, TG Therapeutics, Biogen, Abbvie, Genentech, Lundbeck. The institution of Dr. Miller has received research support from Abbvie, Ipsen, Alexion, Pfizer, BMS, Genentech, ThermoFisher Scientific.
Naoir Zaher, MD	No disclosure on file
Antonio Canosa	Antonio Canosa has nothing to disclose.
Timothy J. Turner	Timothy J. Turner has received personal compensation for serving as an employee of Sanofi. Timothy J. Turner has stock in Sanofi. Timothy J. Turner has received intellectual property interests from a discovery or technology relating to health care.
Beatrice Pignolet	Beatrice Pignolet has nothing to disclose.
David Bar-Or	David Bar-Or has received intellectual property interests from a discovery or technology relating to health care.
Keith Van Haren, MD	Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viking Therapeutics. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebirdbio. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orpheris. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME, Inc. The institution of Dr. Van Haren has received research support from Minoryx. The institution of Dr. Van Haren has received research support from bluebirdbio. Dr. Van Haren has a non-compensated relationship as a Board of Directors with ALD Connect that is relevant to AAN interests or activities. Dr. Van Haren has a non-compensated relationship as a Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities.
Sandra Vanotti	Sandra Vanotti has nothing to disclose.
Emile S. Moukheiber, MD	Dr. Moukheiber has nothing to disclose.
Anke Post	No disclosure on file
Nektaria Alexandri	Nektaria Alexandri has received personal compensation for serving as an employee of Merck Healthcare KGaA.
Sibin Stephen	No disclosure on file
Ryan Gotfrit, MD	No disclosure on file
Catarina D. Correa, MD	No disclosure on file
Jan P. Jurs	Mr. Jurs has nothing to disclose.
Paula Trujillo Diaz	Paula Trujillo Diaz has nothing to disclose.
Leann Lewis	Leann Lewis has nothing to disclose.
Chad Hoyle, MD	Dr. Hoyle has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for National Football League. Dr. Hoyle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avexis. Dr. Hoyle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata. The institution of Dr. Hoyle has received research support from REATA. The institution of Dr. Hoyle has received research support from TAKEDA.
William D. Arnold, MD	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Yian Gu, PhD	The institution of Dr. Gu has received research support from NIH.
Codrin I. Lungu, MD, FAAN	Dr. Lungu has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, inc..
Ian M. Grant, MD	No disclosure on file
Khashayar Dashtipour, MD, PhD	Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for teva. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for abbvie. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acadia. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for kyowa kirin . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal . Dr. Dashtipour has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for neurocrine . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for teva. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for abbvie. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for kyowa Kirin . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ipsen. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for amneal . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Dashtipour has received research support from Abbvie. The institution of Dr. Dashtipour has received research support from ipsen. The institution of Dr. Dashtipour has received research support from amneal.
Barbara Bumstead, NP	Ms. Bumstead has nothing to disclose.
Jose Gutierrez, MD	Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardiovascular Research Foundation. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for White and Rusell. Dr. Gutierrez has received research support from NIH. Dr. Gutierrez has received publishing royalties from a publication relating to health care. Dr. Gutierrez has received publishing royalties from a publication relating to health care.
Kristina M. Fanning, PhD	The institution of Dr. Fanning has received research support from Abbvie. The institution of Dr. Fanning has received research support from NYC Langone Health . The institution of Dr. Fanning has received research support from Uiversity of SC - Irvine. The institution of Dr. Fanning has received research support from AESARA.
Björn Tackenberg, MD, FAAN	Dr. Tackenberg has received personal compensation for serving as an employee of F. Hoffmann-La Roche AG. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GILEAD. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tackenberg has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck Serono. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Tackenberg has received stock or an ownership interest from F. Hoffmann-La Roche AG. The institution of Dr. Tackenberg has received research support from Biogen. The institution of Dr. Tackenberg has received research support from Novartis. The institution of Dr. Tackenberg has received research support from Roche.
Myassar Zarif	Myassar Zarif has nothing to disclose.
Berenice Silva	SIlva Berenice has nothing to disclose.
Etsegenet F. Tizazu, MD	No disclosure on file
Sean Selva	Sean Selva has nothing to disclose.
Daniel S. Newman, MD	Dr. Newman has nothing to disclose.
Eva-Maria Wicklein, MD	Dr. Wicklein has received personal compensation for serving as an employee of Bayer AG.
Wolfgang Brueck, PhD	Dr. Brueck has nothing to disclose.
Tigran Kesayan, MD	Dr. Kesayan has nothing to disclose.
Henry P. Moore, MD	Dr. Moore has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC. The institution of Dr. Moore has received research support from University of Kansas Center for Research.
Kristin Salottolo, MPH	Ms. Salottolo has nothing to disclose.
Emily J. Gilmore, MD	Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
Joy Z. Ding, MD	No disclosure on file
Majid Kerolous, PharmD, MPH	No disclosure on file
Estevana Isaac, MD	Dr. Isaac has nothing to disclose.
Areeba Siddiqui, MD	Dr. Siddiqui has nothing to disclose.
Glen Raffel, MD, PhD	No disclosure on file
Sumire Sato	No disclosure on file
Ali H. Abusrair, MD	Dr. Abusrair has nothing to disclose.
Cynthia Jones, PhD	Dr. Jones has received personal compensation for serving as an employee of Biogen. Dr. Jones has received stock or an ownership interest from Biogen.
Brin Freund, MD	Dr. Freund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Freund has received research support from Mayo Clinic.
Michael Rubenstein, MD, FAAN	Dr. Rubenstein has nothing to disclose.
Tiffany Lee	No disclosure on file
Stephanie Lyden, MD	Dr. Lyden has nothing to disclose.
Thomas Dehmel	No disclosure on file
Urvi G. Desai, MD, FAAN	Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Andrei Ivashynka, MD, PhD	Dr. Ivashynka has nothing to disclose.
Roberta Messina, MD, PhD	Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Organon. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly.
Mark M. Stecker, MD, FAAN	No disclosure on file
Gerolama Marfia	No disclosure on file
Luke Whitmire, PhD	No disclosure on file
Patrizia Casaccia, MD, PhD	No disclosure on file
Camilo Diaz-Cruz, MD	Dr. Diaz-Cruz has nothing to disclose.
Sarah H. Ying, MD	Dr. Ying has nothing to disclose.
Stuart D. Cook, MD, FAAN	No disclosure on file
Noah Rosen, MD, FAAN	Dr. Rosen has received personal compensation for serving as an employee of Northwell Health. An immediate family member of Dr. Rosen has received personal compensation for serving as an employee of New York University. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer . Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. Dr. Rosen has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer.
Sana Syed, DO	No disclosure on file
Igor J. Koralnik, MD, FAAN	Dr. Koralnik has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Investigation. The institution of Dr. Koralnik has received research support from National Institutes of Health. Dr. Koralnik has received publishing royalties from a publication relating to health care.
Stanley L. Cohan, MD, PhD, FAAN	Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb (Celgene). Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Icometrix. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi genzyme. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Icometrix.
Guangbin Xia, MD, PhD	No disclosure on file
Susan A. Eaton, PharmD	No disclosure on file
Daniel Noriega	No disclosure on file
Kjell Svensson	Kjell Svensson has received personal compensation for serving as an employee of Eli Lilly.
Jeremy D. Schmahmann, MD, FAAN	Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
Sheena K. Aurora, MD	Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
Tetsuo Ashizawa, MD, FAAN	An immediate family member of Dr. Ashizawa has received personal compensation for serving as an employee of Biopath Holdings. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cadence. Dr. Ashizawa has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. The institution of Dr. Ashizawa has received research support from NIH. The institution of Dr. Ashizawa has received research support from National Ataxia Foundation. The institution of Dr. Ashizawa has received research support from Myotonic Dystrophy Foundation. The institution of Dr. Ashizawa has received research support from Biogen.
Marco Salvetti, MD	Dr. Salvetti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sanofi. Dr. Salvetti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. The institution of Dr. Salvetti has received research support from bms.
Darren P. Baker, PhD	Dr. Baker has received personal compensation for serving as an employee of Sanofi. Dr. Baker has received stock or an ownership interest from Sanofi.
Pamela Rist, PhD	The institution of Dr. Rist has received research support from National Institutes of Health. The institution of Dr. Rist has received research support from Brigham and Women's Hospital. The institution of Dr. Rist has received research support from American Heart Association. The institution of Dr. Rist has received research support from Mars Edge.
Mariela Bettini, MD	Dr. Bettini has nothing to disclose.
Jihad S. Inshasi, MD, MBBS, FAAN	Dr. Inshasi has nothing to disclose.
Roberto Furlan	Roberto Furlan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Roberto Furlan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Roberto Furlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Roberto Furlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Roberto Furlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Roberto Furlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS.
Pascal Maisonobe	Pascal Maisonobe has received personal compensation for serving as an employee of ipsen pharma. Pascal Maisonobe has received personal compensation for serving as an employee of Ipsen.
Edward J. Gettings, DO	Dr. Gettings has nothing to disclose.
Joan Largent, PhD	No disclosure on file
Samar F. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Balaji Krishnaiah, MD, FAAN	Dr. Krishnaiah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ACP. Dr. Krishnaiah has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Merck Manual. Dr. Krishnaiah has received publishing royalties from a publication relating to health care.
Elizabeth Horne	No disclosure on file
Camelia Valhuerdi Porto, MD	Dr. Valhuerdi Porto has nothing to disclose.
Susan L. Perlman, MD	Dr. Perlman has nothing to disclose.
Sheng-Han Kuo, MD, FAAN	Dr. Kuo has nothing to disclose.
Wolfgang Jost	Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbive. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stada. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stada. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial.
Gloria Dalla Costa	No disclosure on file
Carla F. Bolano Diaz, MD	Dr. Bolano Diaz has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��